
<html lang="en"     class="pb-page"  data-request-id="fdd5744e-f465-49b9-a46a-5f466de3c0a3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm101414h;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2011.54.issue-6;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="1-[(1-Methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 Positive Allosteric Modulators for the Treatment of Psychosis" /></meta><meta name="dc.Creator" content="Lei  Zhang" /></meta><meta name="dc.Creator" content="Michael A.  Brodney" /></meta><meta name="dc.Creator" content="John  Candler" /></meta><meta name="dc.Creator" content="Angela C.  Doran" /></meta><meta name="dc.Creator" content="Allen J.  Duplantier" /></meta><meta name="dc.Creator" content="Ivan V.  Efremov" /></meta><meta name="dc.Creator" content="Edel  Evrard" /></meta><meta name="dc.Creator" content="Kenneth  Kraus" /></meta><meta name="dc.Creator" content="Alan H.  Ganong" /></meta><meta name="dc.Creator" content="Jessica A.  Haas" /></meta><meta name="dc.Creator" content="Ashley N.  Hanks" /></meta><meta name="dc.Creator" content="Keith  Jenza" /></meta><meta name="dc.Creator" content="John T.  Lazzaro" /></meta><meta name="dc.Creator" content="Noha  Maklad" /></meta><meta name="dc.Creator" content="Sheryl A.  McCarthy" /></meta><meta name="dc.Creator" content="Weimin  Qian" /></meta><meta name="dc.Creator" content="Bruce N.  Rogers" /></meta><meta name="dc.Creator" content="Melinda D.  Rottas" /></meta><meta name="dc.Creator" content="Christopher J.  Schmidt" /></meta><meta name="dc.Creator" content="Judith A.  Siuciak" /></meta><meta name="dc.Creator" content="F. David  Tingley, III" /></meta><meta name="dc.Creator" content="Andy Q.  Zhang" /></meta><meta name="dc.Description" content="A novel series of mGluR2 positive allosteric modulators (PAMs), 1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines, is herein disclosed. Structure−activity relationship studies led to potent..." /></meta><meta name="Description" content="A novel series of mGluR2 positive allosteric modulators (PAMs), 1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines, is herein disclosed. Structure−activity relationship studies led to potent..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 2, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm101414h" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm101414h" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm101414h" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm101414h" /></link>
        
    
    

<title>1-[(1-Methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 Positive Allosteric Modulators for the Treatment of Psychosis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm101414h" /></meta><meta property="og:title" content="1-[(1-Methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 Positive Allosteric Modulators for the Treatment of Psychosis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0015.jpeg" /></meta><meta property="og:description" content="A novel series of mGluR2 positive allosteric modulators (PAMs), 1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines, is herein disclosed. Structure−activity relationship studies led to potent, selective mGluR2 PAMs with excellent pharmacokinetic profiles. A representative lead compound (+)-17e demonstrated dose-dependent inhibition of methamphetamine-induced hyperactivity and mescaline-induced scratching in mice, providing support for potential efficacy in treating psychosis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm101414h"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm101414h">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm101414h&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm101414h&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm101414h&amp;href=/doi/10.1021/jm101414h" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 1724-1739</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm101354u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm101421d" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">1-[(1-Methyl-1<i>H</i>-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 Positive Allosteric Modulators for the Treatment of Psychosis</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Zhang">Lei Zhang</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Brodney">Michael A. Brodney</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Candler">John Candler</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela+C.++Doran">Angela C. Doran</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allen+J.++Duplantier">Allen J. Duplantier</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ivan+V.++Efremov">Ivan V. Efremov</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edel++Evrard">Edel Evrard</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth++Kraus">Kenneth Kraus</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+H.++Ganong">Alan H. Ganong</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jessica+A.++Haas">Jessica A. Haas</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ashley+N.++Hanks">Ashley N. Hanks</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith++Jenza">Keith Jenza</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+T.++Lazzaro">John T. Lazzaro</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Noha++Maklad">Noha Maklad</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sheryl+A.++McCarthy">Sheryl A. McCarthy</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weimin++Qian">Weimin Qian</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+N.++Rogers">Bruce N. Rogers</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melinda+D.++Rottas">Melinda D. Rottas</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Schmidt">Christopher J. Schmidt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Judith+A.++Siuciak">Judith A. Siuciak</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=F.+David++Tingley%2C++III">F. David Tingley, III</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andy+Q.++Zhang">Andy Q. Zhang</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: +1-860-441-4116. Fax: +1-860-715-0225. E-mail: <a href="/cdn-cgi/l/email-protection#69250c0047330108070e5a29190f00130c1b470a0604"><span class="__cf_email__" data-cfemail="175b727e394d7f767970245767717e6d72653974787a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm101414h&amp;href=/doi/10.1021%2Fjm101414h" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 1724–1739</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 2, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 November 2010</li><li><span class="item_label"><b>Published</b> online</span>2 March 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 March 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm101414h" title="DOI URL">https://doi.org/10.1021/jm101414h</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1724%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLei%2BZhang%252C%2BMichael%2BA.%2BBrodney%252C%2BJohn%2BCandler%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D6%26contentID%3Djm101414h%26title%3D1-%255B%25281-Methyl-1H-imidazol-2-yl%2529methyl%255D-4-phenylpiperidines%2Bas%2BmGluR2%2BPositive%2BAllosteric%2BModulators%2Bfor%2Bthe%2BTreatment%2Bof%2BPsychosis%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1739%26publicationDate%3DMarch%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm101414h"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2252</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">19</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm101414h" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;1-[(1-Methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 Positive Allosteric Modulators for the Treatment of Psychosis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Brodney&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Candler&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;C. Doran&quot;},{&quot;first_name&quot;:&quot;Allen&quot;,&quot;last_name&quot;:&quot;J. Duplantier&quot;},{&quot;first_name&quot;:&quot;Ivan&quot;,&quot;last_name&quot;:&quot;V. Efremov&quot;},{&quot;first_name&quot;:&quot;Edel&quot;,&quot;last_name&quot;:&quot;Evrard&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;Kraus&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;H. Ganong&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;A. Haas&quot;},{&quot;first_name&quot;:&quot;Ashley&quot;,&quot;last_name&quot;:&quot;N. Hanks&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;Jenza&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;T. Lazzaro&quot;},{&quot;first_name&quot;:&quot;Noha&quot;,&quot;last_name&quot;:&quot;Maklad&quot;},{&quot;first_name&quot;:&quot;Sheryl&quot;,&quot;last_name&quot;:&quot;A. McCarthy&quot;},{&quot;first_name&quot;:&quot;Weimin&quot;,&quot;last_name&quot;:&quot;Qian&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;N. Rogers&quot;},{&quot;first_name&quot;:&quot;Melinda&quot;,&quot;last_name&quot;:&quot;D. Rottas&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Schmidt&quot;},{&quot;first_name&quot;:&quot;Judith&quot;,&quot;last_name&quot;:&quot;A. Siuciak&quot;},{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;David Tingley&quot;},{&quot;first_name&quot;:&quot;Andy&quot;,&quot;last_name&quot;:&quot;Q. Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;1724-1739&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm101414h&quot;},&quot;abstract&quot;:&quot;A novel series of mGluR2 positive allosteric modulators (PAMs), 1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines, is herein disclosed. Structure−activity relationship studies led to potent, selective mGluR2 PAMs with excellent pharmacokinetic profiles. A representative lead compound (+)-17e demonstrated dose-dependent inhibition of methamphetamine-induced hyperactivity and mescaline-induced scratching in mice, providing support for potential efficacy in treating psychosis.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101414h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101414h" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101414h&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101414h" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm101414h&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101414h" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm101414h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm101414h&amp;href=/doi/10.1021/jm101414h" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm101414h" /></input><a href="/doi/pdf/10.1021/jm101414h" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm101414h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm101414h%26sid%3Dliteratum%253Aachs%26pmid%3D21366332%26genre%3Darticle%26aulast%3DZhang%26date%3D2011%26atitle%3D1-%255B%25281-Methyl-1H-imidazol-2-yl%2529methyl%255D-4-phenylpiperidines%2Bas%2BmGluR2%2BPositive%2BAllosteric%2BModulators%2Bfor%2Bthe%2BTreatment%2Bof%2BPsychosis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D6%26spage%3D1724%26epage%3D1739%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291713" title="Polyacrylamide">Polyacrylamide</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291870" title="Piperidines">Piperidines</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jmcmar.2011.54.issue-6/production/jmcmar.2011.54.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel series of mGluR2 positive allosteric modulators (PAMs), 1-[(1-methyl-1<i>H</i>-imidazol-2-yl)methyl]-4-phenylpiperidines, is herein disclosed. Structure−activity relationship studies led to potent, selective mGluR2 PAMs with excellent pharmacokinetic profiles. A representative lead compound (+)-<b>17e</b> demonstrated dose-dependent inhibition of methamphetamine-induced hyperactivity and mescaline-induced scratching in mice, providing support for potential efficacy in treating psychosis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Group II metabotropic glutamate receptors (mGluR2 and 3) are widely expressed in the forebrain and localized presynaptically, serving as inhibitors of neurotransmission.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Activation of these receptors by orthosteric agonists, such as LY-354,740 [(1<i>S</i>,2<i>S</i>,5<i>R</i>,6<i>S</i>)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate monohydrate], led to robust activity in a number of animal models that have been used to predict antipsychotic activity.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Consistent with these animal studies, LY-2,140,023, a methionine amide pro-drug of the selective mGluR2/3 agonist, LY-404,039 [(−)-(1<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>S</i>)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid], was shown to be efficacious in improving both positive and negative symptoms in a recent 4 week phase IIb schizophrenia trial.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Subsequently, preclinical studies revealed that the antipsychotic effect of mGluR2/3 agonists is absent in mGluR2 knockout mice but not mGluR3 knockout mice, suggesting mGluR2 as the main receptor responsible for the antipsychotic efficacy.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Because of the high degree of homology at the orthosteric sites of group II mGluRs, selective mGluR2 agonists have been difficult to design. Positive allosteric modulators (PAMs) provide an opportunity to achieve potentially greater subtype selectivity due to significant sequence differences in the transmembrane domain where modulators bind.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Additional advantages of PAMs include the potential for reduced receptor desensitization<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and structurally diverse lead compounds with physicochemical properties suitable for passive brain penetration. Several structural classes of mGluR2 PAMs have been reported,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> including recent disclosures by our group.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Herein, we describe a novel series of 1-[(1-methyl-1<i>H</i>-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 PAMs, which demonstrated robust in vivo efficacy in rodent psychosis models.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">In an effort to obtain chemical matter with mGluR2 subtype selectivity and central nervous system (CNS) druglike properties, we initiated an in-house high-throughput screen (HTS) of over 1.2 million compounds using a mGluR2 functional fluorescence imaging plate reader (FLIPR) assay that uses a stable human embryonic kidney (HEK) cell line expressing the rat mGluR2 receptor.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Multiple hits were identified including phenyl piperazine <b>1</b> and pyrimidinyl piperidine <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Compound <b>1</b> demonstrated reasonable potency but had a high molecular weight (MWt), whereas compound <b>2</b> had good overall physicochemical properties but weaker potency. Combining fragments from both chemotypes led to an exciting new aryl piperidine series exemplified by compound <b>3</b>. This series offered the potential to possess many CNS druglike characteristics, including low MWt and cLogP, potent in vitro activity, excellent passive permeability as measured by MDCK (Madin−Darby canine kidney) AB, and no multiple drug-resistant (MDR) liability.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Upon further profiling in in vitro absorption, distribution, metabolism, and excretion (ADME) assays and a selectivity panel of CNS receptors,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> compound <b>3</b> was found to have high in vitro clearance in rat and human liver microsomes (<i>r</i>-CLh, >65.5 mL/min/kg; <i>h</i>-CLh, 17.3 mL/min/kg) and potent D<sub>2</sub> affinity (<i>K</i><sub>i</sub> = 426 nM) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Subsequent testing in D<sub>2</sub> functional assay confirmed that compound <b>3</b> was a D<sub>2</sub> antagonist (EC<sub>50</sub> = 951 nM).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> It is well known that D<sub>2</sub> antagonists, such as haloperidol, have potent effects in preclinical psychosis animal models.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Thus, carrying D<sub>2</sub> antagonism as an off-target activity could confound the outcomes from in vivo efficacy models and prevent a clear read on a given compound's antipsychotic efficacy that is truly mediated by the mGluR2 PAM activity. Hence, our chemistry efforts were focused on developing a structure−activity relationship (SAR) around compound <b>3</b>, seeking to improve potency, increase microsomal stability, and remove the D<sub>2</sub> affinity.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0016.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Origin of the 1-[(1-methyl-1<i>H</i>-imidazol-2-yl)methyl]-4-phenylpiperidine series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13460" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13460" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The syntheses of analogues <b>7a</b>−<b>q</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) are illustrated in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Substituted 4-aryl piperidines <b>6</b> were readily prepared either from 4-bromopyridine via a Suzuki coupling with various aryl boronic acids followed by hydrogenation of the pyridine ring or from Boc-protected piperidinone <b>4</b> via a four-step synthetic sequence involving enol triflate formation, Suzuki coupling, hydrogenation of resulting olefin intermediate <b>5</b>, and subsequent Boc removal. Finally, reductive amination of <b>6</b> with imidazolyl aldehydes <b>8a</b>−<b>e</b><a onclick="showRef(event, 'cit8a'); return false;" href="javascript:void(0);" class="ref cit8a">(8a)</a> provided analogues <b>7a</b>−<b>q</b> bearing structural variations on R<sup>1</sup> and the aryl group.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, Ar−B(OH)<sub>2</sub>, NaHCO<sub>3</sub>, DME/H<sub>2</sub>O, reflux; 4 N HCl in dioxane, CH<sub>2</sub>Cl<sub>2</sub>, then triturated with Et<sub>2</sub>O. (b) PtO<sub>2</sub>, H<sub>2</sub> (40 psi), MeOH, room temperature. (c) LDA, PhN(CF<sub>3</sub>SO<sub>2</sub>)<sub>2</sub>, THF, −78 °C to room temperature. (d) PdCl<sub>2</sub>dppf, Ar−B(OH)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O (2:1), 50 °C. (e) Pd/C or PtO<sub>2</sub>, H<sub>2</sub> (40 psi), EtOH, room temperature. (f) 2 N HCl in Et<sub>2</sub>O, Et<sub>2</sub>O, room temperature. (g) Compound <b>8a</b>−<b>e</b>, Et<sub>3</sub>N, MgSO<sub>4</sub>, then Na(OAc)<sub>3</sub>BH, CH<sub>2</sub>Cl<sub>2</sub>, room temperature.</p></p></figure><div class="NLM_p">Analogues <b>13</b>−<b>16</b> bearing various substituents on the piperidine ring (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) were synthesized via routes outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Hydroboration of olefin <b>9</b><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> followed by debenzylation gave piperidine intermediate <b>10a</b> (<i>trans</i>-/<i>cis</i>-isomer 7:3), which upon standard reductive amination with imidazolyl aldehyde <b>8b</b> yielded <i>trans</i>-3-hydroxyl-4-phenyl piperidine analog <b>13</b>. 2-Methyl-4-phenyl piperidine analogue <b>14</b> was synthesized through a three-step sequence from 2-methyl-4-bromopyridine involving a Suzuki coupling, hydrogenation of the pyridine ring, and reductive amination, similar to what is described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Syntheses of analogues <b>15</b> and <b>16</b> started with a Grignard addition to <i>N</i>-benzyl ketones <b>11</b> and <b>12</b>. The resulting tertiary alcohols were methylated and submitted to hydrogenation under strongly acidic conditions, which reduced the olefin and removed the benzyl group in one-pot to give substituted piperidines <b>10c</b> and <b>10d</b>. Standard reductive amination then afforded desired analogues <b>15</b> and <b>16</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaBH<sub>4</sub>, BF<sub>3</sub>·Et<sub>2</sub>O, diglyme; then H<sub>2</sub>O<sub>2</sub>, NaOH. (b) Pd/C(10%), ammonium formate, MeOH, reflux. (c) Compound <b>8b</b>, Et<sub>3</sub>N, MgSO<sub>4</sub>, then Na(OAc)<sub>3</sub>BH, CH<sub>2</sub>Cl<sub>2</sub>, room temperature. (d) Ar−B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, DME/H<sub>2</sub>O (1:1); 4 N HCl in dioxane, DCM, then triturated with Et<sub>2</sub>O. (e) PtO<sub>2</sub>, H<sub>2</sub> (40 psi), 70 °C. (f) 1-Bromo-4-trifluoromethyl benzene, Mg, THF, 35−40 °C; then <b>11</b> or <b>12</b>, Et<sub>2</sub>O, 5 °C to room temperature. (g) NaH, MeI, DMF, 45 °C. (h) Concentrated HCl, 10% Pd/C (10%), MeOH, H<sub>2</sub> (40 psi), 85 °C.</p></p></figure><div class="NLM_p"><i>cis</i>-3-Methyl-4-phenyl piperidine analogues <b>17a</b>−<b>e</b> were prepared from readily available 4-bromo-3-methyl pyridine as illustrated in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Suzuki coupling with aryl boronic acids followed by hydrogenation at elevated temperature gave 3-methyl-substituted piperidines <b>18a</b>−<b>e</b> in high yields (>90%). Reductive amination of <b>18a</b>−<b>e</b> with imdazolyl aldehyde <b>8b</b> afforded the desired racemic analogues <b>17a</b>−<b>e</b>. The corresponding (+)- and (−)-enantiomers were separated by chiral separation using Chiralpak AD columns. Alternatively, chiral separation of racemic piperidine precursors, <b>18a</b>−<b>e</b>, yielded (+)- and (−)-enantiomers, which upon reductive amination gave the corresponding (+)- and (−)-enantiomers of final analogues <b>17a</b>−<b>e</b>. The absolute stereochemistry of the active (+)-enantiomers was determined to be (<i>R</i>,<i>R</i>)- via X-ray analysis of the ditoluoyl-<span class="smallcaps smallerCapital">l</span>-tartaric acid salt of the corresponding amine precursors as exemplified by (+)-<b>18d</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ar−B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, DME/H<sub>2</sub>O (1:1); 4 N HCl in dioxane, DCM, then triturated with Et<sub>2</sub>O. (b) PtO<sub>2</sub>, H<sub>2</sub> (40 psi), EtOH, 50 °C. (c) Compound <b>8b</b>, Et<sub>3</sub>N, MgSO<sub>4</sub>, then Na(OAc)<sub>3</sub>BH, CH<sub>2</sub>Cl<sub>2</sub>, room temperature.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25245" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25245" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We began our SAR studies by exploring substitutions on the terminal phenyl ring of compound <b>3</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Halogens and simple alkyls (<b>7b</b>−<b>e</b>,<b>h</b>−<b>j</b>) were preferred, and substitution at the ortho- or para-position appeared optimal for potency (<b>7b</b> and <b>7d</b> vs <b>7c</b>). While a wide range of substituents were tolerated, polar groups, such as nitrile (<b>7f</b>) or methyl amide (<b>7g</b>), in general led to a significant loss of activity. The high microsomal clearance issue identified in the lead <b>3</b> was effectively addressed by strategically placing substituents at the para-position (<b>7h</b> vs <b>7b</b>), possibly by blocking a site-specific metabolism. Analogues bearing para-substitutions (<b>7d</b> and <b>7i</b>) consistently had improved microsomal stability as compared to their ortho-substituted counterparts (<b>7b</b> and <b>7j</b>). Lowering the lipophilicity by incorporating a polar pyridyl nitrogen (<b>7k</b>−<b>n</b>) at the benzimidazole ring led to a further decrease in microsomal clearance, and <b>7k</b> had the best balance of potency (EC<sub>50</sub> = 48 nM) and microsomal stability (<i>h</i>-CL<sub>h</sub> = <5.3 mL/min/kg). Combining the optimal moieties yielded the most promising ortho, para-disubstituted analogues, exemplified by <b>7o</b>−<b>q</b>, which had superior potency and microsomal stability profiles as compared to the original lead <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. mGluR2 Functional Activity, D<sub>2</sub> Binding Affinity, and in Vitro Human Microsomal Clearances of Analogues <b>3</b> and <b>7a</b>−<b>q</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0004.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0005.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0006.gif" alt="" id="fx7" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values obtained from rat mGluR2 receptor transfected HEK cell line using FLIPR method in the presence of glutamate (EC<sub>10−20</sub>); geometric mean (95% confidence interval); an EC<sub>50</sub> value >10 000 indicates that no curve was noted in the dose−response up to 10 μM.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last"><i>K</i><sub>i</sub> values obtained from a D<sub>2</sub> binding assay using rat corpus striatum tissue prep with [<sup>3</sup>H]-spiperone as the radioligand.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Predicted hepatic clearance (<i>h</i>-CLh) from human liver microsomal stability assay.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">ND, not determined.</p></div></div></div><div class="NLM_p">While progress had been made in improving potency and microsomal stability, D<sub>2</sub> binding remained an unresolved issue. Simple halogens such as −F and −Cl, which were optimal for mGluR2 potency, also introduced the most potent D<sub>2</sub> activities (<b>7b</b>, <b>7d</b>, and <b>7h</b>). Converting the benzimidazole moiety to the aza-benzimidazoles had no effect on D<sub>2</sub> selectivity (<b>7i</b> vs <b>7k</b> and <b>7l</b>). While selected bulky aryl substituents, such as trifluoromethyl or alkoxy (<b>7i</b> and <b>7o</b>), demonstrated a slight reduction in D<sub>2</sub> affinity, a general approach to reduce D<sub>2</sub> affinity that allows the incorporation of optimal aryl substituents for mGluR2 potency such as simple halogens would be preferred.</div><div class="NLM_p">Comparing compound <b>7d</b> (D<sub>2</sub><i>K</i><sub>i</sub> = 24 nM) to known D<sub>2</sub> antagonists, such as haloperidol (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), revealed close resemblance in the aryl piperidine region. We reasoned that suitable substitutions on the piperidine linker could induce a conformational change of the terminal phenyl ring, which in turn could influence D<sub>2</sub> affinity. Computer modeling (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b) suggested that significant conformational changes in the terminal phenyl region could be induced by incorporation of a <i>cis</i>-3-methyl substitution (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a, compound B vs compound A), with the torsional angle between the terminal phenyl ring and the piperidine ring shifted from 118.1° to 138.5°. As a comparison, <i>cis</i>-2-methyl substitution was predicted to have no impact on the conformation of the terminal phenyl ring (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a, compound C vs compound A), therefore offering no potential differentiation in D<sub>2</sub> affinity.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0007.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Structure comparison of lead compounds to haloperidol; (b) comparison of potential conformation changes induced by <i>cis</i>-3-methyl or <i>cis</i>-2-methyl substitutions. Ligand minimizations were performed using Schrodinger's MacroModel software, and the resulting conformers were superimposed to provide the best overlap.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To test this hypothesis, a group of analogues bearing substitutions at the 2- or 3-position of the piperidine linker were examined (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Polar groups, such as hydroxyl (<b>13</b>), led to complete loss of mGluR2 activity. Substitutions at the 2-position had no effect on D<sub>2</sub> affinity as evidenced by analogue <b>14</b> and <b>15</b>, consistent with the prediction of the computer modeling. On the other hand, substitutions at the 3-position decreased D<sub>2</sub> binding (<b>16</b> and <b>17a</b>, <i>K</i><sub>i</sub> > 2800 nM), while still maintaining reasonable mGluR2 activity. The <i>cis</i>-3-methyl-4-phenyl analogue <b>17a</b> was particularly exciting, as its (+)-enantiomer, obtained upon chiral separation, was equipotent (EC<sub>50</sub> = 33 nM) to the parent piperidine analogue <b>7k</b>, with no D<sub>2</sub> affinity (<i>K</i><sub>i</sub> > 2800 nM). It is also worth noting that the mGluR2 activity of <b>17a</b> resides mainly in its (+)-enantiomer, as the corresponding (−)-enantiomer was much weaker.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of Substitutions on the Piperidine Linker</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0008.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0009.gif" alt="" id="fx4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values obtained from rat mGluR2 receptor transfected HEK cell line using FLIPR method in the presence of glutamate (EC<sub>10−20</sub>); geometric mean (95% confidence interval); an EC<sub>50</sub> value >10 000 indicates that no curve was noted in the dose−response up to 10 μM.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last"><i>K</i><sub>i</sub> values obtained from a D<sub>2</sub> binding assay using rat corpus striatum tissue prep with [<sup>3</sup>H]-spiperone as the radioligand; a <i>K</i><sub>i</sub> value >2800 nM indicates that no curve was noted in the dose−response up to 2800 nM.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">ND, not determined.</p></div></div></div><div class="NLM_p">We next examined whether the D<sub>2</sub> selectivity of <b>17a</b> could be expanded to analogues with aryl substituents that offer optimized mGluR2 activity and microsomal stability (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). We were gratified to see that 3-methyl substitution proved to be a general and effective way to remove the undesired D<sub>2</sub> affinity, even for analogues bearing simple halogen substitutions (<b>17b</b>). In all cases, (+)-enantiomers were not only much more potent (up to >100-fold) but also more stable in human liver microsome than their corresponding (−)-enantiomers and had excellent D<sub>2</sub> selectivity that was lacking in the original lead.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of <i>cis</i>-3-Methyl-4-aryl Piperidine Analogues <b>17b</b>−<b>e</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0010.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0011.gif" alt="" id="fx6" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values obtained from mGluR2 receptor transfected HEK cell line using FLIPR method in the presence of glutamate (EC<sub>10−20</sub>); geometric mean (95% confidence interval); an EC<sub>50</sub> value >10 000 indicates that no curve was noted in the dose−response up to 10 μM.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last"><i>K</i><sub>i</sub> values obtained from a D<sub>2</sub> binding assay using rat corpus striatum tissue prep with [<sup>3</sup>H]-spiperone as the radioligand.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Predicted hepatic clearance (<i>h</i>-CLh) from human liver microsomal stability assay.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">ND, not determined.</p></div></div></div><div class="NLM_p">A selected cohort of representative compounds, <b>7k</b> and (+)-<b>17c</b>−<b>e</b>, were evaluated in a FLIPR assay using a HEK cell line transfected with human mGluR2 receptor (<i>h</i>-mGluR2). As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, the EC<sub>50</sub> values generated of these representative compounds in the <i>h</i>-mGluR2 assay were comparable to the corresponding <i>r</i>-mGluR2 values with no significant species difference observed. The <i>cis</i>-2-methyl substitution on the central piperidine ring played an essential role in reducing the D<sub>2</sub> affinities of analogues (+)-<b>17c</b>−<b>e</b>, improving the selectivity to over 100-fold from less than 10-fold observed with earlier analogues (<b>3</b> and <b>7k</b>). In subsequent pharmacokinetic (PK) studies, analogues (+)-<b>17c</b>−<b>e</b> also demonstrated the favorable PK profiles that were comparable to compound <b>7k</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), including high permeability (MDCK AB > 10 × 10<sup>−6</sup> cm/s), no P-glycoprotein (P-gp) liability (MDR BA/AB < 2.5), and excellent brain penetrations in both mice and rats. However, the brain fractions unbound (Fu_brain) of analogues (+)-<b>17c</b>−<b>e</b> were low (0.3−0.6%), which appeared to be a general trait of the potent compounds in this structure series. The improved in vitro microsomal stability of analogues <b>7k</b>, (+)-<b>17d</b>, and (+)-<b>17e</b> translated into low in vivo clearances very nicely, giving rat clearances (<i>r</i>-CLh) ranging from 4.5 to 7.5 mL/min/kg. The low in vivo clearances coupled with the high permeabilities predicted good oral bioavailabilities, which were confirmed (50−100%) in subsequent oral PK studies, with excellent exposures achieved in brain. The nice balance of potencies, selectivities,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and in vivo PK properties rendered analogues (+)-<b>17c</b>−<b>e</b> as useful tools to evaluate the in vivo pharmacology of mGluR2 PAM activity in rodent psychosis models.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro and in Vivo PK Properties of Representative Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>7k</b></th><th class="colsep0 rowsep0" align="center">(+)-<b>17c</b></th><th class="colsep0 rowsep0" align="center">(+)-<b>17d</b></th><th class="colsep0 rowsep0" align="center">(+)-<b>17e</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>r</i>-mGluR2 EC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">48 nM</td><td class="colsep0 rowsep0" align="left">22 nM</td><td class="colsep0 rowsep0" align="left">9 nM</td><td class="colsep0 rowsep0" align="left">35 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>h</i>-mGluR2 EC<sub>50</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">43 nM</td><td class="colsep0 rowsep0" align="left">76 nM</td><td class="colsep0 rowsep0" align="left">3 nM</td><td class="colsep0 rowsep0" align="left">31 nM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>2</sub> selectivity</td><td class="colsep0 rowsep0" align="left">8×</td><td class="colsep0 rowsep0" align="left">>239×</td><td class="colsep0 rowsep0" align="left">>584×</td><td class="colsep0 rowsep0" align="left">>133×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDCK AB (10<sup>−6</sup> cm/s)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDR BA/AB<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B/P (mouse)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn10" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B/P (rat)<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Fu_brain<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.6%</td><td class="colsep0 rowsep0" align="left">0.5%</td><td class="colsep0 rowsep0" align="left">0.3%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vivo <i>r</i>-CLh (mL/min/kg)<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">5.4</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oral bioavailability<a class="ref internalNav" href="#t4fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">100%</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">74%</td><td class="colsep0 rowsep0" align="left">50%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max_brain</sub> (nM)/po dose (mg/kg)<a class="ref internalNav" href="#t4fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">5213/10</td><td class="colsep0 rowsep0" align="left">1579/5</td><td class="colsep0 rowsep0" align="left">3125/10</td><td class="colsep0 rowsep0" align="left">1068/3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values obtained from human mGluR2 receptor transfected HEK cell line using FLIPR method in the presence of glutamate (EC<sub>10−20</sub>).</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">MS-based quantification of the basal/apical transfer rate of a test compound at 1 μM across contiguous monolayers from MDCK cells.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Ratio from the MS-based quantification of apical/basal and basal/apical transfer rates of a test compound at 1 μM across contiguous monolayers from MDR1-transfected MDCK cells.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Determined from PK in mice 60 min post 10 mg/kg subcutaneous dosing.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Determined from PK in rats 60 min post 3.2 mg/kg subcutaneous dosing.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">Fraction unbound in rat brain.</p></div><div class="footnote" id="t4fn7"><sup>g</sup><p class="last">Observed plasma clearance in rats following a single 0.5 [(+)-<b>17e</b>] or 1 mg/kg [<b>7k</b> and (+)-<b>17d</b>] iv bolus administration.</p></div><div class="footnote" id="t4fn8"><sup>h</sup><p class="last">Estimated from rats following 3 [(+)-<b>17e</b>] or 10 mg/kg [<b>7k</b> and (+)-<b>17d</b>) oral dose as the ratio of dose-normalized AUC after oral and intravenous administration.</p></div><div class="footnote" id="t4fn9"><sup>i</sup><p class="last">Determined in rats following a single 3 [(+)-<b>17e</b>], 5 [(+)-<b>17c</b>], or 10 mg/kg [<b>7k</b> and (+)-<b>17d</b>] oral dose.</p></div><div class="footnote" id="t4fn10"><sup>j</sup><p class="last">ND, not determined.</p></div></div></div><div class="NLM_p">Two rodent psychosis models, inhibition of methamphetamine (MAP)-induced hyperlocomotor activity and mescaline-induced scratching (MIS), were used to evaluate the in vivo efficacy of this new class of mGluR2 PAMs. The results of compound (+)-<b>17e</b>, which are representative of this compound series, are described herein. Chronic use of MAP generates symptoms in human that mimic acute psychosis.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> MAP induces hyperlocomotor activity in mice, the inhibition of which has been used as a measurement to predict antipsychotic activity.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> As illustrated in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, compound (+)-<b>17e</b> showed robust and dose-responsive reduction of the MAP-induced hyperlocomotor activity with a minimally effective dose (MED) of 17.8 mg/kg. While the specific experiment was not performed with (+)-<b>17e</b>, the inhibitory effect of (+)-<b>17c</b> was effectively blocked by an mGluR2/3 antagonist, (2<i>S</i>,1′<i>S</i>,2′<i>S</i>)-2-(9-xanthylmethyl)-2-(2′-carboxycyclopropyl)-glycine (LY-341,495),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> indicating such an effect was mediated by mGluR2 potentiation (data not shown).</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of MAP-induced hyperlocomotor activity by (+)-<b>17e</b> in mice. Mice (<i>n</i> = 6/group) were dosed with test compound (sc) concurrently with MAP (1 mg/kg, sc). Data are presented as the group mean (±SEM) recorded for the total duration of the 60 min test period. Data were analyzed by a one-way ANOVA followed by Fisher's PLSD. *<i>P</i> < 0.05 and **<i>P</i> < 0.01 as compared to vehicle/MAP-treated mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound (+)-<b>17e</b> was also examined in a MIS assay (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). This behavioral assay is a good measure of prefrontal cortical activity linked to the cortical-thalamic loop.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> It is broadly published that 5-HT<sub>2A</sub> agonists like mescaline or 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride (DOI) act presynaptically to cause glutamate release from thalamocortical neurons.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Intervention of this response was observed with typical and atypical antipsychotics, such as haloperidol and clozapine, and the mGluR2/3 agonist LY354740. To evaluate the effect of mGluR2 PAM (+)-<b>17e</b>, mice were dosed 20 min prior to oral mescaline, and the behavior was analyzed for a total of 12 min. The mGluR2 PAM inhibited MIS in a dose-responsive fashion (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) with an MED of 10 mg/kg (sc). At this dose, compound (+)-<b>17e</b> had plasma and brain exposures of 15018 and 19644 nM (45 min postdose), respectively. The fraction unbound in mouse brain was measured as 0.3%, which gave an estimated [brain]free of 59 nM, similar to its in vitro mGluR2 EC<sub>50</sub> of 35 nM. Noteworthy in these models, no additional mGluR2 agonist was added, so the effects of compound (+)-<b>17e</b> were solely due to the potentiated response of the endogenous glutamate.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of MIS by (+)-<b>17e</b> in mice CD-1 mice (<i>n</i> = 4/group) were predosed with test compound (sc) 20 min prior to receiving mescaline (10 mg/kg, po). Fifteen minutes later, the mice were placed in glass beakers for videotaping, and the animals were viewed every 30 s for a total of 12 min. Data were presented as % time scratching analyzed by a one-way ANOVA followed by Bonferroni's/Dunnett's posthoc tests. *<i>P</i> < 0.05 and **<i>P</i> < 0.01 as compared to vehicle/mescaline-treated mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, a series of 1-[(1-methyl-1<i>H</i>-imidazol-2-yl)methyl]-4-phenylpiperidines have been developed as novel mGluR2 PAMs. The high clearance and selectivity issues of the original lead were successfully addressed through systematic SAR studies to yield a group of lead compounds [(+)-<b>17c</b>−<b>e</b>] that have excellent potency, selectivity, and PK profiles. Compound (+)-<b>17e</b> was found to be active in inhibiting MAP-induced hyperlocomotor activity and MIS in mice at a free brain exposure similar to its in vitro EC<sub>50</sub>, providing evidence that an mGluR2 PAM could serve as a potential treatment for schizophrenia. However, the required dose and total plasma exposure were high due to low fractions unbound generally observed with these compounds (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Future efforts will be focused on improving mGluR2 potency while increasing fraction unbound in brain as an effort to achieve a lower efficacious dose.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Biology</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> mGluR2 FLIPR Functional Assay</h4><div class="NLM_p">The increases in intracellular calcium release mediated by mGluR2 were measured in HEK 293 cells stably coexpressing the rat mGluR2 receptor and the Gα15 G protein using FLIPR technology (Molecular Devices). Cells were grown in a media containing Dulbecco's modified Eagle's medium (DMEM) high glucose with glutamine and sodium pyruvate (Gibco), 10% (v/v) heat-inactivated fetal bovine serum (FBS, Gibco), 500 μg/mL G418 (Gibco), and 3 μg/mL blasticidin (Invitrogen).</div><div class="NLM_p">Two days prior to the testing, cells were plated on polystyrene 384-well plates (Becton Dickinson) at a density of approximately 15000 cells per well in a volume of 50 μL per well. One day prior to the assay, the growth media were removed from the plates and replaced with a media containing DMEM high glucose without glutamine, sodium pyruvate (Gibco), and 10% (v/v) dialyzed FBS (Gibco). On the day of the assay, an assay buffer was made containing 145 mM NaCl, 10 mM glucose, 5 mM KCl, 1 mM MgSO<sub>4</sub>, 10 mM HEPES [4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid], and 2 mM CaCl<sub>2</sub>, with the pH adjusted to 7.4 with 1 N NaOH. DMSO and P104 (15.8% stock solution) were added to the assay buffer used for compound plates for final concentrations of 0.18 and 0.006%, respectively.</div><div class="NLM_p">A 4 μM dye loading media was prepared by adding a 1 mM (DMSO) stock solution of Fluo-4 am (Molecular Probes) containing 10% pluronic F-127 (Molecular Probes) to DMEM high glucose. A 250 mM stock solution of probenecid (Sigma) in equal volumes of 1 N NaOH and the assay buffer were then added to the dye media for a final concentration of 2.5 mM. Glutamic-pyruvic transaminase (GPT, Sigma, 3 units/mL) and 3 mM sodium pyruvate were added to the dye media to reduce extracellular glutamate in the assay wells.</div><div class="NLM_p last">Growth media were removed from the cell plates, and the dye loading media containing the 4 μM Fluo-4 am were added (50 μL/well). The plates were incubated for 1 h at 37 °C and 5% CO<sub>2</sub>, after which the dye loading media were removed, and the plates were washed three times with the assay buffer using an Embla plate washer (Molecular Devices), leaving 30 μL assay buffer per well. Plates were incubated for 10−15 min at room temperature. Fifteen microliters of test compounds was added by FLIPR at four times their final concentrations. Intracellular calcium release was measured in the FLIPR by collecting five baseline samples, one sample every 2 s, before compound addition. After compound addition, from 5 to 40 samples were collected, one sample every 2 s. Plates were then incubated at room temperature for at least 20 min. Fifteen microliters of an EC<sub>10−20</sub> concentration of glutamate at four times the final concentration was then performed by FLIPR using a similar read protocol (40 samples, one sample every 2 s, after compound addition). The specific concentration of glutamate needed to achieve an EC<sub>10−20</sub> response was determined for each assay, typically ranging between 320 nM and 1 μM. Data for the second FLIPR addition were then analyzed. The ratio of peak fluorescence to baseline was calculated for each well. EC<sub>50</sub> values for the positive modulators were then calculated using a sigmoidal four-parameter curve fit using the EC<sub>10−20</sub> glutamate concentration as a negative control and an EC<sub>100</sub> concentration of glutamate (100 μM) as a positive control.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> [<sup>3</sup>H]-Spiperone (Dopamine-2) Homogenate Binding Assay (Rat Striatum)</h4><div class="NLM_p last">One gram of rat corpus striatum by wet weight was homogenized with a polytron in 40 mL of buffer containing 20 mM HEPES, 118 mM NaCl, 4.5 mM KCl, 2.5 mM CaCl<sub>2</sub>, and 1.2 mM MgSO<sub>4</sub>, pH 7.5. The homogenate was centrifuged at 50000<i>g</i> for 10 min at 4 °C, and the resulting pellet was homogenized and centrifuged again as described above. The final pellet was resuspended to 5.6 mg/mL concentration in the same buffer. The plates were incubated in a shaking water bath in the dark at 37 °C for 15 min with 100 μL of drugs or vehicle for total binding, 100 μL of [<sup>3</sup>H]-spiperone (0.2 nM), and 800 μL of tissue preparation. The reaction was terminated by filtration using 0.5% polyethylene imine-treated Whatman GF/B glass fiberfilters (Brandel Biomedical Research & Development Laboratories, Inc., Gaithersburg, MD) on a Skatron cell harvester (Molecular Devices Corp., Sunnyvale, CA) with ice-cold buffer. Filters were then counted on a Beta plate counter using Betaplate Scint. (Wallac Inc., Gaithersburg, MD). Data are expressed as IC<sub>50</sub> values (concentration that inhibits 50% of the specific binding) or as an apparent <i>K</i><sub>i</sub>, IC<sub>50</sub>/1 + [L]/<i>K</i><sub>D</sub>, where [L] = ligand concentration, and <i>K</i><sub>D</sub> = affinity constant for [<sup>3</sup>H]-spiperone determined in a separate experiment.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Measurement of Fractions Unbound in Brain</h4><div class="NLM_p last">The unbound fraction of each compound was determined in brain tissue homogenate using a 96-well equilibrium dialysis method as described by Kalvass et al.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> with the following exceptions. Brain homogenates were prepared from freshly harvested rat brains following dilution with a 4-fold volume of phosphate buffer and spiked with 1 μM compound. The homogenates were dialyzed against an equal volume (150 uL) of phosphate buffer at 37 °C for 6 h. Following the incubation, equal volumes (50 uL) of brain homogenate and buffer samples were collected and mixed with 50 μL of buffer or control homogenate, respectively, for preparation of mixed matrix samples. All samples were then precipitated with internal standard in acetonitrile (200 μL), vortexed, and centrifuged. Supernatants were analyzed using an LC-MS/MS assay. A dilution factor of 5 was applied to the calculation of brain fraction unbound.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> General Methods</h4><div class="NLM_p last">Solvents and reagents were of reagent grade and were used as supplied by the manufacturer. All reactions were run under a N<sub>2</sub> atmosphere. Organic extracts were routinely dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. Concentration refers to rotory evaporation under reduced pressure. Chromatography refers to flash chromatography using disposable RediSepR<sub>f</sub> 4−120 g silica columns or Biotage disposable columns on a CombiFlash Companion or Biotage horizon automatic purification system. Microwave reactions were carried out in a microwave reactor manufactured by Smithcreator of Personal Chemistry. Purification by mass-triggered HPLC was carried out using Waters XTerra PrepMS C<sub>18</sub> columns, 5 μm, 30 mm × 100 mm steel. Compounds were presalted as TFA salts and diluted with 1 mL of dimethylsulfoxide. Samples were purified by mass-triggered collection using a mobile phase of 0.1% trifluoroacetic acid in water and acetonitrile with a starting gradient of 100% aqueous to 100% acetonitrile over 10 min at 20 mL per minute flow rate. All target compounds were analyzed using ultrahigh-performance liquid chromatography/ultraviolet/evaporative light scattering detection coupled to time-of-flight mass spectrometry (UHPLC/UV/ELSD/TOFMS). Unless otherwise noted, all tested compounds were found to be ≥95% pure by this method.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> UHPLC/MS Analysis</h4><div class="NLM_p last">The UHPLC was performed on a Waters ACQUITY UHPLC system (Waters, Milford, MA), which was equipped with a binary solvent delivery manager, column manager, and sample manager coupled to ELSD and UV detectors (Waters). Detection was performed on a Waters LCT premier XE mass spectrometry (Waters). The instrument was fitted with an Acquity BEH (Bridged Ethane Hybrid) C18 column (30 mm × 2.1 mm, 1.7 μm particle size, Waters) operated at 60 °C.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Reductive Amination Method A (Singleton Format)</h4><div class="NLM_p last">To a stirred solution of the hydrochloride salts of amines (<b>6</b>) (1 equiv) in CH<sub>2</sub>Cl<sub>2</sub> under N<sub>2</sub> at room temperature was added triethylamine (4 equiv), MgSO<sub>4</sub> (10 equiv), and aldehydes (<b>8a</b>−<b>e</b>) (1 equiv). The reaction mixture was stirred for 30 min, and then, NaBH(OAc)<sub>3</sub> (1.5 equiv) was added. The mixture was stirred at room temperature overnight and was then diluted with methylene chloride and washed with water and brine and dried with Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo, and the residue was purified by flash chromatography to give the desired products. To make the hydrochloride salts, the free bases were dissolved in MeOH, and a 4 N HCl solution in dioxane was added. The mixture was stirred for 10 min, and the solvent was then removed in vacuo to give the hydrochloride salts of the desired product as white solids.</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Reductive Amination Method B (Library Format)</h4><div class="NLM_p last">Stock solutions (0.25 M) of amines (<b>6</b>) and aldehydes (<b>8a</b>−<b>e</b>) in DCE were prepared. When applicable, the amine or the aldehyde salt forms were neutralized by addition of 4 equiv of DIPEA. A 0.25 M fine suspension of NaBH(OAc)<sub>3</sub> in anhydrous DMF/DCE mixture (20/80) was prepared. To each vial was added a solution of amine (<b>6</b>) (0.2 mL) followed by a solution of aldehyde (<b>8a</b>−<b>e</b>) (0.2 mL) and the NaBH(OAc)<sub>3</sub> suspension (0.5 mL) to each vial. The vials were capped and shaken at room temperature for 16 h. An additional 0.5 mL of the NaBH(OAc)<sub>3</sub> suspension was added to each vial, the vials were vortexed, capped, and shaken at room temperature for 16 h. The solvent was removed in vacuo. DMSO (1 mL) and water (0.1 mL) were added to each vial. The samples were vortexed for 1 h, and concentrated NH<sub>4</sub>OH (0.05 mL) was added to each vial. The samples were filtered and directly submitted to mass-triggered HPLC purification, and the compounds were characterized by UHPLC and MS.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-((4-(2-Methoxy-phenyl)piperidin-1-yl)methyl)-1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>3</b>)</h4><div id="sec102" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Step 1</h5><div class="NLM_p last">4-Bromopyridine (2.62 g, 16.3 mmol), 2-methoxyphenyl boronic acid (2.50 g, 16.3 mmol), and tetrakis (triphenylphosphine) palladium (0) (1.89 g, 1.63 mmol) were combined in DME (100 mL) and H<sub>2</sub>O (33 mL) under N<sub>2</sub> at room temperature. The reaction mixture was then heated to reflux at 85 °C for 17 h. After it was cooled to room temperature, the mixture was partitioned between brine (300 mL) and ethyl acetate (300 mL). The organic layer was separated and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated in vacuo, and the residue was purified by flash chromatography (silica gel, 1:1 EtOAc:hexane) to give 2.21 g of 4-(2-methoxyphenyl)pyridine as a colorless oil, which crystallized under high vacuum. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ (ppm) 8.6 (m, 2H), 7.5 (m, 2H), 7.3−7.4 (m, 2H), 7.0−7.1 (m, 2H), 3.8 (s, 3H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 186.1 (M + 1). The product was converted to the HCl salt by dissolving the residue in EtOAc (20 mL) and adding 1 M HCl in diethyl ether (20 mL). The solvent was removed in vacuo to 2.6 g of an off-white solid after drying under high vacuum.</div></div><div id="sec101" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Step 2</h5><div class="NLM_p last">4-(2-Methoxyphenyl)pyridine hydrochloride salt (1.0 g) was dissolved in methanol (23 mL), and platinum(IV) oxide (499 mg) was added. The mixture was then shaked on a Parr shaker under hydrogen (40 psi) at room temperature for 90 min. An additional 500 mg of platinum(IV) oxide was added, and the mixture was again placed on the Parr shaker for additional 2 h. The reaction mixture was then filtered through a pad of Celite, and the cake was rinsed several times with methanol. The filtrate was evaporated in vacuo to give 1.0 g of 4-(2-methoxyphenyl)piperidine hydrochloride salt as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 9.5−9.7 (broad d, 2H), 7.2 (m, 2H), 6.9 (m, 1H), 6.8−6.9 (d, 1H), 3.8 (s, 3H), 3.6 (d, 2H), 3.1−3.2 (m, 1H), 3.0 (q, 2H), 2.1−2.2 (m, 2H), 2.0 (d, 2H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 192.0 (M + 1).</div></div><div id="sec100" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Step 3</h5><div class="NLM_p last">The hydrochloride salt of the title compound was prepared by reductive amination method A from 4-(2-methoxyphenyl)piperidine hydrochloride salt and 1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-carbaldehyde (<b>8a</b>). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 7.94 (m, 2H), 7.69 (m, 2H), 7.20 (m, 2H), 6.94 (m, 2H), 5.05 (s, 2H), 4.24 (s, 3H), 3.83 (m, 2H), 3.81 (s, 3H), 3.47 (t, 2H, <i>J</i> = 11 Hz), 3.30 (m, 1H), 2.22 (q, 2H, <i>J</i> = 12 Hz)), 2.09 (d, 2H, <i>J</i> = 14 Hz). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 336.5 (M + 1). UHPLC: 100% (UV), 100% (ELSD).</div></div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1-Methyl-2-((4-phenylpiperidin-1-yl)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>7a</b>)</h4><div class="NLM_p last">The title compound was prepared by reductive amination method B (library format) from commercially available 4-phenyl piperidine hydrochloride salt and 1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-carbaldehyde (<b>8a</b>). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 306.2 (M + 1). UHPLC: 100% (UV), 98% (ELSD).</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-((4-(2-Fluorophenyl)piperidin-1-yl)methyl)-1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>7b</b>)</h4><div class="NLM_p last">The hydrochloride salt of the title compound was prepared by following reductive amination method A from commercially available 4-(2-fluoro-phenyl)piperidine hydrochloride and 1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-carbaldehyde (<b>8a</b>) in 72% overall yield. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 7.59 (d, 1H, <i>J</i> = 7.9 Hz), 7.49 (d, 1H, <i>J</i> = 7.9 Hz), 7.20−7.28 (m, 3H), 7.18 (m, 1H), 7.07 (t, 1H, <i>J</i> = 7 Hz), 6.98 (dd, 1H, <i>J</i> = 11, 8 Hz), 3.93 (s, 3H), 3.85 (s, 2H), 3.00 (d, 2H, <i>J</i> = 12 Hz), 2.86 (m, 1H), 2.30 (m, 2H), 1.78 (m, 4H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 324.1 (M + 1). UHPLC: 100% (UV), 100% (ELSD).</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-((4-(3-Fluorophenyl)piperidin-1-yl)methyl)-1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>7c</b>)</h4><div class="NLM_p last">The title compound was prepared by reductive amination method B (library format) from commercially available 4-(3-fluoro-phenyl)piperidine hydrochloride and 1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-carbaldehyde (<b>8a</b>). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 324.1 (M + 1). UHPLC: 97% (UV), 100% (ELSD).</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-((4-(4-Fluorophenyl)piperidin-1-yl)methyl)-1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>7d</b>)</h4><div id="sec200" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> Step 1</h5><div class="NLM_p last">To a stirred solution of diisopropylamine (7 mL) in THF (150 mL) at −78 °C was added a solution of <i>n</i>-butyl lithium in hexanes (20 mL, 2.5 M). After 1 h, <i>tert</i>-butyl 4-oxo-1-piperidinecarboxylate (10 g) was added. After an additional 1.5 h, <i>N</i>-phenyltrifluoromethanesulfonimide (19.65 g) was added, and the mixture was allowed to warm to room temperature. After it was stirred for 16 h, the solvent was removed in vacuo, and the resulting residue was used without further purification.</div></div><div id="sec201" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Step 2</h5><div class="NLM_p last">To a stirred solution of <i>tert</i>-butyl 4-trifluoromethanesulfonate-1-(1,2,3,6-tetrahydropyridine) carboxylate (8.3 g, crude) in EtOH (85 mL) and water (15 mL) under N<sub>2</sub> at room temperature were added 4-fluorophenylboronic acid (3.5 g) and tetrakis(triphenylphosphine)palladium(0) (2.89 g). The mixture was then heated to 90 °C and stirred for 16 h. The reaction mixture was then cooled to room temperature, and the solvent was removed in vacuo. The residue was suspended in water (100 mL), and the mixture was extracted with ethyl acetate (100 mL × 2). The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated in vacuo. The residue was purified by flash chromatography (silica gel, 0−20% EtOAc in hexanes) gave 3.2 g of <i>tert</i>-butyl 4-(4-fluorophenyl)-1-(1,2,3,6-tetrahydropyridine) carboxylate as a brownish oil. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.23−7.44 (m, 3H), 7.04 (t, 1H), 6.04 (m, 1H), 4.03 (m, 2H), 3.61 (m, 2H), 2.49 (m, 2H), 1.47 (s, 9H).</div></div><div id="sec202" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Step 3</h5><div class="NLM_p last">A mixture of <i>tert</i>-butyl 4-(4-fluorophenyl)-1-(1,2,3,6-tetrahydropyridine) carboxylate (3.2 g) and Pd/C (60 mg) in ethanol (20 mL) was shaken in a Parr apparatus under 40 psi of hydrogen. After 16 h, the mixture was purged with nitrogen, filtered through Celite, and concentrated in vacuo to give 3.2 g of <i>tert</i>-butyl 4-(4-fluorophenyl)-1-piperidinecarboxylate as a yellow oil. To this residue was added 4 M HCl/dioxane (10 mL), and the mixture was stirred at room temperature for 2 h. The solvent was removed in vacuo to give 2.5 g of 4-(4-fluorophenyl)pyperidine hydrochloride as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 7.23−7.39 (m, 3H), 7.05 (t, 1H), 3.47−3.50 (m, 2H), 3.09−3.16 (m, 2H), 2.88−2.94 (m, 1H), 2.03−2.08 (m, 2H), 1.82−1.93 (m, 2H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 180.1 (M + 1).</div></div><div id="sec203" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Step 4</h5><div class="NLM_p last">The hydrochloride salt of the title compound was prepared by reductive amination method A from 4-(4-fluoro-phenyl)piperidine hydrochloride and 1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-carbaldehyde (<b>8a</b>) in 83% yield. NMR (400 MHz, CD<sub>3</sub>OD): 7.90 (m, 2H), 7.68 (m, 2H), 7.28 (m, 2H), 7.03 (m, 2H), 5.03 (s, 2H), 4.24 (s, 3H), 3.80 (m, 2H), 3.45 (m, 2H), 2.95 (m, 1H), 2.20 (m, 2H), 2.18 (m, 2H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 324.1 (M + 1). UHPLC: 100% (UV), 100% (ELSD).</div></div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-((4-(2-Chlorophenyl)piperidin-1-yl)methyl)-1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>7e</b>)</h4><div class="NLM_p last">The title compound was prepared by reductive amination method B (library format) from commercially available 4-(2-chloro-phenyl)piperidine hydrochloride and 1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-carbaldehyde (<b>8a</b>). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 340.2 (M + 1). UHPLC: 100% (UV), 99% (ELSD).</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-(1-((1-Methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)methyl)piperidin-4-yl)benzonitrile (<b>7f</b>)</h4><div class="NLM_p last">The title compound was prepared by reductive amination method B (library format) from commercially available 3-(piperidin-4-yl)benzonitrile and 1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-carbaldehyde (<b>8a</b>). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 331.2 (M + 1). UHPLC: 100% (UV), 98% (ELSD).</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-Methyl-3-(1-((1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)methyl)piperidin-4-yl)benzamide (<b>7g</b>)</h4><div class="NLM_p last">The title compound was prepared by reductive amination method B (library format) from commercially available <i>N</i>-methyl-3-(piperidin-4-yl)benzamide and 1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-carbaldehyde (<b>8a</b>). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 363.2 (M + 1). UHPLC: 100% (UV), 100% (ELSD).</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-((4-(4-Chloro-2-fluorophenyl)piperidin-1-yl)methyl)-1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>7h</b>)</h4><div class="NLM_p last"><i>tert</i>-Butyl 4-(4-chloro-3-fluorophenyl)-1-(1,2,3,6-tetrahydropyridine) carboxylate was prepared by the method described in the synthesis of <b>7d</b> (steps 1 and 2) from commercially available 4-chloro-3-fluorophenyl boronic acid. A mixture of <i>tert</i>-butyl 4-(3-chloro-4-fluorophenyl)-1-(1,2,3,6-tetrahydropyridine) carboxylate (465 mg, 1.49 mmol) and PtO<sub>2</sub> (20 mg) in methanol (8 mL) was shaken in a Parr apparatus at room temperature under 45 psi of hydrogen. After 1 h, the mixture was purged with nitrogen, filtered through Celite, and concentrated in vacuo to give 443 mg of <i>tert</i>-butyl 4-(3-chloro-4-fluorophenyl)-1-piperidinecarboxylate as a yellow oil. The residue was the treated with 4 N HCl in dioxane (3 mL) to yield 375 mg of 4-(4-chloro-3-fluorophenyl)pyperidine hydrochloride. MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 255, 257 (M + CH<sub>3</sub>CN). The free base of the title compound was prepared by reductive amination method A from 4-(4-chloro-3-fluorophenyl)pyperidine hydrochloride in 87% yield. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.72 (dd, 1H, <i>J</i> = 7.0, 1.5 Hz), 7.31 (dd, 1H, <i>J</i> = 7.0, 1.5 Hz), 7.20−7.25 (m, 3H), 7.07 (t, 1H, <i>J</i> = 7.8 Hz), 7.01 (dd, 1H, <i>J</i> = 12, 7.8 Hz), 3.87 (s, 3H), 3.84 (s, 2H), 3.00 (d, 2H, <i>J</i> = 12 Hz), 2.82 (m, 1H), 2.30 (m, 2H), 1.75 (m, 4H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 358.2 (M + 1). UHPLC: 100% (UV), 100% (ELSD).</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 1-Methyl-2-((4-(4-(trifluoromethyl)phenyl)piperidin-1-yl)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>7i</b>)</h4><div class="NLM_p last">The title compound was prepared by reductive amination method B (library format) from commercially available 4-(4-trifluoromethyl-phenyl)piperidine hydrochloride salt and 1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-carbaldehyde (<b>8a</b>). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 374.2 (M + 1). UHPLC: 100% (UV), 98% (ELSD).</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-Methyl-2-((4-(2-(trifluoromethyl)phenyl)piperidin-1-yl)methyl)-1<i>H</i>-benzo[<i>d</i>]imidazole (<b>7j</b>)</h4><div class="NLM_p last">The title compound was prepared by reductive amination method B (library format) from commercially available 2-trifluoromethylphenyl piperidine hydrochloride and 1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-carbaldehyde (<b>8a</b>). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 374.2 (M + 1). UHPLC: 100% (UV), 100% (ELSD).</div></div><div id="sec5_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 1-Methyl-2-((4-(4-(trifluoromethyl)phenyl)piperidin-1-yl)methyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>7k</b>)</h4><div class="NLM_p last">The hydrochloride salt of the title compound was prepared by reductive amination method A from commercially available 4-(4-trifluoromethyl-phenyl)piperidine hydrochloride salt and 1-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-2-carbaldehyde hydrochloride hydrate (<b>8b</b>). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 8.60 (dd, 1H, <i>J</i> = 5.4, 1.3 Hz), 8.45 (dd, 1H, <i>J</i> = 8.1, 1.3 Hz), 7.63 (m, 3H), 7.51 (d, 2H, <i>J</i> = 8.3 Hz), 4.03 (m, 2H), 4.02 (s, 3H), 3.64 (s, 2H), 3.47 (m, 2H), 3.10 (m, 1H), 2.20 (m, 4H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 375.1 (M + 1). UHPLC: 100% (UV), 100% (ELSD).</div></div><div id="sec5_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-Methyl-2-((4-(4-(trifluoromethyl)phenyl)piperidin-1-yl)methyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridine (<b>7l</b>)</h4><div class="NLM_p last">The free base of the title compound was prepared by reductive amination method A from commercially available 4-(4-trifluoromethyl-phenyl)piperidine hydrochloride salt and 1-methyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridine-2-carbaldehyde dihydrochloride dihydrate (<b>8c</b>). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 9.04 (s, 1H), 8.44 (d, 1H, <i>J</i> = 5.8 Hz), 7.54 (d, 2H, <i>J</i> = 8.3 Hz), 7.32 (m, 3H), 3.93 (s, 3H), 3.88 (s, 2H), 3.00 (d, 2H, <i>J</i> = 11.3 Hz), 2.60 (m, 1H), 2.31 (m, 2H), 1.84 (m, 2H), 1.75 (m, 2H). MS (ES+): <i>m</i>/<i>z</i> 375.1 (M + 1). UHPLC: 100% (UV), 100% (ELSD).</div></div><div id="sec5_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-Methyl-2-((4-(4-(trifluoromethyl)phenyl)piperidin-1-yl)methyl)-3<i>H</i>-imidazo[4,5-<i>c</i>]pyridine (<b>7m</b>)</h4><div class="NLM_p last">The free base of the title compound was prepared by reductive amination method A from commercially available 4-(4-trifluoromethyl-phenyl)piperidine hydrochloride salt and 3-methyl-3<i>H</i>-imidazo[4,5-<i>c</i>]pyridine-2-carbaldehyde (<b>8d</b>). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 9.00 (s, 1H), 8.43 (d, 1H, <i>J</i> = 5.8 Hz), 7.71 (d, 1H, <i>J</i> = 5.8 Hz), 7.54 (d, 2H, <i>J</i> = 7.8 Hz), 7.32 (d, 2H, <i>J</i> = 7.8 Hz), 4.01 (s, 3H), 3.95 (s, 2H), 3.05 (d, 2H, <i>J</i> = 11.6 Hz), 2.60 (m, 1H), 2.39 (m, 2H), 1.80 (m, 4H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 375.2 (M + 1). UHPLC: 99% (UV), 100% (ELSD).</div></div><div id="sec5_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 3-Methyl-2-((4-(4-(trifluoromethyl)phenyl)piperidin-1-yl)methyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>7n</b>)</h4><div class="NLM_p last">The free base of the title compound was prepared by reductive amination method A from commercially available 4-(4-trifluoromethyl-phenyl)piperidine hydrochloride salt and 3-methyl-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-2-carbaldehyde hydrochloride hydrate (<b>8e</b>). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 8.35 (d, 1H, <i>J</i> = 4.8 Hz), 8.0 (dd, 1H, <i>J</i> = 8.0, 1.3 Hz), 7.54 (d, 2H, <i>J</i> = 8.2 Hz), 7.40 (d, 2H, <i>J</i> = 8.2 Hz), 7.29 (dd, 1H, <i>J</i> = 8.0, 4.8 Hz), 3.98 (s, 3H), 3.89 (s, 2H), 3.02 (d, 2H, <i>J</i> = 11.6 Hz), 2.65 (m, 1H), 2.33 (m, 2H), 1.82 (m, 4H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 375.2 (M + 1). UHPLC: 100% (UV), 100% (ELSD).</div></div><div id="sec5_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-((4-(2-Methoxy-4-(trifluoromethyl)phenyl)piperidin-1-yl)methyl)-1-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>7o</b>)</h4><div class="NLM_p">To a stirred solution of 1-methoxy-3-(trifluoromethyl)benzene (9.8 mL, 68 mmol) in THF (50 mL) under N<sub>2</sub> at 0 °C was added <i>n</i>-BuLi (1.6 M in hexanes, 45 mL, 68 mmol) dropwise. The reaction mixture was stirred at 0 °C for 2 h, and then, triisopropylborate (11.6 mL, 68 mmol) was added. The reaction mixture was slowly warmed up to room temperature and stirred overnight. A solution of 10% HCl in water (50 mL) was added, and the mixture was stirred for 1 h. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (100 mL × 3). The organic layers were combined, washed with brine, and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo to give 8.14 g of 2-methoxy-4-(trifluoromethyl)phenylboronic acid as a viscous oil.</div><div class="NLM_p last">2-Methoxy-4-trifluoromethyl phenylpiperidine was prepared from 2-methoxy-4-(trifluoromethyl)phenylboronic acid and 4-bromopyridine by the method described in the synthesis of <b>3</b> (steps 1 and 2), and the free base of the title compound was prepared by reductive amination method A from 2-methoxy-4-trifluoromethyl phenylpiperidine and 1-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-2-carbaldehyde hydrochloride hydrate (<b>8b</b>). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 8.40 (d, 1H, <i>J</i> = 5.0 Hz), 8.0 (d, 1H, <i>J</i> = 7.9 Hz), 7.34 (m, 2H), 7.19 (d, 1H, <i>J</i> = 7.9 Hz), 7.12 (s, 1H), 3.99 (s, 3H), 3.92 (s 2H), 3.87 (s, 3H), 3.03 (m, 3H), 2.33 (m, 2H), 1.77 (m, 4H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 405.2 (M + 1). UHPLC: 100% (UV), 100% (ELSD).</div></div><div id="sec5_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-((4-(2-Fluoro-4-(trifluoromethyl)phenyl)piperidin-1-yl)methyl)-1-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>7p</b>)</h4><div class="NLM_p last">The free base of the title compound was prepared from 2-fluoro-4-(trifluoromethyl)phenylboronic acid and 4-bromopyridine by the method described in the synthesis of <b>3</b> with 1-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-2-carbaldehyde hydrochloride hydrate (<b>8b</b>). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 8.40 (dd, 1H, <i>J</i> = 5.0, 1.6 Hz), 8.0 (d, 1H, <i>J</i> = 8.3 Hz), 7.51(m, 1H), 7.43 (m, 1H), 7.34 (m, 2H), 3.99 (s, 3H), 3.95 (s 2H), 3.07 (d, 2H, <i>J</i> = 11.2 Hz), 2.96 (m, 1H), 2.37 (m, 2H), 1.97 (m, 2H), 1.83 (m, 2H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 393.2 (M + 1). UHPLC: 100% (UV), 100% (ELSD).</div></div><div id="sec5_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-((4-(2-Fluoro-4-(trifluoromethoxy)phenyl)piperidin-1-yl)methyl)-1-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>7q</b>)</h4><div class="NLM_p last">The free base of the title compound was prepared from 2-fluoro-4-(trifluoromethoxy)phenylboronic acid and 4-bromopyridine by the method described in the synthesis of <b>3</b> with 1-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-2-carbaldehyde hydrochloride hydrate (<b>8b</b>). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 8.39 (dd, 1H, <i>J</i> = 5.0, 1.5 Hz), 8.0 (dd, 1H, <i>J</i> = 8.3, 1.5 Hz), 7.36(m, 2H), 7.38 (t, 1H, <i>J</i> = 10 Hz), 7.35 (dd, 1H, <i>J</i> = 8.3, 5.0 Hz), 7.04 (t, 1H, <i>J</i> = 10 Hz), 3.99 (s, 3H), 3.92 (s, 2H), 3.03 (d, 2H, <i>J</i> = 12.0 Hz), 2.89 (m, 1H), 2.35 (m, 2H), 1.80 (m, 4H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 409.0 (M + 1). UHPLC: 100% (UV), 100% (ELSD).</div></div><div id="sec5_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-Benzyl-4-(4-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine (<b>9</b>)</h4><div class="NLM_p last">To a stirred solution of 1-bromo-4-(trifluoromethyl)benzene (1.84 mL, 13 mmol) in THF (5 mL) under N<sub>2</sub> at −78 °C was added BuLi (5.5 mL, 2.5 M in hexanes, 14 mmol) dropwise. The reaction mixture turned into a yellow and then dark orange solution upon stirring for 15 min. A solution of 1-benzylpiperidin-4-one (246 mg, 13 mmol) in THF (4 mL) was then added dropwise. The resulting mixture was stirred at −78 °C for 30 min, then allowed to warm up to room temperature, and stirred for additional 3 h. The reaction was quenched with water, and the mixture was extracted with EtOAc (10 mL × 2). The organic layer was washed with water and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo, and the residue was purified with flash chromatography (silica gel, 10−40% EtOAc in hexanes) to give 238 mg of 1-benzyl-4-(4-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine as a viscous oil. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 7.66 (s, 4H), 7.30−7.40 (m, 5H), 6.26 (s, br, 1H), 3.68 (s, 2H), 3.20 (m, 2H), 2.77 (m, 2H), 2.60 (m, 2H). MS (APCI): <i>m</i>/<i>z</i> 318.3 (M + 1).</div></div><div id="sec5_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 4-(4-(Trifluoromethyl)phenyl)piperidin-3-ol (<b>10a</b>)</h4><div id="sec301" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> Step 1</h5><div class="NLM_p last">To a stirred solution of 1-benzyl-4-(4-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine (300 mg, 0.95 mmol) in diglyme (1 mL) under N<sub>2</sub> at room temperature was added NaBH<sub>4</sub> (57 mg, 1.51 mmol). The reaction mixture was then cooled to 0 °C, and a solution of BF<sub>3</sub>·Et<sub>2</sub>O (0.24 mL, 1.89 mmol) in diglyme (0.25 mL) was added dropwise. After the addition was complete, the reaction mixture was warmed to room temperature and stirred for 2 h. H<sub>2</sub>O (0.1 mL) was added very slowly to the mixture, followed by 6 N NaOH aqueous solution (0.25 mL). The reaction mixture was then heated to 65 °C, and 30% H<sub>2</sub>O<sub>2</sub> (0.18 mL, 1.89 mmol) was added slowly. The mixture was stirred at 65 °C for additional 45 min and then was cooled to room temperature. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with water and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo to give 298 mg of 1-benzyl-4-(4-(trifluoromethyl)phenyl)piperidin-3-ol as a mixture of diastereomers. MS (APCI): <i>m</i>/<i>z</i> 336.3 (M + 1).</div></div><div id="sec300" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> Step 2</h5><div class="NLM_p last">To a stirred solution of 1-benzyl-4-(4-(trifluoromethyl)phenyl)piperidin-3-ol (298 mg, 0.9 mmol) in MeOH (10 mL) were added 10% Pd/C (40 mg) and ammonium formate (673 mg, 10.7 mmol). The reaction mixture was then heated to reflux for 6 h. The mixture was then cooled to room temperature and filtered through a pad of Celite, and the cake was further washed with MeOH (50 mL). The filtrate was concentrated in vacuo to give 219 mg of 4-(4-(trifluoromethyl)phenyl)piperidin-3-ol as a mixture of diastereomers (70/30 <i>trans</i>/<i>cis-</i> ratio). The major <i>trans-</i>diastereomer: <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 7.55 (d, 2H, <i>J</i> = 7.9 Hz), 7.42 (d, 2H, <i>J</i> = 7.9 Hz), 3.27 (m, 1H), 3.20 (m, 2H), 3.00 (m, 1H), 2.60 (m, 1H), 2.42 (m, 2H), 1.75 (m, 2H). MS (APCI): <i>m</i>/<i>z</i> 246.2 (M + 1).</div></div></div><div id="sec5_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 3-[4-(Trifluoromethyl)phenyl]-8-azabicyclo[3.2.1]octane Hydrochloride (<b>10c</b>)</h4><div id="sec402" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> Step 1</h5><div class="NLM_p last">A solution of 1-bromo-4-(trifluoromethyl)benzene (188 g, 0.935 mol) in ether (1.2 L) was added dropwise to a suspension of magnesium (22 g, 0.9 mol) in THF (200 mL) at such a rate that the temperature of the mixture was 35−40 °C. The mixture was stirred at 35 °C for 1 h in a flask equipped with a reflux condenser. The reaction mass was cooled to 0 °C, and a solution of 8-benzyl-8-azabicyclo[3.2.1]octan-3-one (155 g, 0.72 mol) in ether (200 mL) was added dropwise at 5 °C. The reaction mixture was stirred overnight at room temperature. A 5% solution of sodium hydroxide (200 mL) was added dropwise. The mixture was stirred, and the organic layer was separated. The suspension of salts was extracted with ether (400 mL). The combined organic fractions were extracted with a solution of HCl (150 mL) in water (300 mL). The aqueous layer was separated and basified with a solution of sodium hydroxide (120 g) in water (300 mL), and the product was extracted with ether (300 mL × 3). The extract was dried with sodium sulfate and concentrated in vacuo. The residue was purified by flash chromatography (silica gel, CH<sub>2</sub>Cl<sub>2</sub>/Et<sub>2</sub>O 9:1) to give 8-benzyl-3-[4-(trifluoromethyl)phenyl]-8-azabicyclo[3.2.1]octan-3-ol (95.1 g, 36.5%).</div></div><div id="sec401" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> Step 2</h5><div class="NLM_p last">A solution of 8-benzyl-3-[4-(trifluoromethyl)phenyl]-8-azabicyclo[3.2.1]octan-3-ol (95.1 g, 0.263 mol) in DMF (300 mL) was added dropwise under cooling with ice to a suspension of NaH (44 g, 60% suspension in oil, 1.1 mol) in DMF (1 L). The mixture was stirred at 45 °C for 3 h and cooled, and a solution of methyl iodide (41 mL, 0.295 mol) in ether (50 mL) was added dropwise. The mixture was stirred at room temperature overnight. The larger part of DMF was evaporated, and the residue was diluted with water (1 L). The reaction mixture was extracted with ethyl acetate (300 mL × 2). The extract was washed with water and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo, and the residue was diluted with THF (50 mL) and ether (950 mL). A 4 M solution of HCl in dioxane (75 mL, 0.3 mol) was added dropwise. The formed crystals were separated by filtration and dried to give 8-benzyl-3-methoxy-3-[4-(trifluoromethyl)phenyl]-8-azabicyclo[3.2.1]octane (107 g, 98%).</div></div><div id="sec400" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> Step 3</h5><div class="NLM_p last">8-Benzyl-3-methoxy-3-[4-(trifluoromethyl)phenyl]-8-azabicyclo[3.2.1]octane (107 g, ∼0.26 mol) and concentrated HCl (3 mL) were added to a suspension of 10% Pd/C (17 g) in methanol (1 L) in argon. The system was flushed with hydrogen, and the mixture was hydrogenated under a pressure of 40 psi at 84 °C for 5 days. The mixture was cooled and filtered, and methanol was evaporated. The residue was treated with a solution of NaOH (25 g) in water (100 mL) and extracted with dichloromethane (100 mL × 2). The combined organic layers were washed with water and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo, and the residue was dissolved in a mixture of THF (200 mL) and ether (200 mL). A 4 N solution of HCl in dioxane (53 mL) was added. The formed crystals were separated by filtration to give 3-[4-(trifluoromethyl)phenyl]-8-azabicyclo[3.2.1]octane hydrochloride (<b>10c</b>) (53.6 g, 70%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.15 (br, s, 2H), 7.68 (s 4H), 3.95 (m, 2H), 3.40 (m, 1H), 2.45 (m, 2H), 2.20 (m, 2H), 1.88 (m, 2H), 1.55 (m, 2H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 256.1 (M + 1). UHPLC: 96% (UV), 98% (ELSD).</div></div></div><div id="sec5_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 3,3-Dimethyl-4-(4-(trifluoromethyl)phenyl)piperidine Hydrochloride (<b>10d</b>)</h4><div class="NLM_p last">The title compound was prepared by the method described in the synthesis of <b>10c</b>. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 7.56 (d, 2H, <i>J</i> = 7.9 Hz), 7.35 (d, 2H, <i>J</i> = 7.9 Hz), 3.18 (m, 1H), 2.6−2.75 (m, 4H), 2.18 (m, 1H), 1.50 (m, 1H), 0.88 (s, 3H), 0.74 (s, 3H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 299.2 (M + CH<sub>3</sub>CN).</div></div><div id="sec5_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-((1-Methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-2-yl)methyl)-4-(4-(trifluoromethyl)phenyl)piperidin-3-ol (<b>13</b>)</h4><div class="NLM_p last">The free base of the title compound was prepared by reductive amination method A from <i>trans</i>-4-(4-(trifluoromethyl)phenyl)piperidin-3-ol (<b>10a</b>) and 1-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-2-carbaldehyde hydrochloride hydrate (<b>8b</b>). The <i>trans</i>-diastereomer: <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 8.37 (dd, 1H, <i>J</i> = 3.3, 1.2 Hz), 8.0 (m, 1H), 7.50−7.70 (m, 3H), 7.42 (d, 2H, <i>J</i> = 8.4 Hz), 7.32 (m, 1H), 3.97 (s, 3H), 3.93 (s, 2H), 3.78 (m, 1H), 3.12 (m, 1H), 2.91 (m, 1H), 2.78 (m, 1H), 2.68 (m, 1H), 2.52 (m, 1H), 2.25 (m, 1H), 2.10 (m, 1H), 1.80 (m, 1H). MS (APCI): <i>m</i>/<i>z</i> 391.1 (M + 1). UHPLC: 95% (UV), 86% (ELSD).</div></div><div id="sec5_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-Methyl-2-((<i>cis</i>-2-methyl-4-(4-(trifluoromethyl)phenyl)piperidin-1-yl)methyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>14</b>)</h4><div id="sec502" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> Step 1</h5><div class="NLM_p last">4-Bromo-2-methylpyridine (209 mg, 1.16 mmol), 4-trifluoromethylphenyl boronic acid (221 mg, 1.16 mmol), sodium bicarbonate (293 mg, 3.48 mmol), and tetrakis (triphenylphosphine) palladium(0) (18.4 mg, 0.012 mmol) were combined in DME (10 mL) and H<sub>2</sub>O (2 mL) under N<sub>2</sub> at room temperature. The reaction mixture was then heated to reflux at 85 °C for 17 h. After it was cooled to room temperature, the mixture was diluted by water and extracted with ethyl acetate (50 mL × 2). The combined organic layer was washed with water and brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo, and the residue was purified by flash chromatography (silica gel, 30% EtOAc in hexanes) to give 240 mg of 2-methyl-4-(4-(trifluoromethyl)phenyl)pyridine as a viscous oil. The residue was then dissolved in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), and 4 N HCl in dioxane was added (1 mL). The mixture was stirred at room temperature for 10 min, and the solvent was concentrated in vacuo. The resulting solid was suspended in cold ethylether and filtered to yield 250 mg of 2-methyl-4-(4-(trifluoromethyl)phenyl)pyridine hydrochloride salt as pure white solid. MS (APCI): <i>m</i>/<i>z</i> 238.3 (M + 1).</div></div><div id="sec501" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> Step 2</h5><div class="NLM_p last">2-Methyl-4-(4-(trifluoromethyl)phenyl)pyridine hydrochloride salt (250 mg, 0.92 mmol) was dissolved in methanol (10 mL), and platinum(IV) oxide (20 mg) was added. The mixture was then shaken on a Parr shaker under hydrogen (45 psi) at 50 °C for 5 h. The reaction mixture was then filtered through a pad of Celite, and the cake was rinsed several times with methanol. The filtrate was evaporated in vacuo to give 253 mg of 2-methyl-4-(4-(trifluoromethyl)phenyl)piperidine hydrochloride salt (<b>10b</b>) as a white solid. MS (APCI): <i>m</i>/<i>z</i> 244.3 (M + 1).</div></div><div id="sec500" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Step 3</h5><div class="NLM_p last">The free base of the title compound was prepared by reductive amination method A with 2-methyl-4-(4-(trifluoromethyl)phenyl)piperidine hydrochloride salt (<b>10b</b>) and 1-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-2-carbaldehyde hydrochloride hydrate (<b>8b</b>). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.42 (dd, 1H, <i>J</i> = 5.5, 1.0 Hz), 7.98 (d, 1H, <i>J</i> = 8.0 Hz), 7.53 (d, 2H, <i>J</i> = 8.9 Hz), 7.30 (m, 3H), 4.40 (d, 1H, <i>J</i> = 13.7 Hz), 3.91 (s, 3H), 3.49 (d, 1H, <i>J</i> = 13.3 Hz), 2.84 (m, 1H), 2.68 (m, 1H), 2.50 (m, 1H), 2.24 (m, 1H), 1.86 (m, 1H), 1.70 (m, 1H), 1.58 (m, 2H), 1.20 (d, 3H, <i>J</i> = 6.2 Hz). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 389.2 (M+1). UHPLC: 100% (UV), 100% (ELSD).</div></div></div><div id="sec5_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 1-Methyl-2-((3-(4-(trifluoromethyl)phenyl)-8-azabicyclo[3.2.1]octan-8-yl)methyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>15</b>)</h4><div class="NLM_p last">The hydrochloride salt of the title compound was prepared by reductive amination method A from 3-[4-(trifluoromethyl)phenyl]-8-azabicyclo[3.2.1]octane hydrochloride (<b>10c</b>) and 1-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-2-carbaldehyde hydrochloride hydrate (<b>8b</b>). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 8.53 (dd, 1H, <i>J</i> = 5.0, 1.2 Hz), 8.30 (d, 1H, <i>J</i> = 8.3 Hz), 7.79 (d, 2H, <i>J</i> = 8.3 Hz), 7.68 (d, 2H, <i>J</i> = 8.3 Hz), 7.53 (dd, 1H, <i>J</i> = 8.3, 5.0 Hz), 4.78 (m, 1H), 4.45 (m, 2H), 3.95 (s, 3H), 3.46 (m, 1H), 2.80 (m, 4H), 2.28 (m, 2H), 1.88 (m, 2H). MS (APCI): <i>m</i>/<i>z</i> 401.1 (M + 1). UHPLC: 100% (UV), 100% (ELSD).</div></div><div id="sec5_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-((3,3-Dimethyl-4-(4-(trifluoromethyl)phenyl)piperidin-1-yl)methyl)-1-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>16</b>)</h4><div class="NLM_p last">The free base of the title compound was prepared by reductive amination method A from 3,3-dimethyl-4-(4-(trifluoromethyl)phenyl)piperidine hydrochloride (<b>10d</b>) and 1-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-2-carbaldehyde hydrochloride hydrate (<b>8b</b>). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 8.39 (dd, 1H, <i>J</i> = 5.5, 1.2 Hz), 8.01 (d, 1H, <i>J</i> = 8.0 Hz), 7.53 (d, 2H, <i>J</i> = 8.9 Hz), 7.35 (m, 3H), 4.03 (s, 3H), 3.87 (s, 2H), 3.00 (d, 1H, <i>J</i> = 8.3 Hz), 2.53 (m, 2H), 2.23 (m, 2H), 2.18 (m, 1H), 1.56 (m, 1H), 0.89 (s, 3H), 0.71 (s, 3H). MS (APCI): <i>m</i>/<i>z</i> 403.4 (M + 1). UHPLC: 100% (UV), 97% (ELSD).</div></div><div id="sec5_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 1-Methyl-2-((<i>cis</i>-3-methyl-4-(4-(trifluoromethyl)phenyl)piperidin-1-yl)methyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>17a</b>)</h4><div id="sec603" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> Step 1</h5><div class="NLM_p last">4-Bromo-3-methylpyridine (1.36 g, 7.89 mmol), 4-trifluoromethylphenyl boronic acid (1.50 g, 7.89 mmol), sodium bicarbonate (2.65 g, 31.6 mmol), and tetrakis (triphenylphosphine) palladium(0) (912 mg, 0.79 mmol) were combined in DME (40 mL) and H<sub>2</sub>O (10 mL) under N<sub>2</sub> at room temperature. The reaction mixture was then heated to reflux at 85 °C for 17 h. After it was cooled to room temperature, the mixture was diluted by water and extracted with ethyl acetate. The organic layers were combined and washed with water and brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed in vacuo, and the residue was purified by flash chromatography (silica gel, 30% EtOAc in hexanes) to give 1.42 g (76% yield) of 3-methyl-4-(4-(trifluoromethyl)phenyl)pyridine as a viscous oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.52 (s, 1H), 8.47 (d, 1H, <i>J</i> = 5 Hz), 7.69 (d, 2H, <i>J</i> = 8.3 Hz), 7.42 (d, 2H, <i>J</i> = 7.9 Hz), 7.10 (d, 1H, <i>J</i> = 5 Hz), 2.24 (s, 3H). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 238.1 (M + 1). The free base was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 mL), and 4 N HCl in dioxane was added (2 mL). The mixture was stirred at room temperature for 10 min, and the solvent was concentrated in vacuo. The resulting solid was suspended in cold ethyl ether and filtered to yield 1.58 g of the hydrochloride salt as a white solid, which was used in the next step.</div></div><div id="sec602" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> Step 2</h5><div class="NLM_p last">2-Methyl-4-(4-(trifluoromethyl)phenyl)pyridine hydrochloride salt (1.27 g, 4.68 mmol) was dissolved in ethanol (20 mL), and platinum(IV) oxide (50 mg) was added. The mixture was then shaken on a Parr shaker under hydrogen (45 psi) at 50 °C overnight. The reaction mixture was then filtered through a pad of Celite, and the cake was rinsed several times with methanol. The filtrate was evaporated in vacuo to give 1.25 g of <i>cis</i>-3-methyl-4-(4-(trifluoromethyl)phenyl)piperidine hydrochloride salt (<b>18a</b>) as a white solid. MS (APCI): <i>m</i>/<i>z</i> 244.1 (M + 1).</div></div><div id="sec601" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> Step 3</h5><div class="NLM_p last">The free base of the title compound was prepared by reductive amination method A with <i>cis</i>-3-methyl-4-(4-(trifluoromethyl)phenyl)piperidine hydrochloride salt (<b>18a</b>) and 1-methyl-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine-2-carbaldehyde hydrochloride hydrate (<b>8b</b>). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 8.52 (dd, 1H, <i>J</i> = 5.0, 1.7 Hz), 7.65 (d, 1H, <i>J</i> = 8.0 Hz), 7.52 (d, 2H, <i>J</i> = 8.3 Hz), 7.23 (m, 2H), 7.18 (m, 1H), 3.92 (s, 3H), 3.86 (m, 3H), 3.02 (m, 1H), 2.95 (m, 1H), 2.78 (m, 1H), 2.51 (m, 1H), 2.26 (m, 1H), 2.00−2.20 (m, 2H), 1.60 (m, 1H), 0.72 (d, 3H, <i>J</i> = 7.0 Hz). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 389.1 (M + 1).</div></div><div id="sec600" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> Step 4</h5><div class="NLM_p last">Two enantiomers were separated by chiral HPLC from 368 mg of the racemic <b>17a</b> using a Chiralcel OD column (5 cm × 50 cm) with 80/20 heptane/EtOH as the mobile phase at a flow rate of 145 mL/min. The individual enantiomers were then dissolved in DCM and treated with 4 N HCl in dioxane (3 equiv). The solvent was removed in vacuo, and the resulting solids were triturated with ethylether and dried under vacuum. (+)-<b>17a</b>: retention time, 21.94 min. MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 389.1 (M + 1). UHPLC: 100% (UV), 100% (ELSD). Optical rotation: [α]<sub>D</sub><sup>20</sup> + 25.9° (<i>c</i> 0.57, MeOH). (−)-<b>17a</b>: retention time, 26.31 min. MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 389.1 (M + 1). UHPLC: 100% (UV), 100% (ELSD). Optical rotation: [α]<sub>D</sub><sup>20</sup> − 26.2° (<i>c</i> 0.62, MeOH).</div></div></div><div id="sec5_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 1-Methyl-2-((<i>cis</i>-3-methyl-4-(4-chloro-2-fluorophenyl)piperidin-1-yl)methyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>17b</b>)</h4><div class="NLM_p last">The free base of the title compound was prepared by the method described for the synthesis of <b>17a</b> from commercially available 4-chloro-2-fluorophenyl boronic acid. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 8.91 (d, 1H, <i>J</i> = 8.3 Hz), 8.74 (d, 1H, <i>J</i> = 6.8 Hz), 7.92 (m, 1H), 7.22 (m, 3H), 5.10 (s, 2H), 4.12 (s, 3H), 4.00 (m, 2H), 3.60 (m, 3H), 2.65(m, 1H), 2.55 (m, 1H), 2.02 (m, 1H), 1.03 (d, 3H, <i>J</i> = 7.1 Hz). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 373.1 (M + 1). Two enantiomers were separated by chiral HPLC from 1.46 g of the racemic <b>17b</b> using a Chiralcel OJ-H column (3 cm × 25 cm) with 83/17 CO<sub>2</sub>/MeOH as the mobile phase at flow rate of 65 mL/min. The individual enantiomers were then dissolved in DCM and treated with 4 N HCl in dioxane (3 equiv). The solvent was removed in vacuo, and the resulting solids were triturated with ethylether and dried under vacuum. (+)-<b>17b</b>: retention time, 11.50 min. MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 373.1 (M + 1). UHPLC: 100% (UV), 100% (ELSD). Optical rotation: [α]<sub>D</sub><sup>20</sup> + 27.1° (<i>c</i> 0.37, MeOH). (−)-<b>17b</b>: retention time, 13.46 min. MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 373.1 (M + 1). UHPLC: 100% (UV), 100% (ELSD). Optical rotation: [α]<sub>D</sub><sup>20</sup> − 26.7 (<i>c</i> 0.28, MeOH).</div></div><div id="sec5_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 1-Methyl-2-((<i>cis</i>-3-methyl-4-(4-trifluoromethyl-2-methoxy)phenyl)piperidin-1-yl)methyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>17c</b>)</h4><div class="NLM_p last">The free base of the title compound was prepared by the method described for the synthesis of <b>17a</b> from 4-trifluormethyl-2-methoxyphenyl boronic acid. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 8.90 (dd, 1H, <i>J</i> = 8.3, 1.2 Hz), 8.74 (dd, 1H, <i>J</i> = 5.8, 0.8 Hz), 7.92 (m, 1H), 7.30 (m, 2H), 7.23 (s, 1H), 5.09 (s, 2H), 4.12 (s, 3H), 4.05 (m, 2H), 3.92 (s, 3H), 3.68 (m, 3H), 2.68 (m, 2H), 2.00 (m, 1H), 0.98 (d, 3H, <i>J</i> = 7.5 Hz). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 419.0 (M + 1). Two enantiomers were separated by chiral HPLC from 1.08 g of the racemic <b>17c</b> using a Chiralpak AD column (10 cm × 50 cm) with 85/15 heptane/EtOH as mobile phase at flow rate of 500 mL/min. The individual enantiomers were then dissolved in DCM and treated with 4 N HCl in dioxane (3 equiv). The solvent was removed in vacuo, and the resulting solids were triturated with ethylether and dried under vacuum. (+)-<b>17c</b>: retention time, 9.86 min. MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 373.1 (M + 1). UHPLC: 100% (UV), 100% (ELSD). Optical rotation: [α]<sub>D</sub><sup>20</sup> + 58.0° (<i>c</i> 0.47, MeOH). (−)-<b>17c</b>: retention time, 10.18 min. MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 373.1 (M + 1). UHPLC: 100% (UV), 100% (ELSD). Optical rotation: [α]<sub>D</sub><sup>20</sup> − 57.2° (<i>c</i> 0.56, MeOH).</div></div><div id="sec5_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 1-Methyl-2-((<i>cis</i>-3-methyl-4-(4-trifluoromethyl-2-fluoro)phenyl)piperidin-1-yl)methyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>17d</b>)</h4><div class="NLM_p last">The free base of the title compound was prepared by the method described for the synthesis of <b>17a</b> from 4-trifluormethyl-2-fluorophenyl boronic acid. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 8.88 (dd, 1H, <i>J</i> = 7.1, 0.8 Hz), 8.72 (d, 1H, <i>J</i> = 5.9 Hz), 7.91 (m, 1H), 7.53 (m, 2H), 7.48 (m, 1H), 5.08 (s, 2H), 4.10 (s, 3H), 4.05 (m, 2H), 3.64 (m, 3H), 2.68 (m, 1H), 2.60 (m, 1H), 2.05 (m, 1H), 1.04 (d, 3H, <i>J</i> = 7.4 Hz). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 407.1 (M + 1). Two enantiomers were separated by chiral HPLC from 2.94 g of the racemic <b>17d</b> using a Chiralpak AD column (10 cm × 50 cm) with 80/20 heptane/EtOH as mobile phase at flow rate of 500 mL/min. The individual enantiomers were then dissolved in DCM and treated with 4 N HCl in dioxane (3 equiv). The solvent was removed in vacuo, and the resulting solids were triturated with ethylether and dried under vacuum. (+)-<b>17d</b>: retention time, 8.12 min. MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 407.1 (M + 1). UHPLC: 100% (UV), 100% (ELSD). Optical rotation: [α]<sub>D</sub><sup>20</sup> + 18° (<i>c</i> 0.47, MeOH). (−)-<b>17d</b>: retention time, 10.18 min. MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 407.1 (M + 1). UHPLC: 100% (UV), 100% (ELSD). Optical rotation: [α]<sub>D</sub><sup>20</sup> − 18° (<i>c</i> 0.50, MeOH).</div></div><div id="sec5_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Determination of the Absolute Stereochemistry of Active Enantiomer (+)-<b>17d</b></h4><div class="NLM_p">The racemic <i>cis</i>-4-(2-fluoro-4-(trifluoromethyl)phenyl)-3-methylpiperidine hydrochloride (<b>18d</b>) was prepared by the method described in the synthesis of <b>18a</b> from 4-trifluoromethyl-2-fluorophenyl boronic acid. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 7.41−7.50 (m, 3H), 3.55 (m, 2H), 3.36 (m, 2H), 3.16 (m, 1H), 2.44 (m, 2H), 1.85 (m, 1H), 0.85 (d, 3H, <i>J</i> = 7.4 Hz). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 262.1 (M + 1). Two enantiomers were separated by chiral HPLC using a Chiralpak AD-H column (21 cm × 250 cm) with 90/10 CO<sub>2</sub>/PrOH as the mobile phase at a flow rate of 65 mL/min. (+)-<b>18d</b>: retention time, 3.11 min. Pptical rotation: [α]<sub>D</sub><sup>20</sup> + 78.1° (<i>c</i> 0.32, MeOH). (−)-<b>18d</b>: retention time, 3.92 min. Optical rotation: [α]<sub>D</sub><sup>20</sup> − 77.5° (<i>c</i> 0.45, MeOH).</div><div class="NLM_p">Following the reductive amination method A, (+)-<b>18d</b> yielded the active enantiomer (+)-<b>17d</b>. The absolute stereochemistry of (+)-<b>18d</b> was determined by X-ray crystallography of its (−)-ditoluoyl-<span class="smallcaps smallerCapital">l</span>-tartaric acid salt, generated via the procedure shown below.</div><div class="NLM_p">To a stirred solution of (+)-<b>18d</b> (220 mg, 0.842 mmol) in DCM/MeOH (9/1) at room temperature was added (−)-ditoluoyl-<span class="smallcaps smallerCapital">l</span>-tartaric acid (325 mg, 0.842 mmol). The mixture was stirred for 30 min and concentrated in vacuo to give the desired (−)-ditoluoyl-<span class="smallcaps smallerCapital">l</span>-tartaric acid salt of (+)-<b>18d</b>, which was recrystallized in MeOH to yield crystals suitable for X-ray crystallography.</div><div class="NLM_p last">Data collection was performed on a Bruker APEX, diffractometer at room temperature. Data collection consisted of three ω scans at low angle and three at high angle, each with a 0.5 step. In addition, 2 φ scans were collected to improve the quality of the absorption correction. The structure was solved by direct methods using SHELX software suite in the space group <i>P</i>2(1)2(1)2. The structure was subsequently refined by the full-matrix least-squares method, and the ORTEP representation is shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. All nonhydrogen atoms were found and refined using anisotropic displacement parameters. The hydrogen atoms located on nitrogen and oxygen were found from the Fourier difference map and refined freely. The remaining hydrogen atoms were placed in calculated positions and were allowed to ride on their carrier atoms. The final refinement included isotropic displacement parameters for all hydrogen atoms. The CF<sub>3</sub> group was disordered and modeled freely as a 55:45 ratio between both positions. Most likely, this group is rotating in the structure. The absolute stereochemistry of (+)-<b>18d</b> was determined to be <i>cis</i>-(<i>R</i>,<i>R</i>)-4-(2-fluoro-4-(trifluoromethyl)phenyl)-3-methylpiperidine, from the known chiral centers on the acid. The crystal structure has been deposited in Cambridge Crystallography Data Centre (CCDC) and allocated with the deposition number CCDC 782631. On the basis of this result, the absolute stereochemistry of (+)-<b>17d</b> was determined to be 1-methyl-2-((<i>cis</i>-(<i>R</i>,<i>R</i>)-3-methyl-4-(4-trifluoromethyl-2-fluoro)phenyl)piperidin-1-yl)methyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine.</div></div><div id="sec5_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 1-Methyl-2-((<i>cis</i>-3-methyl-4-(4-trifluoromethyl-2-fluoro)phenyl)piperidin-1-yl)methyl)-1<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>17e</b>)</h4><div class="NLM_p last">The title compound was prepared by the method described for the synthesis of <b>17a</b> from 4-trifluormethoxy-2-fluorophenyl boronic acid. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 8.90 (d, 1H, <i>J</i> = 7.8 Hz), 8.72 (d, 1H, <i>J</i> = 5.4 Hz), 7.90 (m, 1H), 7.40 (m, 1H), 7.13 (m, 2H), 5.10 (s, 2H), 4.13 (s, 3H), 4.00 (m, 2H), 3.66 (m, 3H), 2.68 (m, 1H), 2.55 (m, 1H), 2.01 (m, 1H), 1.03 (d, 3H, <i>J</i> = 6.6 Hz). MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 423.4 (M + 1). Two enantiomers were separated by chiral HPLC from 2.94 g of the racemic <b>17e</b> using a Chiralpak AD column (10 cm × 50 cm) with 85/15 heptane/EtOH as the mobile phase at a flow rate of 500 mL/min. The individual enantiomers were then dissolved in DCM and treated with 4 N HCl in dioxane (3 equiv). The solvent was removed in vacuo, and the resulting solids were triturated with ethylether and dried under vacuum. (+)-<b>17e</b>: retention time, 9.19 min. MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 423.4 (M + 1). UHPLC: 100% (UV), 100% (ELSD). Optical rotation: [α]<sub>D</sub><sup>20</sup> + 19.4° (<i>c</i> 0.60, MeOH). (−)-<b>17e</b>: retention time, 11.38 min. MS (ES<sup>+</sup>): <i>m</i>/<i>z</i> 423.4 (M + 1). UHPLC: 100% (UV), 100% (ELSD). Optical rotation: [α]<sub>D</sub><sup>20</sup> − 19° (<i>c</i> 0.45, MeOH).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74"><a href="/doi/suppl/10.1021/jm101414h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44336" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44336" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">X-ray report of (+)-<b>18d</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm101414h/suppl_file/jm101414h_si_001.pdf">jm101414h_si_001.pdf (144.04 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm101414h" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05686" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05686" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Zhang</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8ec2ebe7a0d4e6efe0e9bdcefee8e7f4ebfca0ede1e3"><span class="__cf_email__" data-cfemail="df93bab6f185b7beb1b8ec9fafb9b6a5baadf1bcb0b2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Brodney</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Candler</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela C. Doran</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allen J. Duplantier</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ivan V. Efremov</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edel Evrard</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth Kraus</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan H. Ganong</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica A. Haas</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ashley N. Hanks</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith Jenza</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John T. Lazzaro</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noha Maklad</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sheryl A. McCarthy</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weimin Qian</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce N. Rogers</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melinda D. Rottas</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Schmidt</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Judith A. Siuciak</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. David Tingley</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andy Q. Zhang</span> - <span class="hlFld-Affiliation affiliation">Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, Connecticut 06340, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Joel Schachter and Diane Lang for the cell generation, Prof. Shigetada Nakanishi of Kyoto University for the cDNA supply, Rebecca O'Connor and Anne Schmidt for the D<sub>2</sub> selectivity data, Brian Samas and Ivan Samardjiev for X-ray analysis, and Pfizer ADME technology group for in vitro PK data. We also thank Dr. Brian O'Neill, Dr. Jotham Coe, and Dr. Christopher J. O'Donnell for their helpful suggestions and comments.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i75" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i75"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i76" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i76"> Abbreviations Used</h2><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco's modified Eagle's medium</p></td></tr><tr><td class="NLM_term">DOI</td><td class="NLM_def"><p class="first last">1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride</p></td></tr><tr><td class="NLM_term">ELSD</td><td class="NLM_def"><p class="first last">evaporative light scattering detection</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">FLIPR</td><td class="NLM_def"><p class="first last">fluorescence imaging plate reader</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">MAP</td><td class="NLM_def"><p class="first last">methamphetamine</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin−Darby canine kidney</p></td></tr><tr><td class="NLM_term">MDR</td><td class="NLM_def"><p class="first last">multiple-drug resistant</p></td></tr><tr><td class="NLM_term">MED</td><td class="NLM_def"><p class="first last">minimally effective dose</p></td></tr><tr><td class="NLM_term">mGluR</td><td class="NLM_def"><p class="first last">metatropic glutamate receptor</p></td></tr><tr><td class="NLM_term">MIS</td><td class="NLM_def"><p class="first last">mescaline-induced scratching</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectrometry</p></td></tr><tr><td class="NLM_term">MWt</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulators</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per os</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure−activity relationship</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">UHPLC</td><td class="NLM_def"><p class="first last">ultrahigh-performance liquid chromatography</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52577" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52577" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Poisik, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verreault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeniyi, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Y.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor 2 modulates excitatory synaptic transmission in the rat globus pallidus</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=57-69&author=O.+Poisikauthor=D.+V.+Rajuauthor=M.+Verreaultauthor=A.+Rodriguezauthor=O.+A.+Abeniyiauthor=P.+J.+Connauthor=Y.+Smith&title=Metabotropic+glutamate+receptor+2+modulates+excitatory+synaptic+transmission+in+the+rat+globus+pallidus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoisik%26aufirst%3DO.%26aulast%3DRaju%26aufirst%3DD.%2BV.%26aulast%3DVerreault%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DAbeniyi%26aufirst%3DO.%2BA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DSmith%26aufirst%3DY.%26atitle%3DMetabotropic%2520glutamate%2520receptor%25202%2520modulates%2520excitatory%2520synaptic%2520transmission%2520in%2520the%2520rat%2520globus%2520pallidus%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D57%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Linden, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor targets for neuropsychiatric disorders</span> <span class="citation_source-journal">Drug Discovery Today: Ther. Strategies</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1016%2Fj.ddstr.2006.10.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=507-517&author=A.-M.+Lindenauthor=D.+D.+Schoepp&title=Metabotropic+glutamate+receptor+targets+for+neuropsychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ddstr.2006.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddstr.2006.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DLinden%26aufirst%3DA.-M.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DMetabotropic%2520glutamate%2520receptor%2520targets%2520for%2520neuropsychiatric%2520disorders%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Ther.%2520Strategies%26date%3D2006%26volume%3D3%26spage%3D507%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Patil, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreev, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avedisova, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardenstein, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurovich, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morozova, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosolov, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neznanov, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reznik, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smulevich, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tochilov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1102-1107&author=S.+T.+Patilauthor=L.+Zhangauthor=F.+Martenyiauthor=S.+L.+Loweauthor=K.+A.+Jacksonauthor=B.+V.+Andreevauthor=A.+S.+Avedisovaauthor=L.+M.+Bardensteinauthor=I.+Y.+Gurovichauthor=M.+A.+Morozovaauthor=S.+N.+Mosolovauthor=N.+G.+Neznanovauthor=A.+M.+Reznikauthor=A.+B.+Smulevichauthor=V.+A.+Tochilovauthor=B.+G.+Johnsonauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Activation+of+mGlu2%2F3+receptors+as+a+new+approach+to+treat+schizophrenia%3A+A+randomized+Phase+2+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DK.%2BA.%26aulast%3DAndreev%26aufirst%3DB.%2BV.%26aulast%3DAvedisova%26aufirst%3DA.%2BS.%26aulast%3DBardenstein%26aufirst%3DL.%2BM.%26aulast%3DGurovich%26aufirst%3DI.%2BY.%26aulast%3DMorozova%26aufirst%3DM.%2BA.%26aulast%3DMosolov%26aufirst%3DS.%2BN.%26aulast%3DNeznanov%26aufirst%3DN.%2BG.%26aulast%3DReznik%26aufirst%3DA.%2BM.%26aulast%3DSmulevich%26aufirst%3DA.%2BB.%26aulast%3DTochilov%26aufirst%3DV.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DActivation%2520of%2520mGlu2%252F3%2520receptors%2520as%2520a%2520new%2520approach%2520to%2520treat%2520schizophrenia%253A%2520A%2520randomized%2520Phase%25202%2520clinical%2520trial%26jtitle%3DNature%2520Med.%26date%3D2007%26volume%3D13%26spage%3D1102%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (−)-(1<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>S</i>)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1124%2Fjpet.108.136861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=18424625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlyltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2008&pages=209-217&author=M.+J.+Fellauthor=K.+A.+Svenssonauthor=B.+G.+Johnsonauthor=D.+D.+Schoepp&title=Evidence+for+the+role+of+metabotropic+glutamate+%28mGlu%292+not+mGlu3+receptors+in+the+preclinical+antipsychotic+pharmacology+of+the+mGlu2%2F3+receptor+agonist+%28%E2%88%92%29-%281R%2C4S%2C5S%2C6S%29-4-amino-2-sulfonylbicyclo%5B3.1.0%5Dhexane-4%2C6-dicarboxylic+acid+%28LY404039%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)</span></div><div class="casAuthors">Fell, Matthew J.; Svensson, Kjell A.; Johnson, Bryan G.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">209-217</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039) is a potent and selective group II metabotropic glutamate [(mGlu)2 and mGlu3] receptor agonist for which its prodrug LY2140023 [(1R,4S,5S,6S)-2-thiabicyclo[3.1.0]-hexane-4,6-dicarboxylic acid,4-[(2S)-2-amino-4-(methylthio)-1-oxobutyl]amino-, 2,2-dioxide monohydrate] has recently been shown to have efficacy in the treatment of the pos. and neg. symptoms of schizophrenia.  In this article, we use mGlu receptor-deficient mice to investigate the relative contribution of mGlu2 and mGlu3 receptors in mediating the antipsychotic profile of LY404039 in the phencyclidine (PCP) and d-amphetamine (AMP) models of psychosis.  To further explore the mechanism of action of LY404039, we compared the drugs' ability to block PCP-induced hyperlocomotion to that of atypical antipsychotics in wild-type and mice lacking mGlu2/3 receptors.  In wild-type animals, LY404039 (3-30 mg/kg i.p.) significantly reversed AMP (5 mg/kg, i.p.)-induced increases in ambulations, distance traveled, and reduced time spent at rest.  LY404039 reversed PCP (7.5 mg/kg i.p.)-evoked behaviors at 10 mg/kg.  The antipsychotic-like effects of LY404039 (10 mg/kg i.p.) on PCP and AMP-evoked behavioral activation were absent in mGlu2 and mGlu2/3 but not in mGlu3 receptor-deficient mice, indicating that the activation of mGlu2 and not mGlu3 receptors is responsible for the antipsychotic-like effects of the mGlu2/3 receptor agonist LY404039.  In contrast, the atypical antipsychotic drugs clozapine and risperidone inhibited PCP-evoked behaviors in both wild-type and mGlu2/3 receptor-deficient mice.  These data demonstrate that the antipsychotic-like effects of the mGlu2/3 receptor agonist LY404039 in psychostimulant models of psychosis are mechanistically distinct from those of atypical antipsychotic drugs and are dependent on functional mGlu2 and not mGlu3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQQM2jpXbmkLVg90H21EOLACvtfcHk0lgjHtJiso3_BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlyltrw%253D&md5=795527aeddef2ee2829f2ae2c6803b6e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.136861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.136861%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DEvidence%2520for%2520the%2520role%2520of%2520metabotropic%2520glutamate%2520%2528mGlu%25292%2520not%2520mGlu3%2520receptors%2520in%2520the%2520preclinical%2520antipsychotic%2520pharmacology%2520of%2520the%2520mGlu2%252F3%2520receptor%2520agonist%2520%2528%25E2%2588%2592%2529-%25281R%252C4S%252C5S%252C6S%2529-4-amino-2-sulfonylbicyclo%255B3.1.0%255Dhexane-4%252C6-dicarboxylic%2520acid%2520%2528LY404039%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D326%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Recasens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiramand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdulkarium, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbanel, G.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors as drug targets</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=651-681&author=M.+Recasensauthor=J.+Guiramandauthor=R.+Aimarauthor=A.+Abdulkariumauthor=G.+Barbanel&title=Metabotropic+glutamate+receptors+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRecasens%26aufirst%3DM.%26aulast%3DGuiramand%26aufirst%3DJ.%26aulast%3DAimar%26aufirst%3DR.%26aulast%3DAbdulkarium%26aufirst%3DA.%26aulast%3DBarbanel%26aufirst%3DG.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520as%2520drug%2520targets%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2007%26volume%3D8%26spage%3D651%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Gjoni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, S.</span><span> </span><span class="NLM_article-title">Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABA<sub>B</sub> receptor desensitization</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=1293-1299&author=T.+Gjoniauthor=S.+Urwyler&title=Receptor+activation+involving+positive+allosteric+modulation%2C+unlike+full+agonism%2C+does+not+result+in+GABAB+receptor+desensitization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGjoni%26aufirst%3DT.%26aulast%3DUrwyler%26aufirst%3DS.%26atitle%3DReceptor%2520activation%2520involving%2520positive%2520allosteric%2520modulation%252C%2520unlike%2520full%2520agonism%252C%2520does%2520not%2520result%2520in%2520GABAB%2520receptor%2520desensitization%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D1293%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="note"><p class="first last">For recent reviews, see </p></div><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fraley, M.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1517%2F13543770903045009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=19552508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1259-1275&author=M.+Fraley&title=Positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia</span></div><div class="casAuthors">Fraley, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1259-1275</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Normalization of excessive glutamate neurotransmission through activation of the metabotropic glutamate receptor 2 (mGluR2) represents a novel and promising approach for the treatment of schizophrenia.  This strategy has gained support through the evaluation of dual mGluR2/3 agonists that act directly at the glutamate (orthosteric) binding site.  Importantly, clin. validation of the mechanism was achieved in a Phase II study in schizophrenia patients with mGluR2/3 agonist LY404039.  Selective pos. allosteric modulators (potentiators) of mGluR2 that bind to the transmembrane region of the receptor have shown efficacy in rodent models predictive of antipsychotic activity, but have yet to be evaluated in the clinic.  Allosteric mGluR2 potentiators may offer advantages over orthosteric mGluR2/3 agonists as a result of their unique mode of action and ability to achieve superior mGluR2 selectivity.  This review focuses on the structures and biol. activities of small mol. potentiators of mGluR2 that appeared in the patent literature between 2006 and early 2009.  Potent mGluR2 potentiators that span a broad range of structural diversity have been disclosed.  Narrow patent filings within select series and drug-like properties of corresponding preferred compds. suggest that development candidates have likely been nominated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpieKt-A0iqRrVg90H21EOLACvtfcHk0lg-jxg4IdBPzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FK&md5=eb77bf795ab4dba6594b08e7c2ea891e</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1517%2F13543770903045009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903045009%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%26atitle%3DPositive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D1259%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span> </span><span class="NLM_article-title">Allosteric modulators for mGlu receptors</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.2174%2F157015907781695900" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=19305801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=187-194&author=F.+Gaspariniauthor=W.+Spooren&title=Allosteric+modulators+for+mGlu+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulators for mGlu receptors</span></div><div class="casAuthors">Gasparini, F.; Spooren, W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-194</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1570-159X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The metabotropic glutamate receptor family comprises eight subtypes (mGlu-8) of G-protein coupled receptors.  MGlu receptors have a large extracellular domain which acts as recognition domain for the natural agonist glutamate.  In contrast to the ionotropic glutamate receptors which mediate the fast excitatory neurotransmission, mGlu receptors have been shown to play a more modulatory role and have been proposed as alternative targets for pharmacol. interventions.  The potential use of mGluRs as drug targets for various nervous system pathologies such as anxiety, depression, schizophrenia, pain or Parkinson's disease has triggered an intense search for subtype selective modulators and resulted in the identification of numerous novel pharmacol. agents capable to modulate the receptor activity through an interaction at an allosteric site located in the transmembrane domain.  The present review presents the most recent developments in the identification and the characterization of allosteric modulators for the mGlu receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprfsRW0fdwSrVg90H21EOLACvtfcHk0lg-jxg4IdBPzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqsLnK&md5=5c87ae2e61d77de86cd14cb24ca31ef0</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.2174%2F157015907781695900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015907781695900%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DSpooren%26aufirst%3DW.%26atitle%3DAllosteric%2520modulators%2520for%2520mGlu%2520receptors%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2007%26volume%3D5%26spage%3D187%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.2174%2F1568026054750281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=16178732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvVCgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=869-884&author=M.+T.+Ruddauthor=J.+A.+McCauley&title=Positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+subtype+2+%28mGluR2%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2)</span></div><div class="casAuthors">Rudd, Michael T.; McCauley, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">869-884</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes recent medicinal chem. progress toward selective potentiators of the metabotropic glutamate receptor 2 (mGluR2).  Groups at Lilly and Merck have identified new classes of potentiators that exhibit selectivity for mGluR2 over the seven other subtypes of mGluRs.  Structure-activity relationships as well as pharmacokinetic properties and in vivo activity are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonTbRY2wz7h7Vg90H21EOLACvtfcHk0lg-jxg4IdBPzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvVCgsLc%253D&md5=f349eab15af2064ef7b52fde8cdc3c20</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.2174%2F1568026054750281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054750281%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DPositive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%2520subtype%25202%2520%2528mGluR2%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D869%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For more recent publications, see the following:</p></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesmans, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Scaffold hopping from pyridone to imidazo[1,2-a]puridines. New positive allosteric modulators of metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=175-179&author=G.+Tresadernauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+De+Lucasauthor=A.+Garciaauthor=E.+Matesanzauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=I.+Biesmansauthor=A.+A.+Trabanco&title=Scaffold+hopping+from+pyridone+to+imidazo%5B1%2C2-a%5Dpuridines.+New+positive+allosteric+modulators+of+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DDe%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DBiesmans%26aufirst%3DI.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DScaffold%2520hopping%2520from%2520pyridone%2520to%2520imidazo%255B1%252C2-a%255Dpuridines.%2520New%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D175%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Brnardic, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslander, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillgrove, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3129</span><span class="NLM_x">–</span> <span class="NLM_lpage">3133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3129-3133&author=E.+J.+Brnardicauthor=M.+E.+Fraleyauthor=R.+M.+Garbaccioauthor=M.+E.+Laytonauthor=J.+M.+Sandersauthor=C.+Culbersonauthor=M.+Jacobsonauthor=B.+C.+Magliaroauthor=P.+H.+Hutsonauthor=J.+A.+O%27Brienauthor=S.+L.+Huszarauthor=J.+M.+Uslanderauthor=K.+L.+Fillgroveauthor=C.+Tangauthor=Y.+Kuoauthor=S.+M.+Surauthor=G.+D.+Hartman&title=3-Aryl-5-phenoxymethyl-1%2C3-oxazolidin-2-ones+as+positive+allosteric+modulators+of+mGluR2+for+the+treatment+of+schizophrenia%3A+Hit-to-lead+efforts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DCulberson%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DO%2527Brien%26aufirst%3DJ.%2BA.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DUslander%26aufirst%3DJ.%2BM.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DSur%26aufirst%3DS.%2BM.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3D3-Aryl-5-phenoxymethyl-1%252C3-oxazolidin-2-ones%2520as%2520positive%2520allosteric%2520modulators%2520of%2520mGluR2%2520for%2520the%2520treatment%2520of%2520schizophrenia%253A%2520Hit-to-lead%2520efforts%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3129%26epage%3D3133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brnardict, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillgrove, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span> </span><span class="NLM_article-title">Discovery of oxazolobenzimidazoles as Postive Allosteric Modulators for the mGluR2 Receptor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100115a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=406-410&author=R.+M.+Garbaccioauthor=E.+J.+Brnardictauthor=M.+E.+Fraleyauthor=G.+D.+Hartmanauthor=P.+H.+Hutsonauthor=J.+A.+O%27Brienauthor=B.+C.+Magliaroauthor=J.+M.+Uslanerauthor=S.+L.+Huszarauthor=K.+L.+Fillgroveauthor=J.+H.+Smallauthor=C.+Tangauthor=Y.+Kuoauthor=M.+A.+Jacobson&title=Discovery+of+oxazolobenzimidazoles+as+Postive+Allosteric+Modulators+for+the+mGluR2+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1021%2Fml100115a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100115a%26sid%3Dliteratum%253Aachs%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DBrnardict%26aufirst%3DE.%2BJ.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DO%2527Brien%26aufirst%3DJ.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DSmall%26aufirst%3DJ.%2BH.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%2520oxazolobenzimidazoles%2520as%2520Postive%2520Allosteric%2520Modulators%2520for%2520the%2520mGluR2%2520Receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D406%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macary, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urios, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epping-Jordan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamelot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derouet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">Discovery of 1, 5-disubstituted pyridines: A new class of positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn1000638" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgsbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=788-795&author=J.+M.+Cidauthor=G.+Duveyauthor=P.+Cluzeauauthor=V.+Nhemauthor=K.+Macaryauthor=A.+Rauxauthor=N.+Poirierauthor=J.+Mullerauthor=C+Boleaauthor=T.+Finnauthor=I.+Uriosauthor=M.+Epping-Jordanauthor=E.+Chamelotauthor=F.+Derouetauthor=F.+Girardauthor=G.+J.+MacDonaldauthor=J.+A.+Vegaauthor=A.+I.+De+Lucasauthor=E.+Matesanzauthor=H.+Lavreysenauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=H.+Oyarzabalauthor=G.+Tresadernauthor=A.+A.+Trabancoauthor=J.+I.+Andresauthor=E.+Le+Poulauthor=H.+Imogaiauthor=R.+Lutjensauthor=J.-P.+Rocher&title=Discovery+of+1%2C+5-disubstituted+pyridines%3A+A+new+class+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7gR"><div class="casContent"><span class="casTitleNuber">7g</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,5-Disubstituted Pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor</span></div><div class="casAuthors">Cid, Jose Maria; Duvey, Guillaume; Cluzeau, Philippe; Nhem, Vanthea; Macary, Karim; Raux, Alexandre; Poirier, Nicolas; Muller, Jessica; Bolea, Christelle; Finn, Terry; Urios, Isabelle; Epping-Jordan, Mark; Chamelot, Emilie; Derouet, Francis; Girard, Francoise; MacDonald, Gregor J.; Vega, Juan Antonio; de Lucas, Ana Isabel; Matesanz, Encarnacion; Lavreysen, Hilde; Linares, Maria Lourdes; Oehlrich, Daniel; Oyarzabal, Julen; Tresadern, Gary; Trabanco, Andres A.; Andres, Jose Ignacio; Le Poul, Emmanuel; Imogai, Hassan; Lutjens, Robert; Rocher, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">788-795</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 1,5-disubstituted pyridones was identified as pos. allosteric modulators (PAMs) of the metabotropic glutamate receptor 2 (mGluR2) via high throughput screening (HTS).  Subsequent SAR exploration led to the identification of several compds. with improved in vitro activity.  Lead compd. 8 (I) was further profiled and found to attenuate the increase in PCP induced locomotor activity in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-saUfhQDgzLVg90H21EOLACvtfcHk0lj_8IWjDR_2iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgsbzO&md5=85204e53809a7efcbd7d9fb5f04a3601</span></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.1021%2Fcn1000638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn1000638%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DMacary%26aufirst%3DK.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DBolea%26aufirst%3DC%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DUrios%26aufirst%3DI.%26aulast%3DEpping-Jordan%26aufirst%3DM.%26aulast%3DChamelot%26aufirst%3DE.%26aulast%3DDerouet%26aufirst%3DF.%26aulast%3DGirard%26aufirst%3DF.%26aulast%3DMacDonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DDe%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DOyarzabal%26aufirst%3DH.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DDiscovery%2520of%25201%252C%25205-disubstituted%2520pyridines%253A%2520A%2520new%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D788%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span> </span><span class="NLM_article-title">3-(Imidazolylmethyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: A novel series of mGluR2 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5493</span><span class="NLM_x">–</span> <span class="NLM_lpage">5496</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5493-5496&author=L.+Zhangauthor=B.+N.+Rogersauthor=A.+J.+Duplantierauthor=S.+F.+McHardyauthor=I.+Efremovauthor=H.+Berkeauthor=W.+Qianauthor=A.+Q.+Zhangauthor=N.+Makladauthor=J.+Candlerauthor=A.+C.+Doranauthor=J.+T.+Lazzaroauthor=A.+H.+Ganong&title=3-%28Imidazolylmethyl%29-3-aza-bicyclo%5B3.1.0%5Dhexan-6-yl%29methyl+ethers%3A+A+novel+series+of+mGluR2+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DMcHardy%26aufirst%3DS.%2BF.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DBerke%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DA.%2BQ.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DCandler%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26atitle%3D3-%2528Imidazolylmethyl%2529-3-aza-bicyclo%255B3.1.0%255Dhexan-6-yl%2529methyl%2520ethers%253A%2520A%2520novel%2520series%2520of%2520mGluR2%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5493%26epage%3D5496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarro, J. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spracklin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2524</span><span class="NLM_x">–</span> <span class="NLM_lpage">2529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2524-2529&author=A.+J.+Duplantierauthor=I.+Efremovauthor=J.+Candlerauthor=A.+C.+Doranauthor=A.+H.+Ganongauthor=J.+A.+Haasauthor=A.+N.+Hanksauthor=K.+G.+Krausauthor=J.+T.+Lazarroauthor=J.+Luauthor=N.+Makladauthor=S.+A.+McCarthyauthor=T.+J.+O%27Sullivanauthor=B.+N.+Rogersauthor=J.+A.+Siuciakauthor=D.+K.+Spracklinauthor=L.+Zhang&title=3-Benzyl-1%2C3-oxazolidin-2-ones+as+mGluR2+positive+allosteric+modulators%3A+Hit-to+lead+and+lead+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DCandler%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26aulast%3DHaas%26aufirst%3DJ.%2BA.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DKraus%26aufirst%3DK.%2BG.%26aulast%3DLazarro%26aufirst%3DJ.%2BT.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DO%2527Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3D3-Benzyl-1%252C3-oxazolidin-2-ones%2520as%2520mGluR2%2520positive%2520allosteric%2520modulators%253A%2520Hit-to%2520lead%2520and%2520lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2524%26epage%3D2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><div class="note"><p class="first last">During the preparation of this manuscript, a structurally related series of mGluR2 PAMs was disclosed by D'Alessandro et al. For a reference, see </p></div><span class="NLM_contrib-group">D'Alessandro, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugolini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montanari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powney, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppe, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocheville, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De la Fuente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Los Frailes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=759-762&author=P.+L.+D%27Alessandroauthor=C.+Cortiauthor=A.+Rothauthor=A.+Ugoliniauthor=A.+Savaauthor=D.+Montanariauthor=F.+Bianchiauthor=S.+L.+Garlandauthor=B.+Powneyauthor=E.+L.+Koppeauthor=M.+Rochevilleauthor=G.+Osborneauthor=P.+Perezauthor=J.+De+la+Fuenteauthor=M.+De+Los+Frailesauthor=P.+W.+Smithauthor=C.+Branchauthor=D.+Nashauthor=S.+P.+Watson&title=The+identification+of+structurally+novel%2C+selective%2C+orally+bioavailable+positive+modulators+of+mGluR2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%2527Alessandro%26aufirst%3DP.%2BL.%26aulast%3DCorti%26aufirst%3DC.%26aulast%3DRoth%26aufirst%3DA.%26aulast%3DUgolini%26aufirst%3DA.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DD.%26aulast%3DBianchi%26aufirst%3DF.%26aulast%3DGarland%26aufirst%3DS.%2BL.%26aulast%3DPowney%26aufirst%3DB.%26aulast%3DKoppe%26aufirst%3DE.%2BL.%26aulast%3DRocheville%26aufirst%3DM.%26aulast%3DOsborne%26aufirst%3DG.%26aulast%3DPerez%26aufirst%3DP.%26aulast%3DDe%2Bla%2BFuente%26aufirst%3DJ.%26aulast%3DDe%2BLos%2BFrailes%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DBranch%26aufirst%3DC.%26aulast%3DNash%26aufirst%3DD.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520identification%2520of%2520structurally%2520novel%252C%2520selective%252C%2520orally%2520bioavailable%2520positive%2520modulators%2520of%2520mGluR2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D759%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="note"><p class="first last">The mGluR2 FLIPR functional assay uses a stable HEK cell line expressing the rat mGluR2 receptor and Gα15 G protein. Cells are plated in 384-well poly-<span class="smallcaps smallerCapital">d</span>-lysine-coated plates and incubated in glutamine-free medium. Cells are loaded with Fluo-4 am containing glutamic pyruvic transaminase to reduce endogenous glutamate. Compound is added with the FLIPR, incubated at room temperature for approximately 30 min, and then tested against an approximate EC<sub>10</sub> to EC<sub>20</sub> glutamate challenge. Data are analyzed as a ratio of the peak fluorescence to the baseline after compound addition. Assay to assay variability in PAM potency required multiple experiments to determine potency, typically <i>n</i> > 3.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Blood-brain barrier permeability considerations for CNS-targeted compound library design</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1016%2Fj.cbpa.2008.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=18435937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1ers74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=318-323&author=S.+A.+Hitchcock&title=Blood-brain+barrier+permeability+considerations+for+CNS-targeted+compound+library+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier permeability considerations for CNS-targeted compound library design</span></div><div class="casAuthors">Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">318-323</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A further refinement of the concept of drug-likeness is required for compd. libraries intended for central nervous system (CNS) targets to account for the limitations imposed by blood-brain barrier permeability.  This review describes criteria and processes that can be applied in the de novo design and assembly of libraries to increase the odds of compds. residing within CNS-accessible chem. space.  A no. of published examples where CNS activity and/or penetration characteristics have been a factor in library design are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorhMoAmlVhlrVg90H21EOLACvtfcHk0ljFSSA8mTGr3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1ers74%253D&md5=7b6962e237bc80c1d44053b54c5f3f40</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2008.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2008.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DBlood-brain%2520barrier%2520permeability%2520considerations%2520for%2520CNS-targeted%2520compound%2520library%2520design%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D12%26spage%3D318%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-891&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="note"><p class="first last">Compound <b>3</b> was screened against a panel of CNS receptors consist of H1, D<sub>2</sub>, 5HT<sub>1A</sub>, 5HT<sub>2B</sub>, 5HT<sub>2A</sub>, α 2A, α 1A, M1, and dofetilide receptors, with no significant binding affinities detected at the highest concentration tested (less than 50% at 3.16 μM) in all other receptors with the exception of D2 receptor (<i>K</i><sub>i</sub> = 426 nM). Compound <b>3</b> was also screened in mGluR1 (agonist, antagonist mode), mGluR5 (agonist, antagonist, PAM mode) functional assays with no activity detected up to 10 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">The D<sub>2</sub> functional assay uses a stable CHO cell line transfected with human D<sub>2</sub> receptors and measures the inhibition of quinpirole stimulation by the test compounds.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><div class="note"><p class="first last">For a recent review, see </p></div><span class="NLM_contrib-group">Seeman, P.</span><span> </span><span class="NLM_article-title">Targeting the dopamine D2 receptor in schizophrenia</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1517%2F14728222.10.4.515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=16848689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1ahtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=515-531&author=P.+Seeman&title=Targeting+the+dopamine+D2+receptor+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dopamine D2 receptor in schizophrenia</span></div><div class="casAuthors">Seeman, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">515-531</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  After a 12-yr search for the antipsychotic receptor, the binding site was discovered and labeled by [3H]haloperidol in 1975.  Of the various neurotransmitters, dopamine was the most potent in inhibiting the binding of [3H]haloperidol, indicating that the antipsychotic receptor was a dopamine receptor, now named the dopamine D2 receptor, a major targeting site in schizophrenia.  All antipsychotic drugs, including traditional and newer antipsychotics, either bind to D2 in direct relation to their clin. potencies or hinder normal dopamine neurotransmission, as in the case of partial dopamine agonists.  In fact, the antipsychotic concns. found in the plasma water of treated patients closely match the predicted therapeutic abs. concns., adjusted for the 60-75% D2 occupancy needed for clin. efficacy.  Antipsychotics that elicit low or no Parkinsonism or prolactinemia are loosely attached to D2 and rapidly dissoc. from D2, whereas those eliciting Parkinsonism stay tightly attached to D2 for many hours.  Because animal models of psychosis (amfetamine sensitization, brain lesions) all show a marked elevation in the no. of high-affinity states of D2, the antipsychotics are thought to specifically target these D2High states in psychosis in general and schizophrenia in particular.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGjVyTQvf6orVg90H21EOLACvtfcHk0lj2Hy67kO-ZHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1ahtro%253D&md5=4ac073cabc6f50e8d0e3a2ecc631e781</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F14728222.10.4.515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.10.4.515%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520dopamine%2520D2%2520receptor%2520in%2520schizophrenia%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2006%26volume%3D10%26spage%3D515%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Jaen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, L. D.</span><span> </span><span class="NLM_article-title">Synthesis of the 1,2,3,4-tetrahydrobenzofuro[2,3-c]pyridine ring system</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1319</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1987&pages=1317-1319&author=J.+C.+Jaenauthor=L.+D.+Wise&title=Synthesis+of+the+1%2C2%2C3%2C4-tetrahydrobenzofuro%5B2%2C3-c%5Dpyridine+ring+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DWise%26aufirst%3DL.%2BD.%26atitle%3DSynthesis%2520of%2520the%25201%252C2%252C3%252C4-tetrahydrobenzofuro%255B2%252C3-c%255Dpyridine%2520ring%2520system%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1987%26volume%3D24%26spage%3D1317%26epage%3D1319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="note"><p class="first last">Compounds (+)-<b>17c</b>−<b>e</b> were profiled in a broad spectrum selectivity panel (CEREP, Bioprint) that consists of 122 targets without no significant off-target activities identified (IC<sub>50</sub> values > 3000 nM); compounds (+)-<b>17c</b>−<b>e</b> were also screened in mGluR1 (agonist, antagonist mode), mGluR5 (agonist, antagonist, PAM mode) functional assays with no activity detected up to 10 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Yui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikemoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, K.</span><span> </span><span class="NLM_article-title">Studies of Amphetamine or Methamphetamine Psychosis in Japan: Relation of Methamphetamine Psychosis to Schizophrenia</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">914</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=914&publication_year=2000&pages=1-12&author=K.+Yuiauthor=S.+Ikemotoauthor=T.+Ishiguroauthor=K.+Goto&title=Studies+of+Amphetamine+or+Methamphetamine+Psychosis+in+Japan%3A+Relation+of+Methamphetamine+Psychosis+to+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYui%26aufirst%3DK.%26aulast%3DIkemoto%26aufirst%3DS.%26aulast%3DIshiguro%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DK.%26atitle%3DStudies%2520of%2520Amphetamine%2520or%2520Methamphetamine%2520Psychosis%2520in%2520Japan%253A%2520Relation%2520of%2520Methamphetamine%2520Psychosis%2520to%2520Schizophrenia%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2000%26volume%3D914%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hirota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, S.</span><span> </span><span class="NLM_article-title">Neuropharmacological Profile of an Atypical Antipsychotic, NRA0562</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=375-388&author=S.+Hirotaauthor=N.+Kawashimaauthor=S.+Chakiauthor=S.+Okuyama&title=Neuropharmacological+Profile+of+an+Atypical+Antipsychotic%2C+NRA0562"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirota%26aufirst%3DS.%26aulast%3DKawashima%26aufirst%3DN.%26aulast%3DChaki%26aufirst%3DS.%26aulast%3DOkuyama%26aufirst%3DS.%26atitle%3DNeuropharmacological%2520Profile%2520of%2520an%2520Atypical%2520Antipsychotic%252C%2520NRA0562%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2003%26volume%3D9%26spage%3D375%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Satow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maehara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ise, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hikichi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span> </span><span class="NLM_article-title">Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1<i>H</i>-1,2,3-triazol-4-yl]-<i>N</i>-isopropyl-<i>N</i>-methyl-3,6-dihydropyridine-1(2<i>H</i>)-carboxamide]</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1124%2Fjpet.108.138107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=18487514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVWqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2008&pages=577-586&author=A.+Satowauthor=S.+Maeharaauthor=S.+Iseauthor=H.+Hikichiauthor=M.+Fukushimaauthor=G.+Suzukiauthor=T.+Kimuraauthor=T.+Tanakaauthor=S.+Itoauthor=H.+Kawamotoauthor=H.+Ohta&title=Pharmacological+effects+of+the+metabotropic+glutamate+receptor+1+antagonist+compared+with+those+of+the+metabotropic+glutamate+receptor+5+antagonist+and+metabotropic+glutamate+receptor+2%2F3+agonist+in+rodents%3A+detailed+investigations+with+a+selective+allosteric+metabotropic+glutamate+receptor+1+antagonist%2C+FTIDC+%5B4-%5B1-%282-fluoropyridine-3-yl%29-5-methyl-1H-1%2C2%2C3-triazol-4-yl%5D-N-isopropyl-N-methyl-3%2C6-dihydropyridine-1%282H%29-carboxamide%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide]</span></div><div class="casAuthors">Satow, Akio; Maehara, Shunsuke; Ise, Satoko; Hikichi, Hirohiko; Fukushima, Miyuki; Suzuki, Gentaroh; Kimura, Toshifumi; Tanaka, Takeshi; Ito, Satoru; Kawamoto, Hiroshi; Ohta, Hisashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">577-586</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The functional roles of metabotropic glutamate receptor (mGluR) 1 in integrative brain functions were investigated using a potent and selective mGluR1 allosteric antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide], in comparison with the mGluR5 allosteric antagonist and the mGluR2/3 orthosteric agonist in rodents.  FTIDC reduced maternal sepn.-induced ultrasonic vocalization and stress-induced hyperthermia without affecting behaviors in the elevated plus maze.  An mGluR5 antagonist, 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and an mGluR2/3 agonist, LY379268 [(1R,4R,5S,6R)-4-amino-2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylic acid], showed anxiolytic activities in these models, suggesting involvement of postsynaptic mGluR1 in stress-related responses comparable with mGluR5 and mGluR2/3.  Analgesic effects of FTIDC were seen in the formalin test but not in the tail immersion test.  FTIDC selectively blocked methamphetamine-induced hyperlocomotion and disruption of prepulse inhibition, whereas MPEP and LY379268 did not alter those behaviors, suggesting that pharmacol. blockade of mGluR1 could result in antipsychotic-like effects.  FTIDC did not elicit catalepsy or impair motor functions at 10 times higher dose than doses showing antipsychotic-like action.  In conclusion, blockade of mGluR1 showed antipsychotic-like effects without impairing motor functions, whereas blockade of mGluR5 and activation of mGluR2/3 did not display such activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlZn0-fiQ-DrVg90H21EOLACvtfcHk0lhHFQkZsfvDDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVWqs7g%253D&md5=be3da3ecd67e1cd19d4d56b0800e5e8e</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.138107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.138107%26sid%3Dliteratum%253Aachs%26aulast%3DSatow%26aufirst%3DA.%26aulast%3DMaehara%26aufirst%3DS.%26aulast%3DIse%26aufirst%3DS.%26aulast%3DHikichi%26aufirst%3DH.%26aulast%3DFukushima%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DG.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DKawamoto%26aufirst%3DH.%26aulast%3DOhta%26aufirst%3DH.%26atitle%3DPharmacological%2520effects%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25201%2520antagonist%2520compared%2520with%2520those%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25205%2520antagonist%2520and%2520metabotropic%2520glutamate%2520receptor%25202%252F3%2520agonist%2520in%2520rodents%253A%2520detailed%2520investigations%2520with%2520a%2520selective%2520allosteric%2520metabotropic%2520glutamate%2520receptor%25201%2520antagonist%252C%2520FTIDC%2520%255B4-%255B1-%25282-fluoropyridine-3-yl%2529-5-methyl-1H-1%252C2%252C3-triazol-4-yl%255D-N-isopropyl-N-methyl-3%252C6-dihydropyridine-1%25282H%2529-carboxamide%255D%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D326%26spage%3D577%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Marinozzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natalini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tijskens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacological Characterization of All Sixteen Stereoisomers of 2-(2′-Carboxy-3′-phenylcyclopropyl)glycine. Focus on (2<i>S</i>,1′<i>S</i>,2′<i>S</i>,3′<i>R</i>)-2-(2′-Carboxy-3′-phenylcyclopropyl)glycine, a Novel and Selective Group II Metabotropic Glutamate Receptor Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2259</span><span class="NLM_x">–</span> <span class="NLM_lpage">2269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=2259-2269&author=M.+Marinozziauthor=B.+Nataliniauthor=G.+Constantinoauthor=P.+Tijskensauthor=C.+Thomsenauthor=R.+Pellicciari&title=Synthesis+and+Pharmacological+Characterization+of+All+Sixteen+Stereoisomers+of+2-%282%E2%80%B2-Carboxy-3%E2%80%B2-phenylcyclopropyl%29glycine.+Focus+on+%282S%2C1%E2%80%B2S%2C2%E2%80%B2S%2C3%E2%80%B2R%29-2-%282%E2%80%B2-Carboxy-3%E2%80%B2-phenylcyclopropyl%29glycine%2C+a+Novel+and+Selective+Group+II+Metabotropic+Glutamate+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarinozzi%26aufirst%3DM.%26aulast%3DNatalini%26aufirst%3DB.%26aulast%3DConstantino%26aufirst%3DG.%26aulast%3DTijskens%26aufirst%3DP.%26aulast%3DThomsen%26aufirst%3DC.%26aulast%3DPellicciari%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Characterization%2520of%2520All%2520Sixteen%2520Stereoisomers%2520of%25202-%25282%25E2%2580%25B2-Carboxy-3%25E2%2580%25B2-phenylcyclopropyl%2529glycine.%2520Focus%2520on%2520%25282S%252C1%25E2%2580%25B2S%252C2%25E2%2580%25B2S%252C3%25E2%2580%25B2R%2529-2-%25282%25E2%2580%25B2-Carboxy-3%25E2%2580%25B2-phenylcyclopropyl%2529glycine%252C%2520a%2520Novel%2520and%2520Selective%2520Group%2520II%2520Metabotropic%2520Glutamate%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D2259%26epage%3D2269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Gross, G.; Wicke, K. M.; Mezler, M.; Schoemaker, H.</span><span> </span><span class="NLM_article-title">Glutamate mGluR2/3 agonists inhibit mescaline-induced scratching in mice: A potential model of antipsychotic activity</span>.  <span class="citation_source-journal">34th Annual Meeting of the Society for Neuroscience</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span>abstract 1030.16.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=G.+Gross&author=K.+M.+Wicke&author=M.+Mezler&author=H.+Schoemaker&title=Glutamate+mGluR2%2F3+agonists+inhibit+mescaline-induced+scratching+in+mice%3A+A+potential+model+of+antipsychotic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DG.%26atitle%3DGlutamate%2520mGluR2%252F3%2520agonists%2520inhibit%2520mescaline-induced%2520scratching%2520in%2520mice%253A%2520A%2520potential%2520model%2520of%2520antipsychotic%2520activity%26jtitle%3D34th%2520Annual%2520Meeting%2520of%2520the%2520Society%2520for%2520Neuroscience%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gonzalez-Maeso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisstaub, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley-Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sealfon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, J. A.</span><span> </span><span class="NLM_article-title">Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2007&pages=439-452&author=J.+Gonzalez-Maesoauthor=N.+V.+Weisstaubauthor=M.+Zhouauthor=P.+Chanauthor=L.+Ivicauthor=R.+Angauthor=A+Liraauthor=M.+Bradley-Mooreauthor=Y.+Geauthor=Q.+Zhouauthor=S.+C.+Sealfonauthor=J.+A.+Gingrich&title=Hallucinogens+recruit+specific+cortical+5-HT2A+receptor-mediated+signaling+pathways+to+affect+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Maeso%26aufirst%3DJ.%26aulast%3DWeisstaub%26aufirst%3DN.%2BV.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DP.%26aulast%3DIvic%26aufirst%3DL.%26aulast%3DAng%26aufirst%3DR.%26aulast%3DLira%26aufirst%3DA%26aulast%3DBradley-Moore%26aufirst%3DM.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DSealfon%26aufirst%3DS.%2BC.%26aulast%3DGingrich%26aufirst%3DJ.%2BA.%26atitle%3DHallucinogens%2520recruit%2520specific%2520cortical%25205-HT2A%2520receptor-mediated%2520signaling%2520pathways%2520to%2520affect%2520behavior%26jtitle%3DNeuron%26date%3D2007%26volume%3D53%26spage%3D439%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Scruggs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span> </span><span class="NLM_article-title">The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2003&pages=137-140&author=J.+L.+Scruggsauthor=D.+Schmidtauthor=A.+Y.+Deutch&title=The+hallucinogen+1-%5B2%2C5-dimethoxy-4-iodophenyl%5D-2-aminopropane+%28DOI%29+increases+cortical+extracellular+glutamate+levels+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScruggs%26aufirst%3DJ.%2BL.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26atitle%3DThe%2520hallucinogen%25201-%255B2%252C5-dimethoxy-4-iodophenyl%255D-2-aminopropane%2520%2528DOI%2529%2520increases%2520cortical%2520extracellular%2520glutamate%2520levels%2520in%2520rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D2003%26volume%3D346%26spage%3D137%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Scruggs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span> </span><span class="NLM_article-title">DOI -induced activation of the cortex: Dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">8846</span><span class="NLM_x">–</span> <span class="NLM_lpage">8852</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=11102493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpslWg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=8846-8852&author=J.+L.+Scruggsauthor=S.+Patelauthor=M.+Bubserauthor=A.+Y.+Deutch&title=DOI+-induced+activation+of+the+cortex%3A+Dependence+on+5-HT2A+heteroceptors+on+thalamocortical+glutamatergic+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">DOI-induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons</span></div><div class="casAuthors">Scruggs, Jennifer L.; Patel, Sachin; Bubser, Michael; Deutch, Ariel Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8846-8852</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Administration of the hallucinogenic 5-HT2A/2C agonist 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) induces expression of Fos protein in the cerebral cortex.  To understand the mechanisms subserving this action of DOI, the authors examd. the consequences of pharmacol. and surgical manipulations on DOI-elicited Fos expression in the somatosensory cortex of the rat.  DOI dose-dependently increased cortical Fos expression.  Pretreatment with the selective 5-HT2A antagonist MDL 100,907 completely blocked DOI-elicited Fos expression, but pretreatment with the 5-HT2C antagonist SB 206,553 did not modify DOI-elicited Fos expression.  These data suggest that DOI acts through 5-HT2A receptors to increase cortical Fos expression.  However, the authors found that DOI did not induce Fos in cortical 5-HT2A immunoreactive neurons but did increase expression in a band of neurons spanning superficial layer V to deep III, within the apical dendritic fields of layer V 5-HT2A-immunoreactive cells.  This band of Fos immunoreactive neurons was in register with anterogradely labeled axons from the ventrobasal thalamus, which have previously been shown to be glutamatergic and express the 5-HT2A transcript.  The effects of DOI were markedly reduced in animals pretreated with the AMPA/KA antagonist GYKI 52466, and lesions of the ventrobasal thalamus attenuated DOI-elicited Fos expression in the cortex.  These data suggest that DOI activates 5-HT2A receptors on thalamocortical neurons and thereby increases glutamate release, which in turn drives Fos expression in cortical neurons through an AMPA receptor-dependent mechanism.  These data cast new light on the mechanisms of action of hallucinogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuwcdyIu41XLVg90H21EOLACvtfcHk0lhHFQkZsfvDDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpslWg&md5=f277728e0ede8ec3bc29b7782cb0d6bf</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScruggs%26aufirst%3DJ.%2BL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26atitle%3DDOI%2520-induced%2520activation%2520of%2520the%2520cortex%253A%2520Dependence%2520on%25205-HT2A%2520heteroceptors%2520on%2520thalamocortical%2520glutamatergic%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2000%26volume%3D20%26spage%3D8846%26epage%3D8852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Marek, G. J.</span><span> </span><span class="NLM_article-title">A novel approach to the identification of psychiatric drugs: Serotonin-glutamate interactions in the prefrontal cortex</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=206-218&author=G.+J.+Marek&title=A+novel+approach+to+the+identification+of+psychiatric+drugs%3A+Serotonin-glutamate+interactions+in+the+prefrontal+cortex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarek%26aufirst%3DG.%2BJ.%26atitle%3DA%2520novel%2520approach%2520to%2520the%2520identification%2520of%2520psychiatric%2520drugs%253A%2520Serotonin-glutamate%2520interactions%2520in%2520the%2520prefrontal%2520cortex%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2000%26volume%3D6%26spage%3D206%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span> </span><span class="NLM_article-title">Influence of nonspecific brain and plasma binding on CNS exposure: Implications for rational drug discovery</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327-338&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+nonspecific+brain+and+plasma+binding+on+CNS+exposure%3A+Implications+for+rational+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0lgvUFRER85RQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520nonspecific%2520brain%2520and%2520plasma%2520binding%2520on%2520CNS%2520exposure%253A%2520Implications%2520for%2520rational%2520drug%2520discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e','cit7f','cit7g'],'ref8':['cit8a','cit8b'],'ref9':['cit9'],'ref10':[],'ref11':['cit11a','cit11b'],'ref12':[],'ref13':[],'ref14':['cit14'],'ref15':['cit15'],'ref16':[],'ref17':['cit17'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b','cit21c','cit21d'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 19 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">György Szabó, Péter Erdélyi, Sándor Kolok, Mónika Vastag, Attila S. Halász, Istvánné Kis-Varga, György I. Lévay, Zoltán Béni, János Kóti, István Greiner, <span class="NLM_string-name hlFld-ContribAuthor">György M. Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Optimization of Dihydropyrazino-Benzimidazolones as Metabotropic Glutamate Receptor-2 Positive Allosteric Modulators against Migraine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8607-8620. <a href="https://doi.org/10.1021/acs.jmedchem.1c00563" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00563%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BOptimization%252Bof%252BDihydropyrazino-Benzimidazolones%252Bas%252BMetabotropic%252BGlutamate%252BReceptor-2%252BPositive%252BAllosteric%252BModulators%252Bagainst%252BMigraine%26aulast%3DSzab%25C3%25B3%26aufirst%3DGy%25C3%25B6rgy%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D29032021%26date%3D03062021%26volume%3D64%26issue%3D12%26spage%3D8607%26epage%3D8620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Gengyang Yuan, Xiying Qu, Baohui Zheng, Ramesh Neelamegam, Sepideh Afshar, Suhasini Iyengar, Chuzhi Pan, Junfeng Wang, Hye Jin Kang, Mary Jo Ondrechen, Pekka Poutiainen, Georges El Fakhri, Zhaoda Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Anna-Liisa Brownell</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Characterization of Benzimidazole Derivatives as Positron Emission Tomography Imaging Ligands for Metabotropic Glutamate Receptor 2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 12060-12072. <a href="https://doi.org/10.1021/acs.jmedchem.0c01394" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01394</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01394%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BCharacterization%252Bof%252BBenzimidazole%252BDerivatives%252Bas%252BPositron%252BEmission%252BTomography%252BImaging%252BLigands%252Bfor%252BMetabotropic%252BGlutamate%252BReceptor%252B2%26aulast%3DYuan%26aufirst%3DGengyang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08082020%26date%3D07102020%26date%3D28092020%26volume%3D63%26issue%3D20%26spage%3D12060%26epage%3D12072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhongyi  Zeng</span>, <span class="hlFld-ContribAuthor ">Hongming  Jin</span>, <span class="hlFld-ContribAuthor ">Jin  Xie</span>, <span class="hlFld-ContribAuthor ">Bing  Tian</span>, <span class="hlFld-ContribAuthor ">Matthias  Rudolph</span>, <span class="hlFld-ContribAuthor ">Frank  Rominger</span>, and <span class="hlFld-ContribAuthor ">A. Stephen K.  Hashmi</span>  . </span><span class="cited-content_cbyCitation_article-title">α-Imino Gold Carbenes from 1,2,4-Oxadiazoles: Atom-Economical Access to Fully Substituted 4-Aminoimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (5)
                                     , 1020-1023. <a href="https://doi.org/10.1021/acs.orglett.7b00001" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b00001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b00001%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3D%2525CE%2525B1-Imino%252BGold%252BCarbenes%252Bfrom%252B1%25252C2%25252C4-Oxadiazoles%25253A%252BAtom-Economical%252BAccess%252Bto%252BFully%252BSubstituted%252B4-Aminoimidazoles%26aulast%3DZeng%26aufirst%3DZhongyi%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D01012017%26date%3D20022017%26date%3D03032017%26volume%3D19%26issue%3D5%26spage%3D1020%26epage%3D1023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shyama  Sidique</span>, <span class="hlFld-ContribAuthor ">Raveendra-Panickar  Dhanya</span>, <span class="hlFld-ContribAuthor ">Douglas J.  Sheffler</span>, <span class="hlFld-ContribAuthor ">Hilary Highfield  Nickols</span>, <span class="hlFld-ContribAuthor ">Li  Yang</span>, <span class="hlFld-ContribAuthor ">Russell  Dahl</span>, <span class="hlFld-ContribAuthor ">Arianna  Mangravita-Novo</span>, <span class="hlFld-ContribAuthor ">Layton H.  Smith</span>, <span class="hlFld-ContribAuthor ">Manoranjan S.  D’Souza</span>, <span class="hlFld-ContribAuthor ">Svetlana  Semenova</span>, <span class="hlFld-ContribAuthor ">P. Jeffrey  Conn</span>, <span class="hlFld-ContribAuthor ">Athina  Markou</span>, and <span class="hlFld-ContribAuthor ">Nicholas D. P.  Cosford</span>  . </span><span class="cited-content_cbyCitation_article-title">Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure–Activity Relationships and Assessment in a Rat Model of Nicotine Dependence. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 9434-9445. <a href="https://doi.org/10.1021/jm3005306" title="DOI URL">https://doi.org/10.1021/jm3005306</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3005306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3005306%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOrally%252BActive%252BMetabotropic%252BGlutamate%252BSubtype%252B2%252BReceptor%252BPositive%252BAllosteric%252BModulators%25253A%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Band%252BAssessment%252Bin%252Ba%252BRat%252BModel%252Bof%252BNicotine%252BDependence%26aulast%3DSidique%26aufirst%3DShyama%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D14042012%26date%3D23102012%26date%3D26112012%26date%3D25092012%26volume%3D55%26issue%3D22%26spage%3D9434%26epage%3D9445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jose María  Cid</span>, <span class="hlFld-ContribAuthor ">Guillaume  Duvey</span>, <span class="hlFld-ContribAuthor ">Gary  Tresadern</span>, <span class="hlFld-ContribAuthor ">Vanthea  Nhem</span>, <span class="hlFld-ContribAuthor ">Rocco  Furnari</span>, <span class="hlFld-ContribAuthor ">Philippe  Cluzeau</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Vega</span>, <span class="hlFld-ContribAuthor ">Ana Isabel  de Lucas</span>, <span class="hlFld-ContribAuthor ">Encarnación  Matesanz</span>, <span class="hlFld-ContribAuthor ">José Manuel  Alonso</span>, <span class="hlFld-ContribAuthor ">María Lourdes  Linares</span>, <span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Sonia M.  Poli</span>, <span class="hlFld-ContribAuthor ">Robert  Lutjens</span>, <span class="hlFld-ContribAuthor ">Hassan  Himogai</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Rocher</span>, <span class="hlFld-ContribAuthor ">Gregor J.  Macdonald</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>, <span class="hlFld-ContribAuthor ">Abdelah  Ahnaou</span>, <span class="hlFld-ContribAuthor ">Wilhelmus  Drinkenburg</span>, <span class="hlFld-ContribAuthor ">Claire  Mackie</span>, and <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 1,4-Disubstituted 3-Cyano-2-pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (5)
                                     , 2388-2405. <a href="https://doi.org/10.1021/jm2016864" title="DOI URL">https://doi.org/10.1021/jm2016864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm2016864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm2016864%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B1%25252C4-Disubstituted%252B3-Cyano-2-pyridones%25253A%252BA%252BNew%252BClass%252Bof%252BPositive%252BAllosteric%252BModulators%252Bof%252Bthe%252BMetabotropic%252BGlutamate%252B2%252BReceptor%26aulast%3DCid%26aufirst%3DJose%2BMar%25C3%25ADa%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D14122011%26date%3D24022012%26date%3D08032012%26volume%3D55%26issue%3D5%26spage%3D2388%26epage%3D2405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joost  Steverlynck</span>, <span class="hlFld-ContribAuthor ">Ruzal  Sitdikov</span>, <span class="hlFld-ContribAuthor ">Magnus  Rueping</span>. </span><span class="cited-content_cbyCitation_article-title">The Deuterated “Magic Methyl” Group: A Guide to Site‐Selective Trideuteromethyl Incorporation and Labeling by Using CD
              3
              Reagents. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>26 </em><a href="https://doi.org/10.1002/chem.202101179" title="DOI URL">https://doi.org/10.1002/chem.202101179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202101179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202101179%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DThe%252BDeuterated%252B%2525E2%252580%25259CMagic%252BMethyl%2525E2%252580%25259D%252BGroup%25253A%252BA%252BGuide%252Bto%252BSite%2525E2%252580%252590Selective%252BTrideuteromethyl%252BIncorporation%252Band%252BLabeling%252Bby%252BUsing%252BCD%252B3%252BReagents%26aulast%3DSteverlynck%26aufirst%3DJoost%26date%3D2021%26date%3D2021%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janos  Sapi</span>, <span class="hlFld-ContribAuthor ">Stéphane  Gérard</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems: Three Heteroatoms 2:1. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00021-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00021-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00021-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00021-4%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%25253A%252BThree%252BHeteroatoms%252B2%25253A1%26aulast%3DSapi%26aufirst%3DJanos%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%252010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">György  Szabó</span>, <span class="hlFld-ContribAuthor ">Sándor  Kolok</span>, <span class="hlFld-ContribAuthor ">Zoltán  Orgován</span>, <span class="hlFld-ContribAuthor ">Mónika  Vastag</span>, <span class="hlFld-ContribAuthor ">Zoltán  Béni</span>, <span class="hlFld-ContribAuthor ">János  Kóti</span>, <span class="hlFld-ContribAuthor ">Katalin  Sághy</span>, <span class="hlFld-ContribAuthor ">György I.  Lévay</span>, <span class="hlFld-ContribAuthor ">István  Greiner</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of dihydropyrazino-benzimidazole derivatives as metabotropic glutamate receptor-2 (mGluR2) positive allosteric modulators (PAMs). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>186 </em>, 111881. <a href="https://doi.org/10.1016/j.ejmech.2019.111881" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111881</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111881%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bdihydropyrazino-benzimidazole%252Bderivatives%252Bas%252Bmetabotropic%252Bglutamate%252Breceptor-2%252B%252528mGluR2%252529%252Bpositive%252Ballosteric%252Bmodulators%252B%252528PAMs%252529%26aulast%3DSzab%25C3%25B3%26aufirst%3DGy%25C3%25B6rgy%26date%3D2020%26volume%3D186%26spage%3D111881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chaobin  Jin</span>, <span class="hlFld-ContribAuthor ">Shutao  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the medicinal chemistry of group II and group III mGlu receptors. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 501-515. <a href="https://doi.org/10.1039/C6MD00612D" title="DOI URL">https://doi.org/10.1039/C6MD00612D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00612D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00612D%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bmedicinal%252Bchemistry%252Bof%252Bgroup%252BII%252Band%252Bgroup%252BIII%252BmGlu%252Breceptors%26aulast%3DJin%26aufirst%3DChaobin%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D3%26spage%3D501%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. R.  Subimol</span>, <span class="hlFld-ContribAuthor ">S. Arul  Antony</span>, <span class="hlFld-ContribAuthor ">K. Karthik  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel and Facile Methodology for Synthesis of Coumarin Coupled Benzimidazole-2-Thione Compounds. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2015,</strong> <em>190 </em>
                                    (4)
                                     , 494-502. <a href="https://doi.org/10.1080/10426507.2014.952000" title="DOI URL">https://doi.org/10.1080/10426507.2014.952000</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2014.952000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2014.952000%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DA%252BNovel%252Band%252BFacile%252BMethodology%252Bfor%252BSynthesis%252Bof%252BCoumarin%252BCoupled%252BBenzimidazole-2-Thione%252BCompounds%26aulast%3DSubimol%26aufirst%3DK.%2BR.%26date%3D2015%26date%3D2015%26volume%3D190%26issue%3D4%26spage%3D494%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">References. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 290-333. <a href="https://doi.org/10.1002/9781118943670.refs" title="DOI URL">https://doi.org/10.1002/9781118943670.refs</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118943670.refs&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118943670.refs%26sid%3Dliteratum%253Aachs%26atitle%3DReferences%26date%3D2014%26date%3D2014%26spage%3D290%26epage%3D333%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DDrug%252BDiscovery%252Bfor%252Bthe%252BTreatment%252Bof%252BAddiction%26aulast%3DFulton%26aufirst%3DBrian%2BS.%26date%3D2014%26volume%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José M.  Cid</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Hilde  Lavreysen</span>. </span><span class="cited-content_cbyCitation_article-title">Metabotropic Glutamate Receptor 2 Activators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 101-142. <a href="https://doi.org/10.1007/7355_2014_48" title="DOI URL">https://doi.org/10.1007/7355_2014_48</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_48%26sid%3Dliteratum%253Aachs%26atitle%3DMetabotropic%252BGlutamate%252BReceptor%252B2%252BActivators%26aulast%3DCid%26aufirst%3DJos%25C3%25A9%2BM.%26date%3D2014%26date%3D2014%26spage%3D101%26epage%3D142%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSmall%252BMolecule%252BTherapeutics%252Bfor%252BSchizophrenia%26aulast%3DCelanire%26aufirst%3DSylvain%26date%3D2015%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuanjie  Cheng</span>, <span class="hlFld-ContribAuthor ">Bo  Wang</span>, <span class="hlFld-ContribAuthor ">Nan  Liu</span>, <span class="hlFld-ContribAuthor ">Wenwen  Chen</span>, <span class="hlFld-ContribAuthor ">Xinyan  Wang</span>, <span class="hlFld-ContribAuthor ">Yuefei  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Controlling chemoselective transformations of 4-acylpyridines via a Pd–C catalytic hydrodechlorination–hydrogenation. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (4)
                                     , 930-935. <a href="https://doi.org/10.1016/j.tet.2013.12.017" title="DOI URL">https://doi.org/10.1016/j.tet.2013.12.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.12.017%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DControlling%252Bchemoselective%252Btransformations%252Bof%252B4-acylpyridines%252Bvia%252Ba%252BPd%2525E2%252580%252593C%252Bcatalytic%252Bhydrodechlorination%2525E2%252580%252593hydrogenation%26aulast%3DCheng%26aufirst%3DChuanjie%26date%3D2014%26volume%3D70%26issue%3D4%26spage%3D930%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heike  Schönherr</span>, <span class="hlFld-ContribAuthor ">Tim  Cernak</span>. </span><span class="cited-content_cbyCitation_article-title">Ausgeprägte Methyleffekte in der Wirkstoff-Forschung und der Bedarf an neuen C-H-Methylierungsreaktionen. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2013,</strong> <em>125 </em>
                                    (47)
                                     , 12480-12492. <a href="https://doi.org/10.1002/ange.201303207" title="DOI URL">https://doi.org/10.1002/ange.201303207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201303207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201303207%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DAusgepr%2525C3%2525A4gte%252BMethyleffekte%252Bin%252Bder%252BWirkstoff-Forschung%252Bund%252Bder%252BBedarf%252Ban%252Bneuen%252BC-H-Methylierungsreaktionen%26aulast%3DSch%25C3%25B6nherr%26aufirst%3DHeike%26date%3D2013%26date%3D2013%26volume%3D125%26issue%3D47%26spage%3D12480%26epage%3D12492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heike  Schönherr</span>, <span class="hlFld-ContribAuthor ">Tim  Cernak</span>. </span><span class="cited-content_cbyCitation_article-title">Profound Methyl Effects in Drug Discovery and a Call for New CH Methylation Reactions. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2013,</strong> <em>52 </em>
                                    (47)
                                     , 12256-12267. <a href="https://doi.org/10.1002/anie.201303207" title="DOI URL">https://doi.org/10.1002/anie.201303207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201303207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201303207%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DProfound%252BMethyl%252BEffects%252Bin%252BDrug%252BDiscovery%252Band%252Ba%252BCall%252Bfor%252BNew%252BC%2525EF%2525A3%2525BFH%252BMethylation%252BReactions%26aulast%3DSch%25C3%25B6nherr%26aufirst%3DHeike%26date%3D2013%26date%3D2013%26volume%3D52%26issue%3D47%26spage%3D12256%26epage%3D12267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrés A  Trabanco</span>, <span class="hlFld-ContribAuthor ">José María  Cid</span>. </span><span class="cited-content_cbyCitation_article-title">mGluR2 positive allosteric modulators: a patent review (2009 – present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (5)
                                     , 629-647. <a href="https://doi.org/10.1517/13543776.2013.777043" title="DOI URL">https://doi.org/10.1517/13543776.2013.777043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.777043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.777043%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DmGluR2%252Bpositive%252Ballosteric%252Bmodulators%25253A%252Ba%252Bpatent%252Breview%252B%2525282009%252B%2525E2%252580%252593%252Bpresent%252529%26aulast%3DTrabanco%26aufirst%3DAndr%25C3%25A9s%2BA%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D5%26spage%3D629%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erin R.  Hascup</span>, <span class="hlFld-ContribAuthor ">Kevin N.  Hascup</span>, <span class="hlFld-ContribAuthor ">Francois  Pomerleau</span>, <span class="hlFld-ContribAuthor ">Peter  Huettl</span>, <span class="hlFld-ContribAuthor ">Eva  Hajos-Korcsok</span>, <span class="hlFld-ContribAuthor ">Jan  Kehr</span>, <span class="hlFld-ContribAuthor ">Greg A.  Gerhardt</span>. </span><span class="cited-content_cbyCitation_article-title">An allosteric modulator of metabotropic glutamate receptors (mGluR2), (+)-TFMPIP, inhibits restraint stress-induced phasic glutamate release in rat prefrontal cortex. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neurochemistry</span><span> <strong>2012,</strong> <em>122 </em>
                                    (3)
                                     , 619-627. <a href="https://doi.org/10.1111/j.1471-4159.2012.07784.x" title="DOI URL">https://doi.org/10.1111/j.1471-4159.2012.07784.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1471-4159.2012.07784.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1471-4159.2012.07784.x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neurochemistry%26atitle%3DAn%252Ballosteric%252Bmodulator%252Bof%252Bmetabotropic%252Bglutamate%252Breceptors%252B%252528mGluR2%252529%25252C%252B%252528%25252B%252529-TFMPIP%25252C%252Binhibits%252Brestraint%252Bstress-induced%252Bphasic%252Bglutamate%252Brelease%252Bin%252Brat%252Bprefrontal%252Bcortex%26aulast%3DHascup%26aufirst%3DErin%2BR.%26date%3D2012%26date%3D2012%26volume%3D122%26issue%3D3%26spage%3D619%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sylvain  Célanire</span>, <span class="hlFld-ContribAuthor ">Guillaume  Duvey</span>, <span class="hlFld-ContribAuthor ">Sonia  Poli</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Rocher</span>. </span><span class="cited-content_cbyCitation_article-title">mGluR2 Activators and mGluR5 Blockers Advancing in the Clinic for Major CNS Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 71-88. <a href="https://doi.org/10.1016/B978-0-12-396492-2.00006-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-396492-2.00006-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396492-2.00006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396492-2.00006-0%26sid%3Dliteratum%253Aachs%26atitle%3DmGluR2%252BActivators%252Band%252BmGluR5%252BBlockers%252BAdvancing%252Bin%252Bthe%252BClinic%252Bfor%252BMajor%252BCNS%252BDisorders%26aulast%3DC%25C3%25A9lanire%26aufirst%3DSylvain%26date%3D2012%26spage%3D71%26epage%3D88%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B47%26date%3D2012%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chester J.  Siok</span>, <span class="hlFld-ContribAuthor ">Shawn M.  Cogan</span>, <span class="hlFld-ContribAuthor ">Lauren B.  Shifflett</span>, <span class="hlFld-ContribAuthor ">Angela C.  Doran</span>, <span class="hlFld-ContribAuthor ">Bernat  Kocsis</span>, <span class="hlFld-ContribAuthor ">Mihály  Hajós</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative analysis of the neurophysiological profile of group II metabotropic glutamate receptor activators and diazepam: Effects on hippocampal and cortical EEG patterns in rats. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2012,</strong> <em>62 </em>
                                    (1)
                                     , 226-236. <a href="https://doi.org/10.1016/j.neuropharm.2011.07.011" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2011.07.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2011.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2011.07.011%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DComparative%252Banalysis%252Bof%252Bthe%252Bneurophysiological%252Bprofile%252Bof%252Bgroup%252BII%252Bmetabotropic%252Bglutamate%252Breceptor%252Bactivators%252Band%252Bdiazepam%25253A%252BEffects%252Bon%252Bhippocampal%252Band%252Bcortical%252BEEG%252Bpatterns%252Bin%252Brats%26aulast%3DSiok%26aufirst%3DChester%2BJ.%26date%3D2012%26volume%3D62%26issue%3D1%26spage%3D226%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0016.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Origin of the 1-[(1-methyl-1<i>H</i>-imidazol-2-yl)methyl]-4-phenylpiperidine series.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, Ar−B(OH)<sub>2</sub>, NaHCO<sub>3</sub>, DME/H<sub>2</sub>O, reflux; 4 N HCl in dioxane, CH<sub>2</sub>Cl<sub>2</sub>, then triturated with Et<sub>2</sub>O. (b) PtO<sub>2</sub>, H<sub>2</sub> (40 psi), MeOH, room temperature. (c) LDA, PhN(CF<sub>3</sub>SO<sub>2</sub>)<sub>2</sub>, THF, −78 °C to room temperature. (d) PdCl<sub>2</sub>dppf, Ar−B(OH)<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O (2:1), 50 °C. (e) Pd/C or PtO<sub>2</sub>, H<sub>2</sub> (40 psi), EtOH, room temperature. (f) 2 N HCl in Et<sub>2</sub>O, Et<sub>2</sub>O, room temperature. (g) Compound <b>8a</b>−<b>e</b>, Et<sub>3</sub>N, MgSO<sub>4</sub>, then Na(OAc)<sub>3</sub>BH, CH<sub>2</sub>Cl<sub>2</sub>, room temperature.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaBH<sub>4</sub>, BF<sub>3</sub>·Et<sub>2</sub>O, diglyme; then H<sub>2</sub>O<sub>2</sub>, NaOH. (b) Pd/C(10%), ammonium formate, MeOH, reflux. (c) Compound <b>8b</b>, Et<sub>3</sub>N, MgSO<sub>4</sub>, then Na(OAc)<sub>3</sub>BH, CH<sub>2</sub>Cl<sub>2</sub>, room temperature. (d) Ar−B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, DME/H<sub>2</sub>O (1:1); 4 N HCl in dioxane, DCM, then triturated with Et<sub>2</sub>O. (e) PtO<sub>2</sub>, H<sub>2</sub> (40 psi), 70 °C. (f) 1-Bromo-4-trifluoromethyl benzene, Mg, THF, 35−40 °C; then <b>11</b> or <b>12</b>, Et<sub>2</sub>O, 5 °C to room temperature. (g) NaH, MeI, DMF, 45 °C. (h) Concentrated HCl, 10% Pd/C (10%), MeOH, H<sub>2</sub> (40 psi), 85 °C.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ar−B(OH)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, DME/H<sub>2</sub>O (1:1); 4 N HCl in dioxane, DCM, then triturated with Et<sub>2</sub>O. (b) PtO<sub>2</sub>, H<sub>2</sub> (40 psi), EtOH, 50 °C. (c) Compound <b>8b</b>, Et<sub>3</sub>N, MgSO<sub>4</sub>, then Na(OAc)<sub>3</sub>BH, CH<sub>2</sub>Cl<sub>2</sub>, room temperature.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0007.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Structure comparison of lead compounds to haloperidol; (b) comparison of potential conformation changes induced by <i>cis</i>-3-methyl or <i>cis</i>-2-methyl substitutions. Ligand minimizations were performed using Schrodinger's MacroModel software, and the resulting conformers were superimposed to provide the best overlap.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of MAP-induced hyperlocomotor activity by (+)-<b>17e</b> in mice. Mice (<i>n</i> = 6/group) were dosed with test compound (sc) concurrently with MAP (1 mg/kg, sc). Data are presented as the group mean (±SEM) recorded for the total duration of the 60 min test period. Data were analyzed by a one-way ANOVA followed by Fisher's PLSD. *<i>P</i> < 0.05 and **<i>P</i> < 0.01 as compared to vehicle/MAP-treated mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/medium/jm-2010-01414h_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of MIS by (+)-<b>17e</b> in mice CD-1 mice (<i>n</i> = 4/group) were predosed with test compound (sc) 20 min prior to receiving mescaline (10 mg/kg, po). Fifteen minutes later, the mice were placed in glass beakers for videotaping, and the animals were viewed every 30 s for a total of 12 min. Data were presented as % time scratching analyzed by a one-way ANOVA followed by Bonferroni's/Dunnett's posthoc tests. *<i>P</i> < 0.05 and **<i>P</i> < 0.01 as compared to vehicle/mescaline-treated mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-6/jm101414h/production/images/large/jm-2010-01414h_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm101414h&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i77">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40608" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40608" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Poisik, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raju, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verreault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeniyi, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, Y.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor 2 modulates excitatory synaptic transmission in the rat globus pallidus</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=57-69&author=O.+Poisikauthor=D.+V.+Rajuauthor=M.+Verreaultauthor=A.+Rodriguezauthor=O.+A.+Abeniyiauthor=P.+J.+Connauthor=Y.+Smith&title=Metabotropic+glutamate+receptor+2+modulates+excitatory+synaptic+transmission+in+the+rat+globus+pallidus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoisik%26aufirst%3DO.%26aulast%3DRaju%26aufirst%3DD.%2BV.%26aulast%3DVerreault%26aufirst%3DM.%26aulast%3DRodriguez%26aufirst%3DA.%26aulast%3DAbeniyi%26aufirst%3DO.%2BA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DSmith%26aufirst%3DY.%26atitle%3DMetabotropic%2520glutamate%2520receptor%25202%2520modulates%2520excitatory%2520synaptic%2520transmission%2520in%2520the%2520rat%2520globus%2520pallidus%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D57%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Linden, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptor targets for neuropsychiatric disorders</span> <span class="citation_source-journal">Drug Discovery Today: Ther. Strategies</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1016%2Fj.ddstr.2006.10.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=507-517&author=A.-M.+Lindenauthor=D.+D.+Schoepp&title=Metabotropic+glutamate+receptor+targets+for+neuropsychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ddstr.2006.10.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddstr.2006.10.018%26sid%3Dliteratum%253Aachs%26aulast%3DLinden%26aufirst%3DA.-M.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DMetabotropic%2520glutamate%2520receptor%2520targets%2520for%2520neuropsychiatric%2520disorders%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Ther.%2520Strategies%26date%3D2006%26volume%3D3%26spage%3D507%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Patil, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreev, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avedisova, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardenstein, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurovich, I. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morozova, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosolov, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neznanov, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reznik, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smulevich, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tochilov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1102</span><span class="NLM_x">–</span> <span class="NLM_lpage">1107</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1102-1107&author=S.+T.+Patilauthor=L.+Zhangauthor=F.+Martenyiauthor=S.+L.+Loweauthor=K.+A.+Jacksonauthor=B.+V.+Andreevauthor=A.+S.+Avedisovaauthor=L.+M.+Bardensteinauthor=I.+Y.+Gurovichauthor=M.+A.+Morozovaauthor=S.+N.+Mosolovauthor=N.+G.+Neznanovauthor=A.+M.+Reznikauthor=A.+B.+Smulevichauthor=V.+A.+Tochilovauthor=B.+G.+Johnsonauthor=J.+A.+Monnauthor=D.+D.+Schoepp&title=Activation+of+mGlu2%2F3+receptors+as+a+new+approach+to+treat+schizophrenia%3A+A+randomized+Phase+2+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatil%26aufirst%3DS.%2BT.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DJackson%26aufirst%3DK.%2BA.%26aulast%3DAndreev%26aufirst%3DB.%2BV.%26aulast%3DAvedisova%26aufirst%3DA.%2BS.%26aulast%3DBardenstein%26aufirst%3DL.%2BM.%26aulast%3DGurovich%26aufirst%3DI.%2BY.%26aulast%3DMorozova%26aufirst%3DM.%2BA.%26aulast%3DMosolov%26aufirst%3DS.%2BN.%26aulast%3DNeznanov%26aufirst%3DN.%2BG.%26aulast%3DReznik%26aufirst%3DA.%2BM.%26aulast%3DSmulevich%26aufirst%3DA.%2BB.%26aulast%3DTochilov%26aufirst%3DV.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DActivation%2520of%2520mGlu2%252F3%2520receptors%2520as%2520a%2520new%2520approach%2520to%2520treat%2520schizophrenia%253A%2520A%2520randomized%2520Phase%25202%2520clinical%2520trial%26jtitle%3DNature%2520Med.%26date%3D2007%26volume%3D13%26spage%3D1102%26epage%3D1107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Fell, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span> </span><span class="NLM_article-title">Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (−)-(1<i>R</i>,4<i>S</i>,5<i>S</i>,6<i>S</i>)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1124%2Fjpet.108.136861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=18424625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlyltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2008&pages=209-217&author=M.+J.+Fellauthor=K.+A.+Svenssonauthor=B.+G.+Johnsonauthor=D.+D.+Schoepp&title=Evidence+for+the+role+of+metabotropic+glutamate+%28mGlu%292+not+mGlu3+receptors+in+the+preclinical+antipsychotic+pharmacology+of+the+mGlu2%2F3+receptor+agonist+%28%E2%88%92%29-%281R%2C4S%2C5S%2C6S%29-4-amino-2-sulfonylbicyclo%5B3.1.0%5Dhexane-4%2C6-dicarboxylic+acid+%28LY404039%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)</span></div><div class="casAuthors">Fell, Matthew J.; Svensson, Kjell A.; Johnson, Bryan G.; Schoepp, Darryle D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">209-217</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">(-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039) is a potent and selective group II metabotropic glutamate [(mGlu)2 and mGlu3] receptor agonist for which its prodrug LY2140023 [(1R,4S,5S,6S)-2-thiabicyclo[3.1.0]-hexane-4,6-dicarboxylic acid,4-[(2S)-2-amino-4-(methylthio)-1-oxobutyl]amino-, 2,2-dioxide monohydrate] has recently been shown to have efficacy in the treatment of the pos. and neg. symptoms of schizophrenia.  In this article, we use mGlu receptor-deficient mice to investigate the relative contribution of mGlu2 and mGlu3 receptors in mediating the antipsychotic profile of LY404039 in the phencyclidine (PCP) and d-amphetamine (AMP) models of psychosis.  To further explore the mechanism of action of LY404039, we compared the drugs' ability to block PCP-induced hyperlocomotion to that of atypical antipsychotics in wild-type and mice lacking mGlu2/3 receptors.  In wild-type animals, LY404039 (3-30 mg/kg i.p.) significantly reversed AMP (5 mg/kg, i.p.)-induced increases in ambulations, distance traveled, and reduced time spent at rest.  LY404039 reversed PCP (7.5 mg/kg i.p.)-evoked behaviors at 10 mg/kg.  The antipsychotic-like effects of LY404039 (10 mg/kg i.p.) on PCP and AMP-evoked behavioral activation were absent in mGlu2 and mGlu2/3 but not in mGlu3 receptor-deficient mice, indicating that the activation of mGlu2 and not mGlu3 receptors is responsible for the antipsychotic-like effects of the mGlu2/3 receptor agonist LY404039.  In contrast, the atypical antipsychotic drugs clozapine and risperidone inhibited PCP-evoked behaviors in both wild-type and mGlu2/3 receptor-deficient mice.  These data demonstrate that the antipsychotic-like effects of the mGlu2/3 receptor agonist LY404039 in psychostimulant models of psychosis are mechanistically distinct from those of atypical antipsychotic drugs and are dependent on functional mGlu2 and not mGlu3 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQQM2jpXbmkLVg90H21EOLACvtfcHk0lgEb2qgUOBXWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlyltrw%253D&md5=795527aeddef2ee2829f2ae2c6803b6e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.136861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.136861%26sid%3Dliteratum%253Aachs%26aulast%3DFell%26aufirst%3DM.%2BJ.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DJohnson%26aufirst%3DB.%2BG.%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26atitle%3DEvidence%2520for%2520the%2520role%2520of%2520metabotropic%2520glutamate%2520%2528mGlu%25292%2520not%2520mGlu3%2520receptors%2520in%2520the%2520preclinical%2520antipsychotic%2520pharmacology%2520of%2520the%2520mGlu2%252F3%2520receptor%2520agonist%2520%2528%25E2%2588%2592%2529-%25281R%252C4S%252C5S%252C6S%2529-4-amino-2-sulfonylbicyclo%255B3.1.0%255Dhexane-4%252C6-dicarboxylic%2520acid%2520%2528LY404039%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D326%26spage%3D209%26epage%3D217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Recasens, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiramand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdulkarium, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbanel, G.</span><span> </span><span class="NLM_article-title">Metabotropic glutamate receptors as drug targets</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=651-681&author=M.+Recasensauthor=J.+Guiramandauthor=R.+Aimarauthor=A.+Abdulkariumauthor=G.+Barbanel&title=Metabotropic+glutamate+receptors+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRecasens%26aufirst%3DM.%26aulast%3DGuiramand%26aufirst%3DJ.%26aulast%3DAimar%26aufirst%3DR.%26aulast%3DAbdulkarium%26aufirst%3DA.%26aulast%3DBarbanel%26aufirst%3DG.%26atitle%3DMetabotropic%2520glutamate%2520receptors%2520as%2520drug%2520targets%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2007%26volume%3D8%26spage%3D651%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Gjoni, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, S.</span><span> </span><span class="NLM_article-title">Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABA<sub>B</sub> receptor desensitization</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=1293-1299&author=T.+Gjoniauthor=S.+Urwyler&title=Receptor+activation+involving+positive+allosteric+modulation%2C+unlike+full+agonism%2C+does+not+result+in+GABAB+receptor+desensitization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGjoni%26aufirst%3DT.%26aulast%3DUrwyler%26aufirst%3DS.%26atitle%3DReceptor%2520activation%2520involving%2520positive%2520allosteric%2520modulation%252C%2520unlike%2520full%2520agonism%252C%2520does%2520not%2520result%2520in%2520GABAB%2520receptor%2520desensitization%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D1293%26epage%3D1299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="note"><p class="first last">For recent reviews, see </p></div><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fraley, M.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1259</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1517%2F13543770903045009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=19552508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1259-1275&author=M.+Fraley&title=Positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia</span></div><div class="casAuthors">Fraley, Mark E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1259-1275</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Normalization of excessive glutamate neurotransmission through activation of the metabotropic glutamate receptor 2 (mGluR2) represents a novel and promising approach for the treatment of schizophrenia.  This strategy has gained support through the evaluation of dual mGluR2/3 agonists that act directly at the glutamate (orthosteric) binding site.  Importantly, clin. validation of the mechanism was achieved in a Phase II study in schizophrenia patients with mGluR2/3 agonist LY404039.  Selective pos. allosteric modulators (potentiators) of mGluR2 that bind to the transmembrane region of the receptor have shown efficacy in rodent models predictive of antipsychotic activity, but have yet to be evaluated in the clinic.  Allosteric mGluR2 potentiators may offer advantages over orthosteric mGluR2/3 agonists as a result of their unique mode of action and ability to achieve superior mGluR2 selectivity.  This review focuses on the structures and biol. activities of small mol. potentiators of mGluR2 that appeared in the patent literature between 2006 and early 2009.  Potent mGluR2 potentiators that span a broad range of structural diversity have been disclosed.  Narrow patent filings within select series and drug-like properties of corresponding preferred compds. suggest that development candidates have likely been nominated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpieKt-A0iqRrVg90H21EOLACvtfcHk0liondHj7l3mSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FK&md5=eb77bf795ab4dba6594b08e7c2ea891e</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1517%2F13543770903045009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903045009%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%26atitle%3DPositive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D1259%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span> </span><span class="NLM_article-title">Allosteric modulators for mGlu receptors</span> <span class="citation_source-journal">Curr. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.2174%2F157015907781695900" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=19305801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=187-194&author=F.+Gaspariniauthor=W.+Spooren&title=Allosteric+modulators+for+mGlu+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulators for mGlu receptors</span></div><div class="casAuthors">Gasparini, F.; Spooren, W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-194</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1570-159X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The metabotropic glutamate receptor family comprises eight subtypes (mGlu-8) of G-protein coupled receptors.  MGlu receptors have a large extracellular domain which acts as recognition domain for the natural agonist glutamate.  In contrast to the ionotropic glutamate receptors which mediate the fast excitatory neurotransmission, mGlu receptors have been shown to play a more modulatory role and have been proposed as alternative targets for pharmacol. interventions.  The potential use of mGluRs as drug targets for various nervous system pathologies such as anxiety, depression, schizophrenia, pain or Parkinson's disease has triggered an intense search for subtype selective modulators and resulted in the identification of numerous novel pharmacol. agents capable to modulate the receptor activity through an interaction at an allosteric site located in the transmembrane domain.  The present review presents the most recent developments in the identification and the characterization of allosteric modulators for the mGlu receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprfsRW0fdwSrVg90H21EOLACvtfcHk0liondHj7l3mSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqsLnK&md5=5c87ae2e61d77de86cd14cb24ca31ef0</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.2174%2F157015907781695900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157015907781695900%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DSpooren%26aufirst%3DW.%26atitle%3DAllosteric%2520modulators%2520for%2520mGlu%2520receptors%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2007%26volume%3D5%26spage%3D187%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2)</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.2174%2F1568026054750281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=16178732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvVCgsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=869-884&author=M.+T.+Ruddauthor=J.+A.+McCauley&title=Positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+subtype+2+%28mGluR2%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2)</span></div><div class="casAuthors">Rudd, Michael T.; McCauley, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">869-884</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This article describes recent medicinal chem. progress toward selective potentiators of the metabotropic glutamate receptor 2 (mGluR2).  Groups at Lilly and Merck have identified new classes of potentiators that exhibit selectivity for mGluR2 over the seven other subtypes of mGluRs.  Structure-activity relationships as well as pharmacokinetic properties and in vivo activity are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonTbRY2wz7h7Vg90H21EOLACvtfcHk0liondHj7l3mSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvVCgsLc%253D&md5=f349eab15af2064ef7b52fde8cdc3c20</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.2174%2F1568026054750281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026054750281%26sid%3Dliteratum%253Aachs%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26atitle%3DPositive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%2520subtype%25202%2520%2528mGluR2%2529%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D869%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last"> For more recent publications, see the following:</p></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biesmans, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">Scaffold hopping from pyridone to imidazo[1,2-a]puridines. New positive allosteric modulators of metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=175-179&author=G.+Tresadernauthor=J.+M.+Cidauthor=G.+J.+Macdonaldauthor=J.+A.+Vegaauthor=A.+I.+De+Lucasauthor=A.+Garciaauthor=E.+Matesanzauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=H.+Lavreysenauthor=I.+Biesmansauthor=A.+A.+Trabanco&title=Scaffold+hopping+from+pyridone+to+imidazo%5B1%2C2-a%5Dpuridines.+New+positive+allosteric+modulators+of+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DMacdonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DDe%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DGarcia%26aufirst%3DA.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DBiesmans%26aufirst%3DI.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3DScaffold%2520hopping%2520from%2520pyridone%2520to%2520imidazo%255B1%252C2-a%255Dpuridines.%2520New%2520positive%2520allosteric%2520modulators%2520of%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D175%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Brnardic, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culberson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslander, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillgrove, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3129</span><span class="NLM_x">–</span> <span class="NLM_lpage">3133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3129-3133&author=E.+J.+Brnardicauthor=M.+E.+Fraleyauthor=R.+M.+Garbaccioauthor=M.+E.+Laytonauthor=J.+M.+Sandersauthor=C.+Culbersonauthor=M.+Jacobsonauthor=B.+C.+Magliaroauthor=P.+H.+Hutsonauthor=J.+A.+O%27Brienauthor=S.+L.+Huszarauthor=J.+M.+Uslanderauthor=K.+L.+Fillgroveauthor=C.+Tangauthor=Y.+Kuoauthor=S.+M.+Surauthor=G.+D.+Hartman&title=3-Aryl-5-phenoxymethyl-1%2C3-oxazolidin-2-ones+as+positive+allosteric+modulators+of+mGluR2+for+the+treatment+of+schizophrenia%3A+Hit-to-lead+efforts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DLayton%26aufirst%3DM.%2BE.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DCulberson%26aufirst%3DC.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DO%2527Brien%26aufirst%3DJ.%2BA.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DUslander%26aufirst%3DJ.%2BM.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DSur%26aufirst%3DS.%2BM.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3D3-Aryl-5-phenoxymethyl-1%252C3-oxazolidin-2-ones%2520as%2520positive%2520allosteric%2520modulators%2520of%2520mGluR2%2520for%2520the%2520treatment%2520of%2520schizophrenia%253A%2520Hit-to-lead%2520efforts%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3129%26epage%3D3133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brnardict, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Brien, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillgrove, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, M. A.</span><span> </span><span class="NLM_article-title">Discovery of oxazolobenzimidazoles as Postive Allosteric Modulators for the mGluR2 Receptor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100115a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=406-410&author=R.+M.+Garbaccioauthor=E.+J.+Brnardictauthor=M.+E.+Fraleyauthor=G.+D.+Hartmanauthor=P.+H.+Hutsonauthor=J.+A.+O%27Brienauthor=B.+C.+Magliaroauthor=J.+M.+Uslanerauthor=S.+L.+Huszarauthor=K.+L.+Fillgroveauthor=J.+H.+Smallauthor=C.+Tangauthor=Y.+Kuoauthor=M.+A.+Jacobson&title=Discovery+of+oxazolobenzimidazoles+as+Postive+Allosteric+Modulators+for+the+mGluR2+Receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1021%2Fml100115a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100115a%26sid%3Dliteratum%253Aachs%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DBrnardict%26aufirst%3DE.%2BJ.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DO%2527Brien%26aufirst%3DJ.%2BA.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DHuszar%26aufirst%3DS.%2BL.%26aulast%3DFillgrove%26aufirst%3DK.%2BL.%26aulast%3DSmall%26aufirst%3DJ.%2BH.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DY.%26aulast%3DJacobson%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%2520oxazolobenzimidazoles%2520as%2520Postive%2520Allosteric%2520Modulators%2520for%2520the%2520mGluR2%2520Receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D406%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duvey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cluzeau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nhem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macary, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolea, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urios, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epping-Jordan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chamelot, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derouet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lucas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matesanz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linares, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imogai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocher, J.-P.</span><span> </span><span class="NLM_article-title">Discovery of 1, 5-disubstituted pyridines: A new class of positive allosteric modulators of the metabotropic glutamate 2 receptor</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn1000638" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGgsbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=788-795&author=J.+M.+Cidauthor=G.+Duveyauthor=P.+Cluzeauauthor=V.+Nhemauthor=K.+Macaryauthor=A.+Rauxauthor=N.+Poirierauthor=J.+Mullerauthor=C+Boleaauthor=T.+Finnauthor=I.+Uriosauthor=M.+Epping-Jordanauthor=E.+Chamelotauthor=F.+Derouetauthor=F.+Girardauthor=G.+J.+MacDonaldauthor=J.+A.+Vegaauthor=A.+I.+De+Lucasauthor=E.+Matesanzauthor=H.+Lavreysenauthor=M.+L.+Linaresauthor=D.+Oehlrichauthor=H.+Oyarzabalauthor=G.+Tresadernauthor=A.+A.+Trabancoauthor=J.+I.+Andresauthor=E.+Le+Poulauthor=H.+Imogaiauthor=R.+Lutjensauthor=J.-P.+Rocher&title=Discovery+of+1%2C+5-disubstituted+pyridines%3A+A+new+class+of+positive+allosteric+modulators+of+the+metabotropic+glutamate+2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7gR"><div class="casContent"><span class="casTitleNuber">7g</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,5-Disubstituted Pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor</span></div><div class="casAuthors">Cid, Jose Maria; Duvey, Guillaume; Cluzeau, Philippe; Nhem, Vanthea; Macary, Karim; Raux, Alexandre; Poirier, Nicolas; Muller, Jessica; Bolea, Christelle; Finn, Terry; Urios, Isabelle; Epping-Jordan, Mark; Chamelot, Emilie; Derouet, Francis; Girard, Francoise; MacDonald, Gregor J.; Vega, Juan Antonio; de Lucas, Ana Isabel; Matesanz, Encarnacion; Lavreysen, Hilde; Linares, Maria Lourdes; Oehlrich, Daniel; Oyarzabal, Julen; Tresadern, Gary; Trabanco, Andres A.; Andres, Jose Ignacio; Le Poul, Emmanuel; Imogai, Hassan; Lutjens, Robert; Rocher, Jean-Philippe</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">788-795</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 1,5-disubstituted pyridones was identified as pos. allosteric modulators (PAMs) of the metabotropic glutamate receptor 2 (mGluR2) via high throughput screening (HTS).  Subsequent SAR exploration led to the identification of several compds. with improved in vitro activity.  Lead compd. 8 (I) was further profiled and found to attenuate the increase in PCP induced locomotor activity in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-saUfhQDgzLVg90H21EOLACvtfcHk0liDyTli35vyaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGgsbzO&md5=85204e53809a7efcbd7d9fb5f04a3601</span></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.1021%2Fcn1000638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn1000638%26sid%3Dliteratum%253Aachs%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDuvey%26aufirst%3DG.%26aulast%3DCluzeau%26aufirst%3DP.%26aulast%3DNhem%26aufirst%3DV.%26aulast%3DMacary%26aufirst%3DK.%26aulast%3DRaux%26aufirst%3DA.%26aulast%3DPoirier%26aufirst%3DN.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DBolea%26aufirst%3DC%26aulast%3DFinn%26aufirst%3DT.%26aulast%3DUrios%26aufirst%3DI.%26aulast%3DEpping-Jordan%26aufirst%3DM.%26aulast%3DChamelot%26aufirst%3DE.%26aulast%3DDerouet%26aufirst%3DF.%26aulast%3DGirard%26aufirst%3DF.%26aulast%3DMacDonald%26aufirst%3DG.%2BJ.%26aulast%3DVega%26aufirst%3DJ.%2BA.%26aulast%3DDe%2BLucas%26aufirst%3DA.%2BI.%26aulast%3DMatesanz%26aufirst%3DE.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DLinares%26aufirst%3DM.%2BL.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DOyarzabal%26aufirst%3DH.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DImogai%26aufirst%3DH.%26aulast%3DLutjens%26aufirst%3DR.%26aulast%3DRocher%26aufirst%3DJ.-P.%26atitle%3DDiscovery%2520of%25201%252C%25205-disubstituted%2520pyridines%253A%2520A%2520new%2520class%2520of%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%25202%2520receptor%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D788%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, A. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span> </span><span class="NLM_article-title">3-(Imidazolylmethyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: A novel series of mGluR2 positive allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5493</span><span class="NLM_x">–</span> <span class="NLM_lpage">5496</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5493-5496&author=L.+Zhangauthor=B.+N.+Rogersauthor=A.+J.+Duplantierauthor=S.+F.+McHardyauthor=I.+Efremovauthor=H.+Berkeauthor=W.+Qianauthor=A.+Q.+Zhangauthor=N.+Makladauthor=J.+Candlerauthor=A.+C.+Doranauthor=J.+T.+Lazzaroauthor=A.+H.+Ganong&title=3-%28Imidazolylmethyl%29-3-aza-bicyclo%5B3.1.0%5Dhexan-6-yl%29methyl+ethers%3A+A+novel+series+of+mGluR2+positive+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DMcHardy%26aufirst%3DS.%2BF.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DBerke%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DA.%2BQ.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DCandler%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26atitle%3D3-%2528Imidazolylmethyl%2529-3-aza-bicyclo%255B3.1.0%255Dhexan-6-yl%2529methyl%2520ethers%253A%2520A%2520novel%2520series%2520of%2520mGluR2%2520positive%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5493%26epage%3D5496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarro, J. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maklad, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siuciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spracklin, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2524</span><span class="NLM_x">–</span> <span class="NLM_lpage">2529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2524-2529&author=A.+J.+Duplantierauthor=I.+Efremovauthor=J.+Candlerauthor=A.+C.+Doranauthor=A.+H.+Ganongauthor=J.+A.+Haasauthor=A.+N.+Hanksauthor=K.+G.+Krausauthor=J.+T.+Lazarroauthor=J.+Luauthor=N.+Makladauthor=S.+A.+McCarthyauthor=T.+J.+O%27Sullivanauthor=B.+N.+Rogersauthor=J.+A.+Siuciakauthor=D.+K.+Spracklinauthor=L.+Zhang&title=3-Benzyl-1%2C3-oxazolidin-2-ones+as+mGluR2+positive+allosteric+modulators%3A+Hit-to+lead+and+lead+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DCandler%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26aulast%3DHaas%26aufirst%3DJ.%2BA.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DKraus%26aufirst%3DK.%2BG.%26aulast%3DLazarro%26aufirst%3DJ.%2BT.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMaklad%26aufirst%3DN.%26aulast%3DMcCarthy%26aufirst%3DS.%2BA.%26aulast%3DO%2527Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DRogers%26aufirst%3DB.%2BN.%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26aulast%3DSpracklin%26aufirst%3DD.%2BK.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3D3-Benzyl-1%252C3-oxazolidin-2-ones%2520as%2520mGluR2%2520positive%2520allosteric%2520modulators%253A%2520Hit-to%2520lead%2520and%2520lead%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2524%26epage%3D2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><div class="note"><p class="first last">During the preparation of this manuscript, a structurally related series of mGluR2 PAMs was disclosed by D'Alessandro et al. For a reference, see </p></div><span class="NLM_contrib-group">D'Alessandro, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugolini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montanari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powney, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppe, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocheville, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De la Fuente, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Los Frailes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=759-762&author=P.+L.+D%27Alessandroauthor=C.+Cortiauthor=A.+Rothauthor=A.+Ugoliniauthor=A.+Savaauthor=D.+Montanariauthor=F.+Bianchiauthor=S.+L.+Garlandauthor=B.+Powneyauthor=E.+L.+Koppeauthor=M.+Rochevilleauthor=G.+Osborneauthor=P.+Perezauthor=J.+De+la+Fuenteauthor=M.+De+Los+Frailesauthor=P.+W.+Smithauthor=C.+Branchauthor=D.+Nashauthor=S.+P.+Watson&title=The+identification+of+structurally+novel%2C+selective%2C+orally+bioavailable+positive+modulators+of+mGluR2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DD%2527Alessandro%26aufirst%3DP.%2BL.%26aulast%3DCorti%26aufirst%3DC.%26aulast%3DRoth%26aufirst%3DA.%26aulast%3DUgolini%26aufirst%3DA.%26aulast%3DSava%26aufirst%3DA.%26aulast%3DMontanari%26aufirst%3DD.%26aulast%3DBianchi%26aufirst%3DF.%26aulast%3DGarland%26aufirst%3DS.%2BL.%26aulast%3DPowney%26aufirst%3DB.%26aulast%3DKoppe%26aufirst%3DE.%2BL.%26aulast%3DRocheville%26aufirst%3DM.%26aulast%3DOsborne%26aufirst%3DG.%26aulast%3DPerez%26aufirst%3DP.%26aulast%3DDe%2Bla%2BFuente%26aufirst%3DJ.%26aulast%3DDe%2BLos%2BFrailes%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DBranch%26aufirst%3DC.%26aulast%3DNash%26aufirst%3DD.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520identification%2520of%2520structurally%2520novel%252C%2520selective%252C%2520orally%2520bioavailable%2520positive%2520modulators%2520of%2520mGluR2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D759%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="note"><p class="first last">The mGluR2 FLIPR functional assay uses a stable HEK cell line expressing the rat mGluR2 receptor and Gα15 G protein. Cells are plated in 384-well poly-<span class="smallcaps smallerCapital">d</span>-lysine-coated plates and incubated in glutamine-free medium. Cells are loaded with Fluo-4 am containing glutamic pyruvic transaminase to reduce endogenous glutamate. Compound is added with the FLIPR, incubated at room temperature for approximately 30 min, and then tested against an approximate EC<sub>10</sub> to EC<sub>20</sub> glutamate challenge. Data are analyzed as a ratio of the peak fluorescence to the baseline after compound addition. Assay to assay variability in PAM potency required multiple experiments to determine potency, typically <i>n</i> > 3.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Blood-brain barrier permeability considerations for CNS-targeted compound library design</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">318</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1016%2Fj.cbpa.2008.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=18435937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1ers74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=318-323&author=S.+A.+Hitchcock&title=Blood-brain+barrier+permeability+considerations+for+CNS-targeted+compound+library+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier permeability considerations for CNS-targeted compound library design</span></div><div class="casAuthors">Hitchcock, Stephen A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">318-323</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A further refinement of the concept of drug-likeness is required for compd. libraries intended for central nervous system (CNS) targets to account for the limitations imposed by blood-brain barrier permeability.  This review describes criteria and processes that can be applied in the de novo design and assembly of libraries to increase the odds of compds. residing within CNS-accessible chem. space.  A no. of published examples where CNS activity and/or penetration characteristics have been a factor in library design are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorhMoAmlVhlrVg90H21EOLACvtfcHk0lhrZGMJCc2krw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1ers74%253D&md5=7b6962e237bc80c1d44053b54c5f3f40</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2008.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2008.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DBlood-brain%2520barrier%2520permeability%2520considerations%2520for%2520CNS-targeted%2520compound%2520library%2520design%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D12%26spage%3D318%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">891</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-891&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="note"><p class="first last">Compound <b>3</b> was screened against a panel of CNS receptors consist of H1, D<sub>2</sub>, 5HT<sub>1A</sub>, 5HT<sub>2B</sub>, 5HT<sub>2A</sub>, α 2A, α 1A, M1, and dofetilide receptors, with no significant binding affinities detected at the highest concentration tested (less than 50% at 3.16 μM) in all other receptors with the exception of D2 receptor (<i>K</i><sub>i</sub> = 426 nM). Compound <b>3</b> was also screened in mGluR1 (agonist, antagonist mode), mGluR5 (agonist, antagonist, PAM mode) functional assays with no activity detected up to 10 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">The D<sub>2</sub> functional assay uses a stable CHO cell line transfected with human D<sub>2</sub> receptors and measures the inhibition of quinpirole stimulation by the test compounds.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><div class="note"><p class="first last">For a recent review, see </p></div><span class="NLM_contrib-group">Seeman, P.</span><span> </span><span class="NLM_article-title">Targeting the dopamine D2 receptor in schizophrenia</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1517%2F14728222.10.4.515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=16848689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1ahtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=515-531&author=P.+Seeman&title=Targeting+the+dopamine+D2+receptor+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dopamine D2 receptor in schizophrenia</span></div><div class="casAuthors">Seeman, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">515-531</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  After a 12-yr search for the antipsychotic receptor, the binding site was discovered and labeled by [3H]haloperidol in 1975.  Of the various neurotransmitters, dopamine was the most potent in inhibiting the binding of [3H]haloperidol, indicating that the antipsychotic receptor was a dopamine receptor, now named the dopamine D2 receptor, a major targeting site in schizophrenia.  All antipsychotic drugs, including traditional and newer antipsychotics, either bind to D2 in direct relation to their clin. potencies or hinder normal dopamine neurotransmission, as in the case of partial dopamine agonists.  In fact, the antipsychotic concns. found in the plasma water of treated patients closely match the predicted therapeutic abs. concns., adjusted for the 60-75% D2 occupancy needed for clin. efficacy.  Antipsychotics that elicit low or no Parkinsonism or prolactinemia are loosely attached to D2 and rapidly dissoc. from D2, whereas those eliciting Parkinsonism stay tightly attached to D2 for many hours.  Because animal models of psychosis (amfetamine sensitization, brain lesions) all show a marked elevation in the no. of high-affinity states of D2, the antipsychotics are thought to specifically target these D2High states in psychosis in general and schizophrenia in particular.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGjVyTQvf6orVg90H21EOLACvtfcHk0lgHFnsFw-NSXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1ahtro%253D&md5=4ac073cabc6f50e8d0e3a2ecc631e781</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F14728222.10.4.515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.10.4.515%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520dopamine%2520D2%2520receptor%2520in%2520schizophrenia%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2006%26volume%3D10%26spage%3D515%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Jaen, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, L. D.</span><span> </span><span class="NLM_article-title">Synthesis of the 1,2,3,4-tetrahydrobenzofuro[2,3-c]pyridine ring system</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1317</span><span class="NLM_x">–</span> <span class="NLM_lpage">1319</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1987&pages=1317-1319&author=J.+C.+Jaenauthor=L.+D.+Wise&title=Synthesis+of+the+1%2C2%2C3%2C4-tetrahydrobenzofuro%5B2%2C3-c%5Dpyridine+ring+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJaen%26aufirst%3DJ.%2BC.%26aulast%3DWise%26aufirst%3DL.%2BD.%26atitle%3DSynthesis%2520of%2520the%25201%252C2%252C3%252C4-tetrahydrobenzofuro%255B2%252C3-c%255Dpyridine%2520ring%2520system%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1987%26volume%3D24%26spage%3D1317%26epage%3D1319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="note"><p class="first last">Compounds (+)-<b>17c</b>−<b>e</b> were profiled in a broad spectrum selectivity panel (CEREP, Bioprint) that consists of 122 targets without no significant off-target activities identified (IC<sub>50</sub> values > 3000 nM); compounds (+)-<b>17c</b>−<b>e</b> were also screened in mGluR1 (agonist, antagonist mode), mGluR5 (agonist, antagonist, PAM mode) functional assays with no activity detected up to 10 μM.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Yui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikemoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, K.</span><span> </span><span class="NLM_article-title">Studies of Amphetamine or Methamphetamine Psychosis in Japan: Relation of Methamphetamine Psychosis to Schizophrenia</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">914</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=914&publication_year=2000&pages=1-12&author=K.+Yuiauthor=S.+Ikemotoauthor=T.+Ishiguroauthor=K.+Goto&title=Studies+of+Amphetamine+or+Methamphetamine+Psychosis+in+Japan%3A+Relation+of+Methamphetamine+Psychosis+to+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYui%26aufirst%3DK.%26aulast%3DIkemoto%26aufirst%3DS.%26aulast%3DIshiguro%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DK.%26atitle%3DStudies%2520of%2520Amphetamine%2520or%2520Methamphetamine%2520Psychosis%2520in%2520Japan%253A%2520Relation%2520of%2520Methamphetamine%2520Psychosis%2520to%2520Schizophrenia%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2000%26volume%3D914%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hirota, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, S.</span><span> </span><span class="NLM_article-title">Neuropharmacological Profile of an Atypical Antipsychotic, NRA0562</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=375-388&author=S.+Hirotaauthor=N.+Kawashimaauthor=S.+Chakiauthor=S.+Okuyama&title=Neuropharmacological+Profile+of+an+Atypical+Antipsychotic%2C+NRA0562"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirota%26aufirst%3DS.%26aulast%3DKawashima%26aufirst%3DN.%26aulast%3DChaki%26aufirst%3DS.%26aulast%3DOkuyama%26aufirst%3DS.%26atitle%3DNeuropharmacological%2520Profile%2520of%2520an%2520Atypical%2520Antipsychotic%252C%2520NRA0562%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2003%26volume%3D9%26spage%3D375%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Satow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maehara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ise, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hikichi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, H.</span><span> </span><span class="NLM_article-title">Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1<i>H</i>-1,2,3-triazol-4-yl]-<i>N</i>-isopropyl-<i>N</i>-methyl-3,6-dihydropyridine-1(2<i>H</i>)-carboxamide]</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1124%2Fjpet.108.138107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=18487514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpsVWqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2008&pages=577-586&author=A.+Satowauthor=S.+Maeharaauthor=S.+Iseauthor=H.+Hikichiauthor=M.+Fukushimaauthor=G.+Suzukiauthor=T.+Kimuraauthor=T.+Tanakaauthor=S.+Itoauthor=H.+Kawamotoauthor=H.+Ohta&title=Pharmacological+effects+of+the+metabotropic+glutamate+receptor+1+antagonist+compared+with+those+of+the+metabotropic+glutamate+receptor+5+antagonist+and+metabotropic+glutamate+receptor+2%2F3+agonist+in+rodents%3A+detailed+investigations+with+a+selective+allosteric+metabotropic+glutamate+receptor+1+antagonist%2C+FTIDC+%5B4-%5B1-%282-fluoropyridine-3-yl%29-5-methyl-1H-1%2C2%2C3-triazol-4-yl%5D-N-isopropyl-N-methyl-3%2C6-dihydropyridine-1%282H%29-carboxamide%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide]</span></div><div class="casAuthors">Satow, Akio; Maehara, Shunsuke; Ise, Satoko; Hikichi, Hirohiko; Fukushima, Miyuki; Suzuki, Gentaroh; Kimura, Toshifumi; Tanaka, Takeshi; Ito, Satoru; Kawamoto, Hiroshi; Ohta, Hisashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">577-586</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The functional roles of metabotropic glutamate receptor (mGluR) 1 in integrative brain functions were investigated using a potent and selective mGluR1 allosteric antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide], in comparison with the mGluR5 allosteric antagonist and the mGluR2/3 orthosteric agonist in rodents.  FTIDC reduced maternal sepn.-induced ultrasonic vocalization and stress-induced hyperthermia without affecting behaviors in the elevated plus maze.  An mGluR5 antagonist, 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and an mGluR2/3 agonist, LY379268 [(1R,4R,5S,6R)-4-amino-2-oxabicyclo[3.1.0]hexane-4,6-dicarboxylic acid], showed anxiolytic activities in these models, suggesting involvement of postsynaptic mGluR1 in stress-related responses comparable with mGluR5 and mGluR2/3.  Analgesic effects of FTIDC were seen in the formalin test but not in the tail immersion test.  FTIDC selectively blocked methamphetamine-induced hyperlocomotion and disruption of prepulse inhibition, whereas MPEP and LY379268 did not alter those behaviors, suggesting that pharmacol. blockade of mGluR1 could result in antipsychotic-like effects.  FTIDC did not elicit catalepsy or impair motor functions at 10 times higher dose than doses showing antipsychotic-like action.  In conclusion, blockade of mGluR1 showed antipsychotic-like effects without impairing motor functions, whereas blockade of mGluR5 and activation of mGluR2/3 did not display such activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlZn0-fiQ-DrVg90H21EOLACvtfcHk0lgHFnsFw-NSXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpsVWqs7g%253D&md5=be3da3ecd67e1cd19d4d56b0800e5e8e</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.138107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.138107%26sid%3Dliteratum%253Aachs%26aulast%3DSatow%26aufirst%3DA.%26aulast%3DMaehara%26aufirst%3DS.%26aulast%3DIse%26aufirst%3DS.%26aulast%3DHikichi%26aufirst%3DH.%26aulast%3DFukushima%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DG.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DKawamoto%26aufirst%3DH.%26aulast%3DOhta%26aufirst%3DH.%26atitle%3DPharmacological%2520effects%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25201%2520antagonist%2520compared%2520with%2520those%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25205%2520antagonist%2520and%2520metabotropic%2520glutamate%2520receptor%25202%252F3%2520agonist%2520in%2520rodents%253A%2520detailed%2520investigations%2520with%2520a%2520selective%2520allosteric%2520metabotropic%2520glutamate%2520receptor%25201%2520antagonist%252C%2520FTIDC%2520%255B4-%255B1-%25282-fluoropyridine-3-yl%2529-5-methyl-1H-1%252C2%252C3-triazol-4-yl%255D-N-isopropyl-N-methyl-3%252C6-dihydropyridine-1%25282H%2529-carboxamide%255D%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D326%26spage%3D577%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Marinozzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natalini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Constantino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tijskens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicciari, R.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacological Characterization of All Sixteen Stereoisomers of 2-(2′-Carboxy-3′-phenylcyclopropyl)glycine. Focus on (2<i>S</i>,1′<i>S</i>,2′<i>S</i>,3′<i>R</i>)-2-(2′-Carboxy-3′-phenylcyclopropyl)glycine, a Novel and Selective Group II Metabotropic Glutamate Receptor Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">2259</span><span class="NLM_x">–</span> <span class="NLM_lpage">2269</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=2259-2269&author=M.+Marinozziauthor=B.+Nataliniauthor=G.+Constantinoauthor=P.+Tijskensauthor=C.+Thomsenauthor=R.+Pellicciari&title=Synthesis+and+Pharmacological+Characterization+of+All+Sixteen+Stereoisomers+of+2-%282%E2%80%B2-Carboxy-3%E2%80%B2-phenylcyclopropyl%29glycine.+Focus+on+%282S%2C1%E2%80%B2S%2C2%E2%80%B2S%2C3%E2%80%B2R%29-2-%282%E2%80%B2-Carboxy-3%E2%80%B2-phenylcyclopropyl%29glycine%2C+a+Novel+and+Selective+Group+II+Metabotropic+Glutamate+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarinozzi%26aufirst%3DM.%26aulast%3DNatalini%26aufirst%3DB.%26aulast%3DConstantino%26aufirst%3DG.%26aulast%3DTijskens%26aufirst%3DP.%26aulast%3DThomsen%26aufirst%3DC.%26aulast%3DPellicciari%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Characterization%2520of%2520All%2520Sixteen%2520Stereoisomers%2520of%25202-%25282%25E2%2580%25B2-Carboxy-3%25E2%2580%25B2-phenylcyclopropyl%2529glycine.%2520Focus%2520on%2520%25282S%252C1%25E2%2580%25B2S%252C2%25E2%2580%25B2S%252C3%25E2%2580%25B2R%2529-2-%25282%25E2%2580%25B2-Carboxy-3%25E2%2580%25B2-phenylcyclopropyl%2529glycine%252C%2520a%2520Novel%2520and%2520Selective%2520Group%2520II%2520Metabotropic%2520Glutamate%2520Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D2259%26epage%3D2269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Gross, G.; Wicke, K. M.; Mezler, M.; Schoemaker, H.</span><span> </span><span class="NLM_article-title">Glutamate mGluR2/3 agonists inhibit mescaline-induced scratching in mice: A potential model of antipsychotic activity</span>.  <span class="citation_source-journal">34th Annual Meeting of the Society for Neuroscience</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span>abstract 1030.16.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=G.+Gross&author=K.+M.+Wicke&author=M.+Mezler&author=H.+Schoemaker&title=Glutamate+mGluR2%2F3+agonists+inhibit+mescaline-induced+scratching+in+mice%3A+A+potential+model+of+antipsychotic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DG.%26atitle%3DGlutamate%2520mGluR2%252F3%2520agonists%2520inhibit%2520mescaline-induced%2520scratching%2520in%2520mice%253A%2520A%2520potential%2520model%2520of%2520antipsychotic%2520activity%26jtitle%3D34th%2520Annual%2520Meeting%2520of%2520the%2520Society%2520for%2520Neuroscience%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gonzalez-Maeso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weisstaub, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley-Moore, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sealfon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, J. A.</span><span> </span><span class="NLM_article-title">Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2007&pages=439-452&author=J.+Gonzalez-Maesoauthor=N.+V.+Weisstaubauthor=M.+Zhouauthor=P.+Chanauthor=L.+Ivicauthor=R.+Angauthor=A+Liraauthor=M.+Bradley-Mooreauthor=Y.+Geauthor=Q.+Zhouauthor=S.+C.+Sealfonauthor=J.+A.+Gingrich&title=Hallucinogens+recruit+specific+cortical+5-HT2A+receptor-mediated+signaling+pathways+to+affect+behavior"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGonzalez-Maeso%26aufirst%3DJ.%26aulast%3DWeisstaub%26aufirst%3DN.%2BV.%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DP.%26aulast%3DIvic%26aufirst%3DL.%26aulast%3DAng%26aufirst%3DR.%26aulast%3DLira%26aufirst%3DA%26aulast%3DBradley-Moore%26aufirst%3DM.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DSealfon%26aufirst%3DS.%2BC.%26aulast%3DGingrich%26aufirst%3DJ.%2BA.%26atitle%3DHallucinogens%2520recruit%2520specific%2520cortical%25205-HT2A%2520receptor-mediated%2520signaling%2520pathways%2520to%2520affect%2520behavior%26jtitle%3DNeuron%26date%3D2007%26volume%3D53%26spage%3D439%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Scruggs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span> </span><span class="NLM_article-title">The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2003&pages=137-140&author=J.+L.+Scruggsauthor=D.+Schmidtauthor=A.+Y.+Deutch&title=The+hallucinogen+1-%5B2%2C5-dimethoxy-4-iodophenyl%5D-2-aminopropane+%28DOI%29+increases+cortical+extracellular+glutamate+levels+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScruggs%26aufirst%3DJ.%2BL.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26atitle%3DThe%2520hallucinogen%25201-%255B2%252C5-dimethoxy-4-iodophenyl%255D-2-aminopropane%2520%2528DOI%2529%2520increases%2520cortical%2520extracellular%2520glutamate%2520levels%2520in%2520rats%26jtitle%3DNeurosci.%2520Lett.%26date%3D2003%26volume%3D346%26spage%3D137%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Scruggs, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deutch, A. Y.</span><span> </span><span class="NLM_article-title">DOI -induced activation of the cortex: Dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">8846</span><span class="NLM_x">–</span> <span class="NLM_lpage">8852</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=11102493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpslWg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=8846-8852&author=J.+L.+Scruggsauthor=S.+Patelauthor=M.+Bubserauthor=A.+Y.+Deutch&title=DOI+-induced+activation+of+the+cortex%3A+Dependence+on+5-HT2A+heteroceptors+on+thalamocortical+glutamatergic+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">DOI-induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons</span></div><div class="casAuthors">Scruggs, Jennifer L.; Patel, Sachin; Bubser, Michael; Deutch, Ariel Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8846-8852</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Administration of the hallucinogenic 5-HT2A/2C agonist 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) induces expression of Fos protein in the cerebral cortex.  To understand the mechanisms subserving this action of DOI, the authors examd. the consequences of pharmacol. and surgical manipulations on DOI-elicited Fos expression in the somatosensory cortex of the rat.  DOI dose-dependently increased cortical Fos expression.  Pretreatment with the selective 5-HT2A antagonist MDL 100,907 completely blocked DOI-elicited Fos expression, but pretreatment with the 5-HT2C antagonist SB 206,553 did not modify DOI-elicited Fos expression.  These data suggest that DOI acts through 5-HT2A receptors to increase cortical Fos expression.  However, the authors found that DOI did not induce Fos in cortical 5-HT2A immunoreactive neurons but did increase expression in a band of neurons spanning superficial layer V to deep III, within the apical dendritic fields of layer V 5-HT2A-immunoreactive cells.  This band of Fos immunoreactive neurons was in register with anterogradely labeled axons from the ventrobasal thalamus, which have previously been shown to be glutamatergic and express the 5-HT2A transcript.  The effects of DOI were markedly reduced in animals pretreated with the AMPA/KA antagonist GYKI 52466, and lesions of the ventrobasal thalamus attenuated DOI-elicited Fos expression in the cortex.  These data suggest that DOI activates 5-HT2A receptors on thalamocortical neurons and thereby increases glutamate release, which in turn drives Fos expression in cortical neurons through an AMPA receptor-dependent mechanism.  These data cast new light on the mechanisms of action of hallucinogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuwcdyIu41XLVg90H21EOLACvtfcHk0ljF1XjlPTL_5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpslWg&md5=f277728e0ede8ec3bc29b7782cb0d6bf</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScruggs%26aufirst%3DJ.%2BL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DBubser%26aufirst%3DM.%26aulast%3DDeutch%26aufirst%3DA.%2BY.%26atitle%3DDOI%2520-induced%2520activation%2520of%2520the%2520cortex%253A%2520Dependence%2520on%25205-HT2A%2520heteroceptors%2520on%2520thalamocortical%2520glutamatergic%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2000%26volume%3D20%26spage%3D8846%26epage%3D8852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Marek, G. J.</span><span> </span><span class="NLM_article-title">A novel approach to the identification of psychiatric drugs: Serotonin-glutamate interactions in the prefrontal cortex</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">206</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=206-218&author=G.+J.+Marek&title=A+novel+approach+to+the+identification+of+psychiatric+drugs%3A+Serotonin-glutamate+interactions+in+the+prefrontal+cortex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarek%26aufirst%3DG.%2BJ.%26atitle%3DA%2520novel%2520approach%2520to%2520the%2520identification%2520of%2520psychiatric%2520drugs%253A%2520Serotonin-glutamate%2520interactions%2520in%2520the%2520prefrontal%2520cortex%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2000%26volume%3D6%26spage%3D206%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span> </span><span class="NLM_article-title">Influence of nonspecific brain and plasma binding on CNS exposure: Implications for rational drug discovery</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm101414h&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm101414h&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm101414h&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327-338&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+nonspecific+brain+and+plasma+binding+on+CNS+exposure%3A+Implications+for+rational+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0lgnJjqrJSFlxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520nonspecific%2520brain%2520and%2520plasma%2520binding%2520on%2520CNS%2520exposure%253A%2520Implications%2520for%2520rational%2520drug%2520discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i74"><a href="/doi/suppl/10.1021/jm101414h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_03655"></div></div></div></div></div><hr /></hr><p class="last">X-ray report of (+)-<b>18d</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm101414h/suppl_file/jm101414h_si_001.pdf">jm101414h_si_001.pdf (144.04 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm101414h&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm101414h%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-6%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm101414h" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679933669ff83ddd","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
